1. Introduction {#sec1}
===============

Alzheimer\'s disease (AD) is one of the most prevalent neurodegenerative disorders amongst adults of advanced age, and it is the most common form of dementia and cognitive impairment \[[@B1], [@B2]\]. The behavioral abnormalities in AD result from dysfunction and death of neurons in brain regions involved in cognition and mood, such as the hippocampus, amygdala, and cortical regions. Progressive short-term and eventual long-term memory loss and reduced cognitive capacity are associated with two primary neurodegenerative lesions, that is, extra- and intracellular *β*-amyloid plaques, as well as neurofibrillary tangles (NFTs) composed of the microtubule protein tau \[[@B3]--[@B5]\]. In addition to the effects of amyloid plaques and NFTs, the lipid trafficking molecule, apolipoprotein E4 (apoE4), has also been demonstrated to be a genetic risk factor for AD \[[@B6], [@B7]\]. The AD characteristic extracellular plaques, found in both the hippocampus and cortex of AD patients, consist of 39--42 amino acid long amyloid-*β* (A*β*) peptides. These extracellular peptides are generated by digestion of a transmembrane amyloid precursor protein (APP). Proteolysis of the transmembrane APP by a set of intramembrane enzymes, *β*- (also known as BACE-1) and *γ*-secretases, is thought to be responsible for toxic A*β* creation \[[@B5]\]. The discovery of familial mutations in the APP gene that were strongly correlated with the presentation of AD reinforced the importance of A*β* processing in this disorder. A growing body of evidence indicates that changes in lipid and cholesterol homeostasis can influence AD progression and specifically A*β* production. One of the prime sub cellular regions of amyloidogenic APP processing is thought to be cholesterol-enriched membrane microdomains, termed lipid rafts \[[@B8]\]. Cellular organization of protein signaling complexes, to enhance the magnitude and fidelity of transmembrane signaling receptors, is facilitated by variations in the lipid constituents of the plasma membrane. Lipid rafts represent discontinuous regions of the plasma membrane that form functional microdomains, which constrain the association of proteins in a coherent and advantageous manner with respect to neurotransmissive signaling \[[@B9]\]. Disruption of the correct stoichiometry of signaling complexes within lipid rafts may underpin the etiology of many different neurodegenerative disorders \[[@B10]--[@B12]\]. The hypothesis that changes in the lipid composition of rafts contribute to AD pathology has gained considerable support. For example, ApoE4 has been strongly correlated with the generation of AD symptomatology. Both of the amyloidogenic processing enzymes (*β*- and *γ*-secretase), as well as APP, are all enriched in lipid raft membranes \[[@B13], [@B14]\]. Reinforcing the connection between lipid density levels and A*β* production, increasing cholesterol levels elevate the activity of both *β*-secretase (BACE-1) and *γ*-secretase \[[@B14], [@B15]\]. In addition, ganglioside lipids, which are also enriched in lipid rafts, can control the assembly of amyloid-*β* proteins \[[@B16], [@B17]\]. Changes in ganglioside composition, similar to those noted in human AD patients, are also observed in different transgenic mouse models of AD \[[@B18]\]. In addition to a role of the lipid components of lipid rafts in controlling amyloidogenesis, these raft environments may also affect NFTs as well. It has been demonstrated that A*β* can induce activation of the tyrosine kinase Fyn in neuronal cells, that is then recruited to lipid rafts which catalyzes phosphorylation of tyrosine residue 18 on tau \[[@B19], [@B20]\]. Association of A*β* plaques to lipid rafts can mediate recruitment of excess Fyn to the rafts, as well as further recruitment and phosphorylation of tau. These activities are thought to induce neurotoxicity via the effects of tau-induced changes in the actin cytoskeleton and receptor/cellular signaling pathways \[[@B21]\]. Therefore, the potential changes in the lipid composition of lipid rafts, caused by exposure to cytotoxic activities characteristic to AD, can induce profound changes in cellular signal transduction and thereby induce intracellular changes that lead to the development of AD. The complexity of protein complexes within the lipid raft environments raises considerable challenges to understanding the molecular mechanisms of AD pathophysiology in both the hippocampus and cortex of animals. Therefore, we have employed a shotgun proteomics approach, allied to advanced bioinformatic functional profiling, to gain a broad and detailed appreciation of the alterations in signaling proteins in lipid rafts in the triple-transgenic (3xTgAD) model of AD \[[@B22]\]. Our study demonstrates that cortical lipid rafts are profoundly affected in the 3xTgAD mice and that many of the neurophysiological deficits characteristic of AD (impaired synaptic strength, impaired learning and memory, and increased oxidative stress) can be strongly linked to changes in receptor and cell signaling events in the lipid rafts in these animals. Therefore, the lipid raft environments can be seen as one of the most important pathophysiological loci of this disorder.

2. Methods {#sec2}
==========

2.1. Animals and Morris Water Maze Testing {#sec2.1}
------------------------------------------

Animal care and experimental procedures followed NIH guidelines and were approved by the National Institute on Aging Animal Care, and Use Committee. Experiments were performed using male 3xTgAD \[[@B22]--[@B24]\] and control male C57-BL6 mice that were maintained under a 12-hour light/12-hour dark cycle with continuous access to food and water. Water maze testing took place using a modified version of the methodology described previously \[[@B25]\]. Briefly, animals (*n* = 10 per group, control male C57-BL6 or male 3xTgAD, on a C57-BL6 background) received 8 days of acquisition training using a nonvisible target platform, consisting of four trials per day, with an intertrial interval of approximately 10 minutes. Each trial lasted until the animal found the platform, or for a maximum of 60 seconds; animals that failed to find the platform within 60 seconds were guided there by the experimenter. On each trial, mice were placed into the pool, facing the wall, with start locations varied pseudorandomly. Distance swam to escape the water, escape time, and swim speed were measured for either control or 3xTgAD mice using a HVS2020 automated tracking system (HVS Image, UK).

2.2. Isolation of Lipid Raft Detergent-Resistant Membranes {#sec2.2}
----------------------------------------------------------

The mice were anesthetized with isoflurane, decapitated, and the brain was microdissected on ice. After removal of the cortex, the tissue was split into left and right hemisphere, half for mass spectrometry raft analysis and half to prepare lipid raft tissues for Western blot analysis. The hemicortices were washed twice in ice-cold phosphate buffered saline (PBS) and then transferred into a Tris-saline buffer supplemented with a cocktail of protease and phosphatase inhibitors (50 mM Tris-HCl, 150 mM NaCl, 5 mM EDTA, and Roche Complete-Mini (Roche Diagnostics Inc.) protease and phosphatase inhibitor cocktail, pH 7.4). Crude tissue disruption was then rapidly achieved (at 4°C) using a sonic dismembrator (Fisher Scientific Model 100) followed by a brief centrifugation (4°C, 1000 ×g, 10 minutes) to pellet cell nuclei and unbroken cells. The resultant supernatant was removed and Triton X-100 (Sigma Aldrich, USA) was added to the Tris-saline buffer to a final concentration of 1%. The supernatant membranes were then incubated at 4°C for 60 minutes in the Triton X-100 Tris-saline solution. After incubation, the supernatant solution was then added to a discontinuous gradient of 30% and 60% OptiPrep (Iodixanol, Sigma Aldrich, and U.S.A.) before centrifugation at 200 000 ×g for 16 hours at 4°C. After centrifugation, a detergent-resistant lipid band was evident in the vertical solution column. Multiple fractions of 300 *μ*l volumes were then removed from the vertical centrifugation column. Proteins were then extracted from these fractions using a proprietary ProteoExtract (EMD Biosciences) kit, according to the manufacturer\'s instructions. Isolated protein pellets were then prepared for mass spectrometric analysis.

2.3. Mass Spectrometric Protein Analysis {#sec2.3}
----------------------------------------

Protein pellets were dissolved into an ammonium bicarbonate buffer (100 mM, pH 8.5) and then reduced with dithiothreitol (500 mM: Pierce Biotechnology), alkylated with iodoacetamide (800 mM: Sigma Aldrich) and then digested with modified trypsin (5--10 *μ*g) (Promega) at 37°C for 17 hours. Proteolysis was terminated by the addition of glacial acetic acid. Tryptic peptides were then loaded onto a desalting column (360 × 200 *μ*m fused silica packed with 15 cm of C18 beads (YMC ODS-AQ, Waters)), washed with 0.1% acetic acid and eluted into sample tubes with 80% acetonitrile in 0.1% acetic acid. Sample volume was reduced to usable volumes under vacuum on a Savant SpeedVac. Samples were then transferred onto a PicoFrit (75 × 100 mm) column packed with ProteoPep II C~18~, 300 Å, 5 *μ*m particles (New Objective) connected to a nanoliquid chromatography system (Dionex, Sunnyvale, CA) online with an LTQ ion trap mass spectrometer (Thermo Finnigan, San Jose, CA). The peptides were eluted using a linear gradient of 0--65% acetonitrile over 90 minutes at a flow rate of 250 nl/min directly into the mass spectrometer, which was operated to generate collision-induced dissociation spectra (data-dependent MS/MS mode). The resultant tandem mass spectrometry data were processed using the BioWorks suite, and multiple collected spectra were used to interrogate the NCBI nonredundant mouse and Swiss-Prot protein sequence databases, using the computer algorithm SEQUEST to generate accurate protein identities. Protein genpept accession identities were then converted to Official Gene Symbol terms using NIAID-DAVID v. 6.7 (<http://david.abcc.ncifcrf.gov/>). The statistical analysis and validation of the search results were performed using MASCOT (Matrix Science). For protein identification, a maximum of three missed tryptic cleavages was used, including fixed modification of carbamidomethylation and variable modifications of oxidized methionine and N-terminal glutamine conversion to pyroglutamic acid in the search. Only proteins with at least two validated peptides and a total score 25 and a confidence of identification of at least 95% were considered valid for reporting. Where required, additional spectral counting was performed to determine simplistic relative quantitation in conjunction with the reported number of identified unambiguous peptides per protein. Three lipid raft fraction samples (fractions 2, 3, and 4) from each three control (nontransgenic gender/age matched C57-BL6) or Alzheimer\'s disease (3xTgAD) were pooled and then run in an individual random order. Proteins identified based on two unambiguous peptides that were present in at least two out of the three individual animals were employed for further expression pattern analysis.

2.4. Lipid Raft Band Quantification {#sec2.4}
-----------------------------------

Digitized images of centrifugal vertical fluid columns were obtained using a Canon Digital camera and were converted from Joint Photographic Experts Group (JPG) files to a TIFF (Tagged Image File Format) form using L-Process v. 2.2 (image handling software: Fuji-Film). Image densitometry was then performed using Fuji-Film Image Gauge v. 4.2. Lipid raft band intensity was represented as a relative absorbance unit (AU) value with background (B) subtraction per square pixel (px^2^) (AU-B/px^2^).

2.5. Western Blotting Procedures {#sec2.5}
--------------------------------

For the examination of specific proteins in cortical cell samples (both lipid raft and nonlipid raft), aliquots were removed from centrifugal fractions from [Section 2.2](#sec2.2){ref-type="sec"} and their protein concentration was determined with a standard BCA protocol. Aliquot samples for western blotting analysis were then mixed with an equal volume of Laemmli sample buffer \[[@B26]\]. Samples were resolved using one-dimensional gel electrophoresis (SDS-PAGE), followed by electrotransfer to polyvinylenedifluoride (PVDF: PerkinElmer, Waltham, MA). PVDF membranes were blocked for one hour at room temperature in 4% nonfat milk (Santa Cruz; Santa Cruz, CA) before application of specific primary antisera in the same nonfat milk. The presence of primary antibody reactivity with the PVDF membrane was detected by the application of a 1 : 5000 dilution of a species-specific alkaline phosphatase-conjugated secondary antibody (Sigma, St. Louis, MO). PVDF-bound immune complexes of secondary and primary antibodies were subsequently detected using enzyme-linked chemifluorescence (ECF: GE Healthcare; Pittsburgh, PA). Chemifluorescent signals from the membranes were captured and quantified using a Typhoon 9410 phosphorimager (GE Healthcare, Pittsburgh, PA). Specific primary antisera used were obtained from the following sources: flotillin-1, proline-rich tyrosine kinase 2 (Pyk2), focal adhesion kinase (FAK), G protein-coupled receptor kinase interactor-1 (GIT-1), and paxilin antibodies were obtained from BD Bioscience, San Jose, CA; Janus kinase 2 (Jak2), v-Crk avian sarcoma virus CT10 oncogene homolog (Crk), and insulin receptor substrate-1 (IRS1) antibodies were obtained from Santa Cruz Biotechnology Corporation, CA; caspase-7, FKBP12-rapamycin complex-associated protein 1/mammalian target of rapamycin (FRAP1/mTOR), and Fyn and IGF-1 receptor beta antibodies were obtained from Cell Signaling Technology, Danvers, MA); G protein-regulated inducer of neurite outgrowth 2 (Grin2) antibody was obtained from Sigma Aldrich. For the identification of nonspecific total proteins in each sample the highly sensitive protein dye, SYPRO Ruby (Invitrogen Corporation) was employed. Fixed SDS-PAGE gels were immersed in SYPRO-Ruby for 1 hour and then washed in deionized water before scanning using a Typhoon 9410 phosphorimager (GE Healthcare, Pittsburgh, PA).

2.6. Bioinformatic Analyses {#sec2.6}
---------------------------

Protein identities were converted to standard gene symbol nomenclature for simplicity of usage with the batch conversion tool of NIH Bioinformatics Resources DAVID v. 6.7 (<http://david.abcc.ncifcrf.gov/>). Primary protein sets (containing consistently identified lipid raft extract proteins) were organized into functional signaling pathway groups and then analyzed for their differential significance of population of these canonical signaling pathways. To compare the relative degree of association of specific signaling pathways with the control or 3xTgAD protein sets, the difference between the signaling pathways "hybrid scores" was calculated (control subtracted from 3xTgAD). The magnitude of the "hybrid score" is indicative of strength and significance of association of the input protein set with the specific signaling pathway. Signaling pathway hybrid scores were generated using a process that takes into account the significant population and potential activation of that pathway by multiplying the pathway enrichment *ratio* (percentage of proteins in a designated pathway that were also found in the experimental dataset) and the probability (*P*) that the respective pathway is significantly associated with the experimental dataset. However, to create a simple numerical value, the hybrid pathway score is calculated by multiplication of the *ratio*with the negative log − 10 of the *P* value. Each signaling pathway considered was required to contain at least two unique proteins from either control or 3xTgAD datasets and possess a *P* value of ≤.05. Unbiased network analysis was also performed on subsets of the primary protein sets that were specifically limited to transmembrane receptor proteins. The networks generated create predictions of the most likely functional interactions between proteins in a complex dataset \[[@B27]\]. Networks are created to indicate the most significant series of molecular interactions. The networks with the highest predictive "*scores*" possess the highest number of statistically significant "*focus molecules*": "*focus molecules*" are proteins that are present in the most statistically-likely predicted functional network and are present in the input experimental dataset. The network "*score*" is a numerical value used to rank networks according to their degree of relevance to the input dataset. The "*score*" accounts for the number of experimental focus molecules (proteins) in the network and its size, as well as the total number of proteins in the Ingenuity Knowledge Base that could potentially be included in the specific networks. The network "*score*" is based on the hypergeometric distribution and is calculated with the right-tailed Fisher\'s Exact Test. Specific scientific textual associations between filtered protein sets (transmembrane receptor proteins IPA analysis) and Alzheimer\'s disease processes were created using latent semantic indexing (LSI) algorithms using GeneIndexer (Computable Genomix, Incorporated: <https://www.computablegenomix.com/geneindexer>). GeneIndexer correlates the strength of association between specific factors (proteins) in a dataset with a user-defined interrogation term. GeneIndexer employs a 2010 murine or human database of over 1 × 10^6^ scientific abstracts to perform text-protein correlation analysis. LSI facilitates the specific textual interrogation of an input dataset with a specific term, that is, Alzheimer\'s disease, to ascertain which of the input dataset proteins are explicitly associated with the interrogation term. Using LSI algorithms, not only is the direct interrogation term used to analyze the input dataset but also closely correlated additional terms, implicitly associated with the user-defined interrogation term, are also employed in the search patterns. A latent semantic indexing correlation score indicates the strength of association of the interrogation term and the specific proteins in the dataset. A highly relevant protein-term correlation yields a large number of explicitly/implicitly associated proteins with high LSI correlation scores. Therefore, a strong correlation between the proteins in a dataset and a specific user-defined interrogation term yields a large number of correlated proteins with high LSI correlation scores.

3. Statistical Analysis {#sec3}
=======================

Statistical analysis on multiple samples was performed using a standard nonparametric two-tailed Student\'s *t*-test using 95% confidence limits. Analyses were computed using built-in software in GraphPad Prism v. 3.0a (GraphPad Software Inc., La Jolla, CA). Results are expressed as means ± SE. *P* ≤ .05 was considered statistically significant. For statistical analysis using Ingenuity Pathway Analysis v. 8.5 of signaling pathways and interaction network analysis, Fisher\'s Exact test was employed with a *P* ≤ .05 cutoff. Network interaction scores were generated using a right-tailed Fisher\'s Exact Test.

4. Results {#sec4}
==========

4.1. 3xTgAD Mice Demonstrate Impaired Learning and Memory Ability in the Morris Water Maze {#sec4.1}
------------------------------------------------------------------------------------------

Using the nonvisible Morris water maze trial and 16-month-old male control (C57-BL6) and 3xTgAD animals (*n* = 10 for both) we noted that the 3xTgAD mice demonstrated a significant reduction in their ability to find the location of the hidden platform ([Figure 1](#fig1){ref-type="fig"}). The 3xTgAD mice demonstrated significantly longer escape latencies and distances traveled compared to the control mice, while not showing any significant difference in calculated swim speed. Retention testing (three trials one week after the initial training) of these animals (control and 3xTgAD) also demonstrated a reduced cognitive capacity of the 3xTgAD mice compared to control (data not shown).

4.2. 3xTgAD Mice Demonstrate a Significant Alteration in Lipid Raft Density and Protein Marker Composition {#sec4.2}
----------------------------------------------------------------------------------------------------------

Employment of the lipid raft isolation process described in the Methods section resulted in the clear visible isolation of a detergent-resistant lipid layer comprising centrifugal fractions 2--4 ([Figure 1(a)](#fig1){ref-type="fig"}). The lipid raft marker protein, flotillin-1, was demonstrated to be specifically enriched in these centrifugal fractions (2--4) ([Figure 2(a)](#fig2){ref-type="fig"}). The visual lipid density (absorbance units-background/square pixel) of the raft layers was quantified using Fuji-Film Image Gauge. Compared to control, both 8-month-old ([Figure 2(c)](#fig2){ref-type="fig"}) and 16-month-old ([Figure 2(d)](#fig2){ref-type="fig"}) 3xTgAD-derived centrifugal raft layers demonstrated a significant (8 months old *P* = .027, *n* = 3; 16 months old *P* = .031, *n* = 3) increase in buoyant detergent-insoluble density. This 3xTgAD increase in raft size, compared to control animals, demonstrated a strong association with a significant increase in expression of flotillin-1 in the raft fractions of 3xTgAD mice, especially in centrifugal fraction 2 ([Figure 2(e)](#fig2){ref-type="fig"}, *P* = .017, *n* = 3). Equal levels of total protein (measured using BCA and also SYPRO gel staining) were employed for each Western blot of the raft extracts. Quantification of fraction 2 was chosen, as this reliably indicated the greatest enrichment of this lipid raft marker. Similar quantitative alterations in expression of flotillin-1 between control and 3xTgAD mice were also seen in the additional lipid raft centrifugal fractions, that is, 3 and 4. Qualitatively similar results, with respect to 3xTgAD mouse lipid raft density and flotillin-1 expression were noted in parallel experiments carried out with age-matched female mice. In addition we also noted a similar qualitative lipid raft expression of flotillin-1 trend in male human cortex tissue (data not shown). These latter data and their significance to our current data will be further addressed in subsequent manuscripts.

4.3. Differential Protein Expression in Lipid Rafts Isolated from 3xTgAD Mice Compared to Control Mice {#sec4.3}
------------------------------------------------------------------------------------------------------

Using an un-biased proteomic analysis of replicate lipid raft extracts, we were able to identify (from at least two individual nonambiguous peptides) multiple proteins in both control and 3xTgAD cortical extracts (control, [Appendix A](#sec7){ref-type="sec"}; 3xTgAD, [Appendix B](#sec8){ref-type="sec"}). When comparing the relative differences in lipid raft protein expression, only a small minority (17%: [Figure 3(a)](#fig3){ref-type="fig"}) of identified proteins were substantively identified in both control and 3xTgAD raft samples; however many of these common proteins identified were differentially detected (see Supplementary Table 1 in Supplementary Material available online at doi:10.4061/2010/604792). To verify the relative differential expression of multiple proteins in the control versus 3xTgAD lipid raft extracts, we also performed multiple Western blot analyses of raft centrifugal fraction-2 (F-2) samples. With loading of total equal protein quantities (50 *μ*g: assessed in an unbiased manner with SYPRO-Ruby: [Figure 3(b)](#fig3){ref-type="fig"}) of either control or 3xTgAD F-2 samples, we assessed the relative differential expression of multiple proteins (Figures [3(c)](#fig3){ref-type="fig"}--[3(n)](#fig3){ref-type="fig"}). From the Western blot analysis it was consistently demonstrated that differential qualitative protein detection in control versus 3xTgAD raft samples strongly correlated with differential semiquantitative protein expression. Hence, the absence of consistent MS-based detection of Pyk2 ([Figure 3(d)](#fig3){ref-type="fig"}), Jak2 ([Figure 3(f)](#fig3){ref-type="fig"}), Fyn ([Figure 3(h)](#fig3){ref-type="fig"}), paxilin ([Figure 3(i)](#fig3){ref-type="fig"}), IRS-1 ([Figure 3(j)](#fig3){ref-type="fig"}), caspase 7 ([Figure 3(k)](#fig3){ref-type="fig"}), mTOR/FRAP1 ([Figure 3(l)](#fig3){ref-type="fig"}) and IGF-1R ([Figure 3(n)](#fig3){ref-type="fig"}) in control raft sample correlated to their significantly lower expression in control raft F-2 samples, compared to that in 3xTgAD samples. Conversely, the absence of consistent MS-based detection of FAK ([Figure 3(c)](#fig3){ref-type="fig"}), GIT-1 ([Figure 3(e)](#fig3){ref-type="fig"}), Crk ([Figure 3(g)](#fig3){ref-type="fig"}), and Grin2 ([Figure 3(m)](#fig3){ref-type="fig"}), correlated to their significantly lower expression in 3xTgAD raft F-2 samples, compared to that in control samples.

4.4. Functional Signaling Cluster Analysis of Control versus 3xTgAD Lipid Raft Proteomes {#sec4.4}
----------------------------------------------------------------------------------------

As our MS-based multidimensional protein identification process identified several hundred proteins from each control or 3xTgAD lipid raft sample, we employed a bioinformatic analysis process to assess the relative functionalities of both the control versus 3xTgAD raft protein lists. As the majority of cellular signaling processes are mediated and regulated by multiple groups of proteins interacting with each other, we clustered, in a statistically significant manner, proteins in control or 3xTgAD animal raft samples into functional signaling groups. To assess the relative changes in regulation of classical signaling pathways, we applied a subtractive approach for the pathway "*hybrid*" scores (indicative of the "activity" of the specific signaling pathway: calculated by significant expression enrichment ratio of proteins in that pathway multiplied by the negative log~10~ (−log~10~) of the probability of the pathway enrichment). For each specific common signaling pathway, our mathematical approach subtracted control pathway "hybrid" scores from the pathway "*hybrid*" scores generated from the 3xTgAD protein set. Hence, a positive result of this subtraction indicates a greater activity of this functional pathway in 3xTgAD animals, and a negative score indicates a greater activity of this functional pathway in the control animals. Analysis of pathways involved in cellular signaling ([Figure 4(a)](#fig4){ref-type="fig"}: proteins and scores in associated [Appendix C](#sec9){ref-type="sec"}) demonstrated that pathways commonly associated with cell stress responses were highly activated in 3xTgAD rafts, for example "*p53 signaling*", "*p38 mitogen-activated protein kinase (MAPK) signaling*", and "*stress-activated protein kinase (SAPK)/JNK pathways"*. In a stark contrast, prosurvival synaptic connectivity and neurotransmissive pathways were more profoundly activated in the control mice, for example, "*tight junction signaling"*, "*calcium signaling*", "*PTEN signaling",* and "*Wnt/*β*-catenin signaling"*. To investigate the specific neuronal functional effects of these disparate signaling activities, we next studied the significant clustering of raft proteins into neuron-functional pathways ([Figure 4(b)](#fig4){ref-type="fig"}: [Appendix D](#sec10){ref-type="sec"}). As one would expect, the 3xTgAD mice raft protein clustering revealed a considerably greater (relative to control) activation of multiple neurodegenerative neuronal processes including: "*amyloid processing"*, "*Amyotrophic lateral sclerosis"*, "*Huntington\'s disease signaling*" and "*Parkinson\'s signaling"*. In addition to the greater activation of these degenerative processes, the 3xTgAD mice also demonstrated profound changes in the significant clustering of proteins into cytoskeletal remodeling groups ("*actin cytoskeleton signaling*", *regulation of actin-based motility by Rho\'*) compared to the control mice. In accordance with our demonstration of the significant diminution of the learning and memory ability of the 3xTgAD mice, it was striking to notice the profoundly greater activation of neuron-functional pathways that control synaptic learning-dependent processes (*i.e.,* "*synaptic long-term depression"*, "*axonal guidance signaling"*,and "*synaptic long-term potentiation*") in the control mice compared to the 3xTgAD mice. Considerable evidence from multiple experimental studies has recently underlined the importance of the regulation of energy metabolism in controlling the aging process and neurodegenerative disorders \[[@B28]--[@B30]\]. Upon inspection of the relative differences in the activation of energy-regulatory pathways created by clustering of control raft proteins versus 3xTgAD raft proteins, a profound functional distinction was noted ([Figure 4(c)](#fig4){ref-type="fig"}: [Appendix E](#sec11){ref-type="sec"}). In control animals versus 3xTgAD, there was a considerably stronger activation of energy-generating pathways connected to the use of the primary metabolic substrate, that is, sugars ("*amino sugars metabolism"*, "*glycolysis/gluconeogenesis"*, and "*pentose phosphate pathway"*). In contrast, the energy regulatory pathways that were more strongly associated with the 3xTgAD animals involved energy derivation from alternative energy sources, for example, "*synthesis and degradation of ketone bodies*", "*butanoate metabolism",* and "*fatty acid biosynthesis"*. Many of the alterations in energy regulation in aging and degenerative disorders are thought to be associated with adaptive responses to the induction of cellular stresses, potentially through toxic effects of A*β*, NFTs and accumulated oxidative damage \[[@B30]\]. When the raft proteins from control and 3xTgAD mice were clustered into functional stress response pathways, again a stark contrast in the control- or 3xTgAD-associated pathways was demonstrated ([Figure 4(d)](#fig4){ref-type="fig"}: [Appendix F](#sec12){ref-type="sec"}). In the 3xTgAD mice raft clustering it was noted that the association of energy-associated stressful and neuronal damage-related pathways (*"PPAR*α*/RXR*α* activation"*, "*hypoxia signaling"*, "*apoptosis signaling"*, and "*endoplasmic reticulum stress pathway"*) was considerably stronger than in the control mice. Indicating a correlated connection between stress response capacity and AD pathology, there was a considerably greater association of the "*Nrf2-mediated oxidative stress response pathway*" in control mice compared to the 3xTgAD. Therefore, the 3xTgAD mice may demonstrate excessive neuronal stress and damage due to the attenuated activation of such stress response pathways in lipid rafts of AD synapses.

4.5. Functional Receptor Signaling Cluster Analysis of Control versus 3xTgAD Lipid Raft Proteomes {#sec4.5}
-------------------------------------------------------------------------------------------------

As one of the most important functions of synaptic lipid rafts is to congregate transmembrane or juxtamembrane receptor systems \[[@B31]\], we next performed an in-depth investigation of the significant differential functional clustering of receptor signaling pathways between control and 3xTgAD rafts. Upon functional clustering of the raft proteins into receptor signaling pathways, strong differences in pathways association between control and 3xTgAD mice were noted ([Figure 5](#fig5){ref-type="fig"}: [Appendix G](#sec13){ref-type="sec"}). Some of the strongest differences were noted by the considerably poorer activation of growth factor-related signaling ("*PDGF signaling"*, "*EGF signaling", and "FGF signaling"*), structural trans-synaptic receptor signaling ("*Neuregulin signaling"* and "*Ephrin receptor signaling"*), excitatory signaling (*glutamate receptor signaling*) and neurodevelopmental signaling (*Sonic hedgehog signaling*) pathways in the 3xTgAD mice, compared to the control mice. The receptor signaling profile of the 3xTgAD mice demonstrated a more profound association compared to control mice for pathways linked to inhibitory synaptic signaling ("*GABA receptor signaling*" and "*Aryl hydrocarbon receptor signaling":*\[[@B32]\]), amyloid processing ("*Notch signaling" and "Integrin signaling":*\[[@B33]\]), and neuronal stress (*glucocorticoid receptor signaling*). Transmembrane receptor signaling by systems including receptor tyrosine kinases or G protein-coupled receptors (GPCRs) represents one of the most important signaling mechanisms of neuronal synaptic regulation \[[@B34]\]. However, the activation of transmembrane receptor systems and the stimulation of their intracellular signaling cascades, especially for GPCRs, is now considered to be far more complex and intricate than initially proposed by two-state receptor models \[[@B34], [@B35]\]. Much of this additional signaling diversity is thought to arise from the additional complexity of receptor-accessory scaffolding protein modification of receptor signaling \[[@B35]\]. To appreciate the multiple connections between receptor (and GPCR in particular) activity and the presence of neurophysiological deficits in AD, we performed a multidimensional analysis of the proteins present in control or 3xTgAD mice. Using the novel, un-biased, bioinformatic GeneIndexer latent semantic indexing (LSI) process (<https://www.computablegenomix.com/geneindexer.php>), explicit correlations can be made between protein/gene factors from input datasets and their linkage (in over 1 × 10^6^ curated scientific abstracts) to a specific interrogation term, for example, Alzheimer\'s. The semantic indexing algorithms of GeneIndexer also allow for multidimensional correlations to be measured for terms significantly related to the interrogation term, hence providing a flexible, intelligent query process. For the control and 3xTgAD datasets, we employed multiple interrogation terms targeted to demonstrate differences between control and 3xTgAD datasets. Using the following interrogation terms: Alzheimer\'s, oxidation, neurodegeneration, synaptic transmission, neurogenesis, scaffolding, and GPCR, we demonstrated that, at a multidimensional interactive level, there is minimal functional cross-over between control and 3xTgAD raft samples ([Figure 6](#fig6){ref-type="fig"}: [Appendix H](#sec14){ref-type="sec"}). Only proteins that demonstrated explicit correlations (latent semantic indexing score of ≥0.1) to at least two of the interrogation terms are denoted in the multidimensional heatmap ([Figure 6](#fig6){ref-type="fig"}: [Appendix H](#sec14){ref-type="sec"}). Therefore, each of the proteins identified in the heatmap are strongly correlated with many of the connected interrogation terms and therefore show potential synergistic activity. Analysis of identified proteins in this manner, that is, selected specifically for multidimensional neurological roles, allows for an un-biased focusing on proteins that may possess keystone-like functions in the molecular signaling networks involved in neurodegeneration. With respect to specific interrogation terms, a strong validation of the technique is demonstrated by the fact that using the Alzheimer\'s interrogation term, 47 3xTgAD-unique multidimensional proteins were indicated while only 10 such multidimensional proteins were shown in control rafts ([Figure 6](#fig6){ref-type="fig"}). Confirming a strong role of oxidative damage, 21 3xTgAD-unique multidimensional proteins were present in the oxidation results while only 6 such control-unique were demonstrated. Interestingly and perhaps suggestive of a potential future line of AD research was the observation that considerably fewer multidimensional 3xTgAD-unique proteins were associated with the process of neurogenesis (15), compared to the 32 control-unique multidimensional proteins associated with this neuroprotective mechanism. In accordance with the important role of receptor systems in AD, we additionally noted that more 3xTgAD-unique proteins were associated with GPCRs (27) compared to control-unique GPCR-related multidimensional proteins (16).

4.6. Functional Interaction Networks of Receptor Signaling Proteins in Control versus 3xTgAD Lipid Raft Proteomes {#sec4.6}
-----------------------------------------------------------------------------------------------------------------

From our investigation of the multidimensional nature of raft proteins with respect to neurodegenerative processes, it is clear that there are many factors that are highly likely to work together in complex and intricate functional networks. To investigate the nature of the most statistically likely functional network interactions, we employed IPA network analysis of a receptor-filtered (using IPA-knowledge base data filtering, IPA v. 8,5) subset of the control or 3xTgAD raft protein datasets (Tables [1](#tab1){ref-type="table"} and [2](#tab2){ref-type="table"}, resp.). Using these datasets, un-biased network analysis is able to predict the most likely series of functional interactions (based on empirically derived experimental evidence) that take place between the receptor-associated raft proteins. The control and 3xTgAD receptor-specific filtered datasets demonstrated a relatively minimal overlap, that is, 11.6% commonality, indicating that substantial alterations of these proteins may occur in the rafts of 3xTgAD animals ([Figure 7(a)](#fig7){ref-type="fig"}). The most statistically likely interaction network that was predicted to occur in control mice centered on neuroprotective and neurotransmissive factors such as phosphoinositide-3-kinse (PI3K), Akt-1, muscarinic GPCRs (Chrm5), and glutamate receptors (Grm5) ([Figure 7(a)](#fig7){ref-type="fig"}: [Appendix I](#sec15){ref-type="sec"}). In contrast, the highest statistically scoring network from 3xTgAD receptor-specific proteins was centered on lipid-regulating factors and stress-related factors including: p38 MAPK; Jnk (c-jun N-terminal kinase), Lrpap1 (low-density lipoprotein receptor-related protein associated protein 1); LDL (low density lipoprotein), and NF-*κ*B ([Figure 7(b)](#fig7){ref-type="fig"}: [Appendix J](#sec16){ref-type="sec"}). Therefore, at the level of functional interaction of receptor-related proteins in the lipid rafts, it is clear that these membrane microdomains are a strong functional locus of this degenerative disease. Reinforcing this AD-relevant microcosm effect in the lipid rafts we analyzed, using latent semantic indexing (LSI) interrogation of these receptor-specific datasets ([Table 2](#tab2){ref-type="table"}---control; [Appendix I](#sec15){ref-type="sec"}-3xTgAD), the Alzheimer\'s disease correlation of these receptor-specific proteins. In [Figure 8](#fig8){ref-type="fig"}, we demonstrate that almost twice as many proteins in the 3xTgAD dataset (21) explicitly correlated with the interrogation term Alzheimer\'s disease compared to the proteins in the control dataset (11). The degree of correlation of the interrogation term (Alzheimer\'s) to each specific protein is indicated by the LSI score. In [Figure 8(b)](#fig8){ref-type="fig"} the cumulated LSI score for the 3xTgAD Alzheimer\'s-related proteins was 2.92 while for the control proteins only 1.21 ([Figure 8(b)](#fig8){ref-type="fig"}), demonstrating that a much stronger correlation of receptor-associated proteins existed for the proteins in 3xTgAD rafts, compared to control. Upon comparison of the phylogenetic relationships of the receptor-specific proteins that form the most likely functional networks (from [Figure 7(b)](#fig7){ref-type="fig"}), it is clear that for the control-set proteins only three of these in this network are highly correlated to reports of Alzheimer\'s disease (27.2%: [Figure 8(c)](#fig8){ref-type="fig"}) while the most coherent interaction network of 3xTgAD raft proteins possessed a much higher percentage of Alzheimer\'s disease-related proteins (62%: [Figure 8(d)](#fig8){ref-type="fig"}). Therefore, this suggests that one of the important pathological loci of AD could be the disruption of interactivity of receptor-associated proteins in the lipid raft microdomains and that such a finding can be uncovered in a completely un-biased informatic format from extremely large and difficult to interpret datasets.

5. Discussion {#sec5}
=============

Multiple informatic techniques were employed to investigate and elucidate the nature of functional protein interactions that occur differentially in the lipid raft microdomains of control versus 3xTgAD Alzheimer\'s disease mice. Cognitively impaired male 3xTgAD mice showed profound differences in the protein constituents of lipid raft extracts compared to age-matched control mice, that is, only 17% of raft proteins were similar between the two groups of mice. Our microdomain proteomic approach was able to specifically assist in the identification of altered proteins that are highly characteristic of AD-related raft pathophysiology, for example, the Src-family tyrosine kinase Fyn ([Figure 3(h)](#fig3){ref-type="fig"}) \[[@B19], [@B20]\].

Currently, biological scientists are often faced with complex biological issues concerning the interpretation of their results due to the development of facile mass data acquisition technologies, that is, extracting relevant and illuminating information from large datasets is often extremely challenging. However, with the application of multiple, sequential un-biased informatic processes, we were able to identify specific lipid raft involvement in altered pathways that can control multiple degenerative mechanisms, for example, attenuation of the Wnt/*β*-catenin signaling pathway, profound reduction of the important Nrf2 stress response pathway ([Figure 4(d)](#fig4){ref-type="fig"}), the loss of neurogenesis association, and the important involvement of synaptic GPCR-systems ([Figure 6](#fig6){ref-type="fig"}) in the 3xTgAD mice \[[@B36]--[@B38]\].

Elucidation of the crucial signaling relationships in this degenerative disorder, and the identity of the proteins that mediate them, could lead to the more rational development of novel therapeutics for Alzheimer\'s disease. Using our informatic receptor-targeted approach, we were also able to reinforce the validity of our discovery process by also identifying the importance of energy-related insulin/insulin-like growth factor (IGF) signaling in AD (Figures [3(j)](#fig3){ref-type="fig"}, [3(n)](#fig3){ref-type="fig"}, [5](#fig5){ref-type="fig"}, and [8(d)](#fig8){ref-type="fig"}) that has recently become more widely appreciated by other researchers \[[@B39]--[@B42]\]. In addition to IGF receptor activity, we noted a potential implication of the presynaptic latrophilins (lphn) in AD pathophysiology ([Figure 8(d)](#fig8){ref-type="fig"}). These unique receptors form the high affinity target of *α*-latrotoxin and may be able to integrate presynaptic calcium regulation with an ability to potentially physically interact with the postsynaptic neuron \[[@B43]\]. Another receptor signaling system that our analysis revealed to possess a potential role in AD is the Sonic Hedgehog (Shh) systems (Figures [5](#fig5){ref-type="fig"} and [8(d)](#fig8){ref-type="fig"}). With a specific correlation to AD pathophysiology, it has been demonstrated that Shh can act in a synergistic manner with nerve growth factor to act on central nervous system cholinergic neurons \[[@B44]\], and cholinergic insufficiency has been strongly associated with cognitive decline and Alzheimer\'s-related pathophysiology \[[@B45]\].

6. Conclusions {#sec6}
==============

The combined use of broad range proteomic analysis, with sequential multidimensional informatic analysis enables the determination of important correlations between pathophysiology and functional protein differences. Using discrete proteomes, that is, lipid raft extracts, versus whole-cell/tissue proteomes, facilitates an improved ability to understand the complex interactivity between transmembrane receptor protein systems in a disease setting. The appreciation and clustering of protein datasets into coherent groups greatly increases our capacity to focus upon potentially important therapeutic target networks. The knowledge gained of protein activity networks may greatly assist in the future development of network-targeting therapeutics that possess a multidimensional efficacy at several interacting proteins.

Supplementary Material {#supplementary-material-sec}
======================

###### 

Supplementary Table 1: the table illustrates the top 50 most upregulated and top 50 most downregulated (*italics*) proteins (commonly identified in 3xTgAD and control WT) in 3xTgAD cortical raft extracts compared to WT.

Ranking was based on relative expression ratios generated by spectral counting for 3xTgAD:WT proteins that displayed a \>95% identity confidence.

Proteins ranked 1-50 for 3xTgAD\>WT (increased in 3xTgAD compared to WT) represent those with expression ratios (3xTgAD:WT) greater than unity while proteins ranked 1-50 for WT\>3xTgAD (decreased in 3xTgAD compared to WT: *italics*) represents those with expression ratios (3xTgAD:WT) less than unity. In each case the most up or downregulated proteins are ranked 1.

###### 

Click here for additional data file.

This work was carried out with the support of the Intramural Research Program of the National Institute on Aging, National Institutes of Health. The authors thank Dr. LaFerla for kindly donating 3xTgAD breeding pairs to the National Institute on Aging.

A. {#sec7}
==

Lipid raft-derived extracted proteins from control mouse 16-month-old cortical tissue. Specific proteins isolated from control mouse cortex were identified with multidimensional protein identification technology (MudPIT) LC MS/MS. Each protein was identified in at least two out of three experimental replicate animals and from at least two isolated peptides per protein. The following are the protein symbol and its corresponding definitions.

1.  Atm: ataxia telangiectasia mutated

2.  Bcat1: branched chain aminotransferase 1, cytosolic

3.  Bcl11a: B-cell CLL/lymphoma 11A (zinc finger protein)

4.  Bnip1: BCL2/adenovirus E1B 19 kDa interacting protein 1

5.  Brd2: bromodomain containing 2

6.  Bteb1: Kruppel-like factor 9

7.  Bzrap1: benzodiazepine receptor (peripheral) associated protein 1

8.  C3: complement component 3

9.  C5: complement component 5

10. Cacna1a: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit

11. Cacna1c: calcium channel, voltage-dependent, L type, alpha 1C subunit

12. Cacna2d2: calcium channel, voltage-dependent, alpha 2/delta subunit 2

13. Cadps: Ca++-dependent secretion activator

14. Calb1: calbindin 1, 28 kDa

15. Calb2: calbindin 2

16. Calm2: calmodulin 2 (phosphorylase kinase, delta)

17. Camkk1: calcium/calmodulin-dependent protein kinase kinase 1, alpha

18. Camkk2: calcium/calmodulin-dependent protein kinase kinase 2, beta

19. Cap1: CAP, adenylate cyclase-associated protein 1 (yeast)

20. Cast: calpastatin

21. Cat: catalase

22. Catsper2: cation channel, sperm associated 2

23. Cav1: caveolin 1, caveolae protein, 22 kDa

24. Cblb: Cas-Br-M (murine) ecotropic retroviral transforming sequence b

25. Cbp: opsin 1 (cone pigments), long-wave-sensitive

26. Cbr1: carbonyl reductase 1

27. Cbwd1: COBW domain containing 1

28. Cbx5: chromobox homolog 5 (HP1 alpha homolog, Drosophila)

29. Ccbl1: cysteine conjugate-beta lyase, cytoplasmic

30. Ccin: calicin

31. Ccl28: chemokine (C-C motif) ligand 28

32. Ccl4: chemokine (C-C motif) ligand 4

33. ccnb1: cyclin B1

34. Ccnc: cyclin C

35. Cct2: chaperonin containing TCP1, subunit 2 (beta)

36. Cct3: chaperonin containing TCP1, subunit 3 (gamma)

37. Cct4: chaperonin containing TCP1, subunit 4 (delta)

38. Cct5: chaperonin containing TCP1, subunit 5 (epsilon)

39. Cct6a: chaperonin containing TCP1, subunit 6A (zeta 1)

40. Cd1: ribosomal protein L5

41. Cd151: CD151 molecule (Raph blood group)

42. Cd200: CD200 molecule

43. Cd276: CD276 molecule

44. Cd2ap: CD2-associated protein

45. Cd4: CD4 molecule

46. Cdc10: septin 7

47. Cdc25b: cell division cycle 25 homolog B (S. pombe)

48. Cdc42: cell division cycle 42 (GTP binding protein, 25 kDa)

49. Cdc42bpa: CDC42 binding protein kinase alpha (DMPK-like)

50. Cdc5l: CDC5 cell division cycle 5-like (S. pombe)

51. Cdh1: cadherin 1, type 1, E-cadherin (epithelial)

52. Cdh10: cadherin 10, type 2 (T2-cadherin)

53. Cdh2: cadherin 2, type 1, N-cadherin (neuronal)

54. Cdh4: cadherin 4, type 1, R-cadherin (retinal)

55. Cdk2: cyclin-dependent kinase 2

56. Cdk5rap2: CDK5 regulatory subunit associated protein 2

57. Cdk5rap3: CDK5 regulatory subunit associated protein 3

58. Cdk6: cyclin-dependent kinase 6

59. Cdk7: cyclin-dependent kinase 7

60. Cdkl2: cyclin-dependent kinase-like 2 (CDC2-related kinase)

61. Cdkl3: cyclin-dependent kinase-like 3

62. Cdkn1b: cyclin-dependent kinase inhibitor 1B (p27, Kip1)

63. Cds1: CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1

64. Cdv1: intraflagellar transport 81 homolog (Chlamydomonas)

65. Cebpe: CCAAT/enhancer binding protein (C/EBP), epsilon

66. Cebpz: CCAAT/enhancer binding protein (C/EBP), zeta

67. Celsr2: cadherin, EGF LAG seven-pass G-type receptor 2 (flamingo homolog, Drosophila)

68. Celsr3: cadherin, EGF LAG seven-pass G-type receptor 3 (flamingo homolog, Drosophila)

69. Cend1: cell cycle exit and neuronal differentiation 1

70. Cenpf: centromere protein F, 350/400ka (mitosin)

71. Centa1: ArfGAP with dual PH domains 1

72. Centg1: ArfGAP with GTPase domain, ankyrin repeat and PH domain 2

73. Cep350: centrosomal protein 350 kDa

74. Ces1: carboxylesterase 1 (monocyte/macrophage serine esterase 1)

75. Ces3: carboxylesterase 3

76. Cetn2: centrin, EF-hand protein, 2

77. Cetn3: centrin, EF-hand protein, 3 (CDC31 homolog, yeast)

78. Cfh: complement factor H

79. Cfl1: cofilin 1 (nonmuscle)

80. Chd3: chromodomain helicase DNA binding protein 3

81. Chd4: chromodomain helicase DNA binding protein 4

82. Chga: chromogranin A (parathyroid secretory protein 1)

83. Chl1: cell adhesion molecule with homology to L1CAM (close homolog of L1)

84. Chmp1a: chromatin modifying protein 1A

85. Chn2: chimerin (chimaerin) 2

86. Chrm5: cholinergic receptor, muscarinic 5

87. Chrnb3: cholinergic receptor, nicotinic, beta 3

88. Chrnb4: cholinergic receptor, nicotinic, beta 4

89. Chrng: cholinergic receptor, nicotinic, gamma

90. Chst7: carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7

91. Chx10: visual system homeobox 2

92. Cirbp: cold inducible RNA binding protein

93. Cit: citron (rho-interacting, serine/threonine kinase 21)

94. Cktsf1b1: gremlin 1, cysteine knot superfamily, homolog (Xenopus laevis)

95. Clasp2: cytoplasmic linker associated protein 2

96. Clcc1: chloride channel CLIC-like 1

97. Clcn7: chloride channel 7

98. Cldn1: claudin 1

99. Cldn19: claudin 19

100. Cldn4: claudin 4

101. CLEC10A: C-type lectin domain family 10, member A

102. Clecsf6: C-type lectin domain family 4, member A

103. Clic4: chloride intracellular channel 4

104. CLIP3: CAP-GLY domain containing linker protein 3

105. Clpb: ClpB caseinolytic peptidase B homolog (E. coli)

106. Clstn1: calsyntenin 1

107. Cltb: clathrin, light chain (Lcb)

108. Cndp2: CNDP dipeptidase 2 (metallopeptidase M20 family)

109. Cnga1: cyclic nucleotide gated channel alpha 1

110. Cnga4: cyclic nucleotide gated channel alpha 4

111. Cnksr2: connector enhancer of kinase suppressor of Ras 2

112. Cnot6: CCR4-NOT transcription complex, subunit 6

113. Cnp: 2^\'^,3^\'^-cyclic nucleotide 3^\'^ phosphodiesterase

114. Cnr1: cannabinoid receptor 1 (brain)

115. Cntfr: ciliary neurotrophic factor receptor

116. Cntn1: contactin 1

117. Cog3: component of oligomeric golgi complex 3

118. Colm: gliomedin

119. Copa: coatomer protein complex, subunit alpha

120. Copb1: coatomer protein complex, subunit beta 1

121. COPB2: coatomer protein complex, subunit beta 2 (beta prime)

122. Cops4: COP9 constitutive photomorphogenic homolog subunit 4 (Arabidopsis)

123. Cops8: COP9 constitutive photomorphogenic homolog subunit 8 (Arabidopsis)

124. Coro1a: coronin, actin binding protein, 1A

125. Coro7: coronin 7

126. Cp: ceruloplasmin (ferroxidase)

127. Cpe: carboxypeptidase E

128. Cplx1: complexin 1

129. Cpt1a: carnitine palmitoyltransferase 1A (liver)

130. Cpt2: carnitine palmitoyltransferase 2

131. Crabp2: cellular retinoic acid binding protein 2

132. Crhbp: corticotropin releasing hormone binding protein

133. Crip2: cysteine-rich protein 2

134. Crk: v-crk sarcoma virus CT10 oncogene homolog (avian)

135. Crkl: v-crk sarcoma virus CT10 oncogene homolog (avian)-like

136. Crmp1: collapsin response mediator protein 1

137. Crnkl1: crooked neck pre-mRNA splicing factor-like 1 (Drosophila)

138. Crp: C-reactive protein, pentraxin-related

139. Cry1: cryptochrome 1 (photolyase-like)

140. Crygc: crystallin, gamma C

141. Crygs: crystallin, gamma S

142. Crym: crystallin, mu

143. Cs: citrate synthase

144. Csf1: colony stimulating factor 1 (macrophage)

145. Csnk1e: casein kinase 1, epsilon

146. Csnk1g2: casein kinase 1, gamma 2

147. Csnk2a1: casein kinase 2, alpha 1 polypeptide

148. Csnk2b: casein kinase 2, beta polypeptide

149. Cspg2: versican

150. Cspg3: neurocan

151. Cspg5: chondroitin sulfate proteoglycan 5 (neuroglycan C)

152. Cspg6: structural maintenance of chromosomes 3

153. Cst6: cystatin E/M

154. Cstb: cystatin B (stefin B)

155. Ctf1: cardiotrophin 1

156. Cthrc1: collagen triple helix repeat containing 1

157. Ctla4: cytotoxic T-lymphocyte-associated protein 4

158. Ctnnb1: catenin (cadherin-associated protein), beta 1, 88 kDa

159. Ctnnd2: catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein)

160. Ctrb: chymotrypsinogen B1

161. Ctrl: chymotrypsin-like

162. Ctsd: cathepsin D

163. Cttn: cortactin

164. Cttnbp2: cortactin binding protein 2

165. Cul1: cullin 1

166. Cul5: cullin 5

167. Cuta: cutA divalent cation tolerance homolog (E. coli)

168. Cutl1: cut-like homeobox 1

169. CX3CL1: chemokine (C-X3-C motif) ligand 1

170. Cxadr: coxsackie virus and adenovirus receptor

171. Cxcl2: chemokine (C-X-C motif) ligand 2

172. Cyb5: cytochrome b5 type A (microsomal)

173. Cyb5b: cytochrome b5 type B (outer mitochondrial membrane)

174. Cyb5r1: cytochrome b5 reductase 1

175. Cybb: cytochrome b-245, beta polypeptide

176. Cyln2: CAP-GLY domain containing linker protein 2

177. Cyp2s1: cytochrome P450, family 2, subfamily S, polypeptide 1

178. Cyr61: cysteine-rich, angiogenic inducer, 61

179. Dab2: disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila)

180. Dab2ip: DAB2 interacting protein

181. Dad1: defender against cell death 1

182. Dag1: dystroglycan 1 (dystrophin-associated glycoprotein 1)

183. Dap: death-associated protein

184. Dapk3: death-associated protein kinase 3

185. Dbc1: deleted in bladder cancer 1

186. DBH: dopamine beta-hydroxylase (dopamine beta-monooxygenase)

187. Dbn1: drebrin 1

188. Dbndd2: dysbindin (dystrobrevin binding protein 1) domain containing 2

189. Dbnl: drebrin-like

190. Dcd: dermcidin

191. Dci: dodecenoyl-Coenzyme A delta isomerase (3,2 trans-enoyl-Coenzyme A isomerase)

192. Dclk2: doublecortin-like kinase 2

193. Dclre1c: DNA cross-link repair 1C (PSO2 homolog, S. cerevisiae)

194. Dctn2: dynactin 2 (p50)

195. Ddah2: dimethylarginine dimethylaminohydrolase 2

196. Ddb1: damage-specific DNA binding protein 1, 127 kDa

197. Ddn: dendrin

198. Ddost: dolichyl-diphosphooligosaccharide-protein glycosyltransferase

199. Ddr2: discoidin domain receptor tyrosine kinase 2

200. Ddt: D-dopachrome tautomerase

201. Ddx1: DEAD (Asp-Glu-Ala-Asp) box polypeptide 1

202. Ddx17: DEAD (Asp-Glu-Ala-Asp) box polypeptide 17

203. Ddx47: DEAD (Asp-Glu-Ala-Asp) box polypeptide 47

204. Ddx5: DEAD (Asp-Glu-Ala-Asp) box polypeptide 5

205. Decr1: 2,4-dienoyl CoA reductase 1, mitochondrial

206. Des: desmin

207. Dgcr14: DiGeorge syndrome critical region gene 14

208. Dgkb: diacylglycerol kinase, beta 90 kDa

209. Dgkg: diacylglycerol kinase, gamma 90 kDa

210. Dhcr7: 7-dehydrocholesterol reductase

211. Dhodh: dihydroorotate dehydrogenase

212. Dhrs8: hydroxysteroid (17-beta) dehydrogenase 11

213. Dhx16: DEAH (Asp-Glu-Ala-His) box polypeptide 16

214. Dhx30: DEAH (Asp-Glu-Ala-His) box polypeptide 30

215. Dia1: cytochrome b5 reductase 3

216. Dio1: deiodinase, iodothyronine, type I

217. Disc1: disrupted in schizophrenia 1

218. Dkc1: dyskeratosis congenita 1, dyskerin

219. Dlat: dihydrolipoamide S-acetyltransferase

220. Dlc1: deleted in liver cancer 1

221. Dld: dihydrolipoamide dehydrogenase

222. Dlgap1: discs, large (Drosophila) homolog-associated protein 1

223. Dlgap2: discs, large (Drosophila) homolog-associated protein 2

224. Dlgap4: discs, large (Drosophila) homolog-associated protein 4

225. Dll1: delta-like 1 (Drosophila)

226. Dll3: delta-like 3 (Drosophila)

227. Dlx5: distal-less homeobox 5

228. Dmd: dystrophin

229. Dmn: synemin, intermediate filament protein

230. Dmrt1: doublesex and mab-3 related transcription factor 1

231. Dnah6: dynein, axonemal, heavy chain 6

232. Dnaja2: DnaJ (Hsp40) homolog, subfamily A, member 2

233. Dnch1: dynein, cytoplasmic 1, heavy chain 1

234. Dncl2a: dynein, light chain, roadblock-type 1

235. Dntt: deoxynucleotidyltransferase, terminal

236. Dock9: dedicator of cytokinesis 9

237. Dpp3: dipeptidyl-peptidase 3

238. Dpyd: dihydropyrimidine dehydrogenase

239. Dpysl3: dihydropyrimidinase-like 3

240. Dpysl4: dihydropyrimidinase-like 4

241. Drd1ip: calcyon neuron-specific vesicular protein

242. Drg1: developmentally regulated GTP binding protein 1

243. Drpla: atrophin 1

244. Dscam: Down syndrome cell adhesion molecule

245. Dscr1l1: regulator of calcineurin 2

246. Dtnb: dystrobrevin, beta

247. Duox1: dual oxidase 1

248. Dusp12: dual specificity phosphatase 12

249. Dusp2: dual specificity phosphatase 2

250. Dvl1: dishevelled, dsh homolog 1 (Drosophila)

251. Dync1h1: dynein, cytoplasmic 1, heavy chain 1

252. Dync1li2: dynein, cytoplasmic 1, light intermediate chain 2

253. Dyx1c1: dyslexia susceptibility 1 candidate 1

254. Eaf2: ELL associated factor 2

255. Ecel1: endothelin converting enzyme-like 1

256. Echdc1: enoyl Coenzyme A hydratase domain containing 1

257. Ecm1: extracellular matrix protein 1

258. Ecm2: extracellular matrix protein 2, female organ and adipocyte specific

259. Edf1: endothelial differentiation-related factor 1

260. Ednrb: endothelin receptor type B

261. Eef2: eukaryotic translation elongation factor 2

262. Efcbp1: N-terminal EF-hand calcium binding protein 1

263. Efemp2: EGF-containing fibulin-like extracellular matrix protein 2

264. Efnb1: ephrin-B1

265. Egf: epidermal growth factor (beta-urogastrone)

266. Egfl3: multiple EGF-like-domains 6

267. Egfr: epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)

268. Ehd2: EH-domain containing 2

269. Ehd4: EH-domain containing 4

270. Eif2c2: eukaryotic translation initiation factor 2C, 2

271. Eif5b: eukaryotic translation initiation factor 5B

272. Elac2: elaC homolog 2 (E. coli)

273. Elavl3: ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C)

274. ELK1: ELK1, member of ETS oncogene family

275. Elmo1: engulfment and cell motility 1

276. Emb: embigin homolog (mouse)

277. Emd: emerin

278. Eml5: echinoderm microtubule associated protein like 5

279. Enah: enabled homolog (Drosophila)

280. Enc1: ectodermal-neural cortex (with BTB-like domain)

281. Eno2: enolase 2 (gamma, neuronal)

282. Eno3: enolase 3 (beta, muscle)

283. Enpp2: ectonucleotide pyrophosphatase/phosphodiesterase 2

284. Enpp3: ectonucleotide pyrophosphatase/phosphodiesterase 3

285. Enpp5: ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative function)

286. Ensa: endosulfine alpha

287. Entpd2: ectonucleoside triphosphate diphosphohydrolase 2

288. Entpd8: ectonucleoside triphosphate diphosphohydrolase 8

289. Epha3: EPH receptor A3

290. Epha5: EPH receptor A5

291. Epha7: EPH receptor A7

292. Ephb3: EPH receptor B3

293. Ephx1: epoxide hydrolase 1, microsomal (xenobiotic)

294. Epn1: epsin 1

295. Eprs: glutamyl-prolyl-tRNA synthetase

296. Eps8l1: EPS8-like 1

297. Erap1: endoplasmic reticulum aminopeptidase 1

298. Erbb3: v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)

299. Erbb4: v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)

300. Ercc5: excision repair cross-complementing rodent repair deficiency, complementation group 5

301. Erp29: endoplasmic reticulum protein 29

302. Esd: esterase D/formylglutathione hydrolase

303. Esr2: estrogen receptor 2 (ER beta)

304. Etfb: electron-transfer-flavoprotein, beta polypeptide

305. Ets1: v-ets erythroblastosis virus E26 oncogene homolog 1 (avian)

306. Evl: Enah/Vasp-like

307. Exoc5: exocyst complex component 5

308. Exoc7: exocyst complex component 7

309. Ezr: ezrin

310. Fabp1: fatty acid binding protein 1, liver

311. Fabp2: fatty acid binding protein 2, intestinal

312. Fabp3: fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor)

313. Fabp4: fatty acid binding protein 4, adipocyte

314. Fabp7: fatty acid binding protein 7, brain

315. Fads1: fatty acid desaturase 1

316. Fads2: fatty acid desaturase 2

317. Faim: Fas apoptotic inhibitory molecule

318. Fancd2: Fanconi anemia, complementation group D2

319. Faslg: Fas ligand (TNF superfamily, member 6)

320. Fasn: fatty acid synthase

321. Fat: FAT tumor suppressor homolog 1 (Drosophila)

322. Fat3: FAT tumor suppressor homolog 3 (Drosophila)

323. Fbn1: fibrillin 1

324. Fbn2: fibrillin 2

325. Fbxw11: F-box and WD repeat domain containing 11

326. Fetub: fetuin B

327. FGA: fibrinogen alpha chain

328. Fgb: fibrinogen beta chain

329. Fgf18: fibroblast growth factor 18

330. Fgf23: fibroblast growth factor 23

331. Fgfr1: fibroblast growth factor receptor 1

332. Fgfr1op2: FGFR1 oncogene partner 2

333. Fgfr2: fibroblast growth factor receptor 2

334. Fgfr3: fibroblast growth factor receptor 3

335. Fhl1: four and a half LIM domains 1

336. Fignl1: fidgetin-like 1

337. Fip1l1: FIP1 like 1 (S. cerevisiae)

338. Fkbp14: FK506 binding protein 14, 22 kDa

339. Fkbp1b: FK506 binding protein 1B, 12.6 kDa

340. Fkbp5: FK506 binding protein 5

341. Flg: filaggrin

342. Flii: flightless I homolog (Drosophila)

343. Fmo3: flavin containing monooxygenase 3

344. Fnta: farnesyltransferase, CAAX box, alpha

345. Fos: FBJ murine osteosarcoma viral oncogene homolog

346. Fpgt: fucose-1-phosphate guanylyltransferase

347. Freq: frequenin homolog (Drosophila)

348. Fshr: follicle stimulating hormone receptor

349. Fthfd: aldehyde dehydrogenase 1 family, member L1

350. Fuca1: fucosidase, alpha-L-1, tissue

351. fut10: fucosyltransferase 10 (alpha (1,3) fucosyltransferase)

352. Fxc1: fracture callus 1 homolog (rat)

353. Fxyd6: FXYD domain containing ion transport regulator 6

354. Fzd9: frizzled homolog 9 (Drosophila)

355. Gaa: glucosidase, alpha; acid

356. Gabarap: GABA(A) receptor-associated protein

357. Gabarapl2: GABA(A) receptor-associated protein-like 2

358. Gabbr1: gamma-aminobutyric acid (GABA) B receptor, 1

359. Gabra3: gamma-aminobutyric acid (GABA) A receptor, alpha 3

360. Gabrg2: gamma-aminobutyric acid (GABA) A receptor, gamma 2

361. Gabrr3: gamma-aminobutyric acid (GABA) receptor, rho 3

362. Gadd45a: growth arrest and DNA-damage-inducible, alpha

363. Galc: galactosylceramidase

364. Galk1: galactokinase 1

365. Galt: galactose-1-phosphate uridylyltransferase

366. Gapdh: glyceraldehyde-3-phosphate dehydrogenase

367. Gars: glycyl-tRNA synthetase

368. Gas6: growth arrest-specific 6

369. Gas7: growth arrest-specific 7

370. Gata2: GATA binding protein 2

371. Gata3: GATA binding protein 3

372. GC: group-specific component (vitamin D binding protein)

373. Gc: group-specific component (vitamin D binding protein)

374. Gcgr: glucagon receptor

375. Gckr: glucokinase (hexokinase 4) regulator

376. Gclc: glutamate-cysteine ligase, catalytic subunit

377. Gcnt3: glucosaminyl (N-acetyl) transferase 3, mucin type

378. Gdap2: ganglioside induced differentiation associated protein 2

379. Gdi1: GDP dissociation inhibitor 1

380. Gdi2: GDP dissociation inhibitor 2

381. Gfap: glial fibrillary acidic protein

382. Gfpt2: glutamine-fructose-6-phosphate transaminase 2

383. Gfra1: GDNF family receptor alpha 1

384. Gfra3: GDNF family receptor alpha 3

385. Ggt1: gamma-glutamyltransferase 1

386. Ggtl3: gamma-glutamyltransferase 7

387. Ggtla1: gamma-glutamyltransferase 5

388. Ghitm: growth hormone inducible transmembrane protein

389. Gif: gastric intrinsic factor (vitamin B synthesis)

390. Gipc1: GIPC PDZ domain containing family, member 1

391. Git1: G protein-coupled receptor kinase interacting ArfGAP 1

392. Gja1: gap junction protein, alpha 1, 43 kDa

393. Gja10: gap junction protein, alpha 10, 62 kDa

394. Gja4: gap junction protein, alpha 4, 37 kDa

395. Gjb6: gap junction protein, beta 6, 30 kDa

396. Gla: galactosidase, alpha

397. Gldc: glycine dehydrogenase (decarboxylating)

398. Glg1: golgi apparatus protein 1

399. Gli: GLI family zinc finger 1

400. Glo1: glyoxalase I

401. Glra2: glycine receptor, alpha 2

402. Glrx2: glutaredoxin 2

403. Glud1: glutamate dehydrogenase 1

404. Glul: glutamate-ammonia ligase (glutamine synthetase)

405. Gm2a: GM2 ganglioside activator

406. Gmcl1: germ cell-less homolog 1 (Drosophila)

407. Gmfb: glia maturation factor, beta

408. Gmfg: glia maturation factor, gamma

409. Gmpr2: guanosine monophosphate reductase 2

410. Gng7: guanine nucleotide binding protein (G protein), gamma 7

411. Gnpat: glyceronephosphate O-acyltransferase

412. Gns: glucosamine (N-acetyl)-6-sulfatase

413. Golga2: golgi autoantigen, golgin subfamily a, 2

414. Golgb1: golgin B1, golgi integral membrane protein

415. Golph3: golgi phosphoprotein 3 (coat-protein)

416. Golph4: golgi integral membrane protein 4

417. Gosr2: golgi SNAP receptor complex member 2

418. Got1: glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)

419. Got2: glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2)

420. Gpam: glycerol-3-phosphate acyltransferase, mitochondrial

421. Gpc2: glypican 2

422. Gpi: glucose phosphate isomerase

423. Gpm6a: glycoprotein M6A

424. Gpr116: G protein-coupled receptor 116

425. Gpr141: G protein-coupled receptor 141

426. Gprc6a: G protein-coupled receptor, family C, group 6, member A

427. Gpsm1: G-protein signaling modulator 1 (AGS3-like, C. elegans)

428. Gpt: glutamic-pyruvate transaminase (alanine aminotransferase)

429. Gramd1a: GRAM domain containing 1A

430. Grasp: GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein

431. Grem1: gremlin 1, cysteine knot superfamily, homolog (Xenopus laevis)

432. Gria1: glutamate receptor, ionotropic, AMPA 1

433. Grid2: glutamate receptor, ionotropic, delta 2

434. Grik1: glutamate receptor, ionotropic, kainate 1

435. Grik4: glutamate receptor, ionotropic, kainate 4

436. Grin2a: glutamate receptor, ionotropic, N-methyl D-aspartate 2A

437. Grin2b: glutamate receptor, ionotropic, N-methyl D-aspartate 2B

438. Grip1: glutamate receptor interacting protein 1

439. Gripap1: GRIP1 associated protein 1

440. Grk4: G protein-coupled receptor kinase 4

441. Grk5: G protein-coupled receptor kinase 5

442. Grk6: G protein-coupled receptor kinase 6

443. Grm4: glutamate receptor, metabotropic 4

444. Grm5: glutamate receptor, metabotropic 5

445. Grpel1: GrpE-like 1, mitochondrial (E. coli)

446. Gstk1: glutathione S-transferase kappa 1

447. Gstm2: glutathione S-transferase mu 2 (muscle)

448. Gsto1: glutathione S-transferase omega 1

449. Gtf2ird1: GTF2I repeat domain containing 1

450. Gtpbp4: GTP binding protein 4

451. Gucy1a2: guanylate cyclase 1, soluble, alpha 2

452. Gucy1a3: guanylate cyclase 1, soluble, alpha 3

453. Gucy1b2: guanylate cyclase 1, soluble, beta 2

454. Gucy2d: guanylate cyclase 2D, membrane (retina-specific)

455. Gulp1: GULP, engulfment adaptor PTB domain containing 1

456. Haao: 3-hydroxyanthranilate 3,4-dioxygenase

457. Itpka: inositol 1,4,5-trisphosphate 3-kinase A

458. Khdrbs2: KH domain containing, RNA binding, signal transduction associated 2

459. Kpnb1: karyopherin (importin) beta 1

460. Lamp2: lysosomal-associated membrane protein 2

461. Ncstn: nicastrin

462. Nedd4l: neural precursor cell expressed, developmentally down-regulated 4-like

463. Nip7: nuclear import 7 homolog (S. cerevisiae)

464. Nnat: neuronatin

465. Nos1: nitric oxide synthase 1 (neuronal)

466. Nox1: NADPH oxidase 1

467. Npepps: aminopeptidase puromycin sensitive

468. Nr1h3: nuclear receptor subfamily 1, group H, member 3

469. Nr1i2: nuclear receptor subfamily 1, group I, member 2

470. Nr6a1: nuclear receptor subfamily 6, group A, member 1

471. Nrcam: neuronal cell adhesion molecule

472. Nrd1: nardilysin (N-arginine dibasic convertase)

473. Ntn1: netrin 1

474. Nucb2: nucleobindin 2

475. Nudc: nuclear distribution gene C homolog (A. nidulans)

476. Nup35: nucleoporin 35 kDa

477. Nup54: nucleoporin 54 kDa

478. Nup98: nucleoporin 98 kDa

479. Oaz1: ornithine decarboxylase antizyme 1

480. Ocrl: oculocerebrorenal syndrome of Lowe

481. Oit3: oncoprotein induced transcript 3

482. Olfm2: olfactomedin 2

483. Opa1: optic atrophy 1 (autosomal dominant)

484. Oplah: 5-oxoprolinase (ATP-hydrolysing)

485. Oprd1: opioid receptor, delta 1

486. Orc4l: origin recognition complex, subunit 4-like (yeast)

487. Osmr: oncostatin M receptor

488. Oxr1: oxidation resistance 1

489. P2rx7: purinergic receptor P2X, ligand-gated ion channel, 7

490. P4hb: prolyl 4-hydroxylase, beta polypeptide

491. Pa2g4: proliferation-associated 2G4, 38 kDa

492. Pabpc4: poly(A) binding protein, cytoplasmic 4 (inducible form)

493. Pace4: proprotein convertase subtilisin/kexin type 6

494. Pacs1: phosphofurin acidic cluster sorting protein 1

495. Pafah1b2: platelet-activating factor acetylhydrolase, isoform Ib, subunit 2 (30 kDa)

496. Pafah1b3: platelet-activating factor acetylhydrolase, isoform Ib, subunit 3 (29 kDa)

497. Pak1: p21 protein (Cdc42/Rac)-activated kinase 1

498. Pak2: p21 protein (Cdc42/Rac)-activated kinase 2

499. Pak3: p21 protein (Cdc42/Rac)-activated kinase 3

500. Palm: paralemmin

501. Pamci: Ras association (RalGDS/AF-6) domain family (N-terminal) member 9

502. Panx1: pannexin 1

503. Panx2: pannexin 2

504. Pard3: par-3 partitioning defective 3 homolog (C. elegans)

505. Parg: poly (ADP-ribose) glycohydrolase

506. Park7: Parkinson disease (autosomal recessive, early onset) 7

507. Pawr: PRKC, apoptosis, WT1, regulator

508. Pax3: paired box 3

509. Pbp: phosphatidylethanolamine binding protein 1

510. Pc: pyruvate carboxylase

511. Pcca: propionyl Coenzyme A carboxylase, alpha polypeptide

512. Pcdh21: protocadherin 21

513. Pcdh7: protocadherin 7

514. Pcdha3: protocadherin alpha 3

515. Pcdhb1: protocadherin beta 1

516. Pck1: phosphoenolpyruvate carboxykinase 1 (soluble)

517. Pclo: piccolo (presynaptic cytomatrix protein)

518. Pcm1: pericentriolar material 1

519. Pcmt1: protein-L-isoaspartate (D-aspartate) O-methyltransferase

520. PCNT: pericentrin

521. Pcnx: pecanex homolog (Drosophila)

522. Pcnxl3: pecanex-like 3 (Drosophila)

523. Pcsk1: proprotein convertase subtilisin/kexin type 1

524. Pcsk1n: proprotein convertase subtilisin/kexin type 1 inhibitor

525. Pcsk5: proprotein convertase subtilisin/kexin type 5

526. Pcyox1: prenylcysteine oxidase 1

527. Pcyt1b: phosphate cytidylyltransferase 1, choline, beta

528. Pdap1: PDGFA associated protein 1

529. Pdc: phosducin

530. Pdcd2: programmed cell death 2

531. Pdcl: phosducin-like

532. Pde10a: phosphodiesterase 10A

533. Pde1a: phosphodiesterase 1A, calmodulin-dependent

534. Pde1c: phosphodiesterase 1C, calmodulin-dependent 70 kDa

535. Pde4a: phosphodiesterase 4A, cAMP-specific (phosphodiesterase E2 dunce homolog, Drosophila)

536. Pde4b: phosphodiesterase 4B, cAMP-specific (phosphodiesterase E4 dunce homolog, Drosophila)

537. Pde4d: phosphodiesterase 4D, cAMP-specific (phosphodiesterase E3 dunce homolog, Drosophila)

538. Pde5a: phosphodiesterase 5A, cGMP-specific

539. Pde7a: phosphodiesterase 7A

540. Pde7b: phosphodiesterase 7B

541. Pdgfra: platelet-derived growth factor receptor, alpha polypeptide

542. Pdhb: pyruvate dehydrogenase (lipoamide) beta

543. Pdia3: protein disulfide isomerase family A, member 3

544. Pdia4: protein disulfide isomerase family A, member 4

545. Pdk4: pyruvate dehydrogenase kinase, isozyme 4

546. Pdlim7: PDZ and LIM domain 7 (enigma)

547. Pds5b: PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae)

548. Pdzd3: PDZ domain containing 3

549. Pepd: peptidase D

550. Per3: period homolog 3 (Drosophila)

551. Pex14: peroxisomal biogenesis factor 14

552. Pfkl: phosphofructokinase, liver

553. Pfkm: phosphofructokinase, muscle

554. Pfkp: phosphofructokinase, platelet

555. Pgam1: phosphoglycerate mutase 1 (brain)

556. PGAP1: post-GPI attachment to proteins 1

557. Pgd: phosphogluconate dehydrogenase

558. Pgf: placental growth factor

559. Pgk1: phosphoglycerate kinase 1

560. Pgm1: phosphoglucomutase 1

561. Pgr: progesterone receptor

562. Pgrmc1: progesterone receptor membrane component 1

563. Phactr1: phosphatase and actin regulator 1

564. Phactr3: phosphatase and actin regulator 3

565. Phb: prohibitin

566. Phex: phosphate regulating endopeptidase homolog, X-linked

567. Phgdh: phosphoglycerate dehydrogenase

568. Phip: pleckstrin homology domain interacting protein

569. Phtf1: putative homeodomain transcription factor 1

570. Phyhipl: phytanoyl-CoA 2-hydroxylase interacting protein-like

571. Pi4ka: phosphatidylinositol 4-kinase, catalytic, alpha

572. Picalm: phosphatidylinositol binding clathrin assembly protein

573. Pigq: phosphatidylinositol glycan anchor biosynthesis, class Q

574. Pigs: phosphatidylinositol glycan anchor biosynthesis, class S

575. Pik3cg: phosphoinositide-3-kinase, catalytic, gamma polypeptide

576. Pip5k1a: phosphatidylinositol-4-phosphate 5-kinase, type I, alpha

577. Pip5k1c: phosphatidylinositol-4-phosphate 5-kinase, type I, gamma

578. Pip5k2a: phosphatidylinositol-5-phosphate 4-kinase, type II, alpha

579. Pip5k2c: phosphatidylinositol-5-phosphate 4-kinase, type II, gamma

580. Pipox: pipecolic acid oxidase

581. Pitpn: phosphatidylinositol transfer protein, alpha

582. Pkd1: polycystic kidney disease 1 (autosomal dominant)

583. Pkia: protein kinase (cAMP-dependent, catalytic) inhibitor alpha

584. Pkm2: pyruvate kinase, muscle

585. Pla2g4c: phospholipase A2, group IVC (cytosolic, calcium-independent)

586. Plaa: phospholipase A2-activating protein

587. Plau: plasminogen activator, urokinase

588. Plcb1: phospholipase C, beta 1 (phosphoinositide-specific)

589. Plcl1: phospholipase C-like 1

590. Pld3: phospholipase D family, member 3

591. Plekha4: pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4

592. Plekhe1: PH domain and leucine rich repeat protein phosphatase 1

593. Plekhm1: pleckstrin homology domain containing, family M (with RUN domain) member 1

594. Plg: plasminogen

595. Plk1: polo-like kinase 1 (Drosophila)

596. Plrg1: pleiotropic regulator 1 (PRL1 homolog, Arabidopsis)

597. Plunc: palate, lung and nasal epithelium associated

598. Plvap: plasmalemma vesicle associated protein

599. Plxnb2: plexin B2

600. Pmpca: peptidase (mitochondrial processing) alpha

601. Pmvk: phosphomevalonate kinase

602. Pnliprp2: pancreatic lipase-related protein 2

603. Pnma1: paraneoplastic antigen MA1

604. Pno1: partner of NOB1 homolog (S. cerevisiae)

605. Pnpla2: patatin-like phospholipase domain containing 2

606. Pofut1: protein O-fucosyltransferase 1

607. Pon2: paraoxonase 2

608. Pon3: paraoxonase 3

609. Pop7: processing of precursor 7, ribonuclease P/MRP subunit (S. cerevisiae)

610. Por: P450 (cytochrome) oxidoreductase

611. Pou2f2: POU class 2 homeobox 2

612. Ppfia3: protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein, alpha 3

613. Ppgb: cathepsin A

614. Ppib: peptidylprolyl isomerase B (cyclophilin B)

615. Ppid: peptidylprolyl isomerase D

616. Ppil3: peptidylprolyl isomerase (cyclophilin)-like 3

617. Ppm2c: pyruvate dehydrogenase phosphatase catalytic subunit 1

618. Ppp1r10: protein phosphatase 1, regulatory (inhibitor) subunit 10

619. Ppp1r14b: protein phosphatase 1, regulatory (inhibitor) subunit 14B

620. Ppp1r14d: protein phosphatase 1, regulatory (inhibitor) subunit 14D

621. Ppp1r1a: protein phosphatase 1, regulatory (inhibitor) subunit 1A

622. Ppp1r7: protein phosphatase 1, regulatory (inhibitor) subunit 7

623. Ppp1r8: protein phosphatase 1, regulatory (inhibitor) subunit 8

624. Ppp1r9a: protein phosphatase 1, regulatory (inhibitor) subunit 9A

625. Ppp1r9b: protein phosphatase 1, regulatory (inhibitor) subunit 9B

626. Ppp2cb: protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform

627. Ppp2r1a: protein phosphatase 2 (formerly 2A), regulatory subunit A, alpha isoform

628. Ppp2r1b: protein phosphatase 2 (formerly 2A), regulatory subunit A, beta isoform

629. Ppp2r2a: protein phosphatase 2 (formerly 2A), regulatory subunit B, alpha isoform

630. PPP2R2B: protein phosphatase 2 (formerly 2A), regulatory subunit B, beta isoform

631. Ppp2r5e: protein phosphatase 2, regulatory subunit B\', epsilon isoform

632. Ppp3cc: protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform

633. Ppp5c: protein phosphatase 5, catalytic subunit

634. Prdm4: PR domain containing 4

635. Prdx1: peroxiredoxin 1

636. Prep: prolyl endopeptidase

637. Prf1: perforin 1 (pore forming protein)

638. Prkaa2: protein kinase, AMP-activated, alpha 2 catalytic subunit

639. Prkaca: protein kinase, cAMP-dependent, catalytic, alpha

640. prkar1a: protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)

641. Prkar1a: protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)

642. Prkar2a: protein kinase, cAMP-dependent, regulatory, type II, alpha

643. Prkar2b: protein kinase, cAMP-dependent, regulatory, type II, beta

644. Prkca: protein kinase C, alpha

645. Prkcb1: protein kinase C, beta

646. Prkci: protein kinase C, iota

647. Prkcm: protein kinase D1

648. PRKCQ: protein kinase C, theta

649. Prkcz: protein kinase C, zeta

650. Prkwnk1: WNK lysine deficient protein kinase 1

651. Prmt3: protein arginine methyltransferase 3

652. Prnp: prion protein

653. Prom2: prominin 2

654. Prph2: peripherin 2 (retinal degeneration, slow)

655. Prpsap1: phosphoribosyl pyrophosphate synthetase-associated protein 1

656. Prpsap2: phosphoribosyl pyrophosphate synthetase-associated protein 2

657. Prr3: proline rich 3

658. Prrx2: paired related homeobox 2

659. Prrxl1: dorsal root ganglia homeobox

660. Prss1: protease, serine, 1 (trypsin 1)

661. Prss12: protease, serine, 12 (neurotrypsin, motopsin)

662. Prss15: lon peptidase 1, mitochondrial

663. Prtg: protogenin homolog (Gallus gallus)

664. Prx: periaxin

665. Psat1: phosphoserine aminotransferase 1

666. Psd: pleckstrin and Sec7 domain containing

667. Psd4: pleckstrin and Sec7 domain containing 4

668. Psmc1: proteasome (prosome, macropain) 26S subunit, ATPase, 1

669. Psmc3: proteasome (prosome, macropain) 26S subunit, ATPase, 3

670. Psmc5: proteasome (prosome, macropain) 26S subunit, ATPase, 5

671. Psmd1: proteasome (prosome, macropain) 26S subunit, non-ATPase, 1

672. Psme1: proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)

673. Psme2: proteasome (prosome, macropain) activator subunit 2 (PA28 beta)

674. Psme3: proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki)

675. Psph: phosphoserine phosphatase

676. Ptbp1: polypyrimidine tract binding protein 1

677. Ptbp2: polypyrimidine tract binding protein 2

678. Ptger2: prostaglandin E receptor 2 (subtype EP2), 53 kDa

679. Ptgis: prostaglandin I2 (prostacyclin) synthase

680. Ptgs1: prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)

681. Pth: parathyroid hormone

682. Pthr2: parathyroid hormone 2 receptor

683. Ptk2: PTK2 protein tyrosine kinase 2

684. Ptn: pleiotrophin

685. Ptov1: prostate tumor overexpressed 1

686. Ptp4a1: protein tyrosine phosphatase type IVA, member 1

687. Ptpn11: protein tyrosine phosphatase, non-receptor type 11

688. Rnmt: RNA (guanine-7-) methyltransferase

689. Rraga: Ras-related GTP binding A

690. Rtn4: reticulon 4

691. Ryr3: ryanodine receptor 3

692. Sca1: ataxin 1

693. Sca10: ataxin 10

694. Scfd1: sec1 family domain containing 1

695. Scgb3a2: secretoglobin, family 3A, member 2

696. Scn1a: sodium channel, voltage-gated, type I, alpha subunit

697. Scn2a1: sodium channel, voltage-gated, type II, alpha subunit

698. Scp2: sterol carrier protein 2

699. Sdad1: SDA1 domain containing 1

700. Sdc2: syndecan 2

701. Sdcbp: syndecan binding protein (syntenin)

702. Sdfr1: neuroplastin

703. Sdha: succinate dehydrogenase complex, subunit A, flavoprotein (Fp)

704. Sec11l3: SEC11 homolog C (S. cerevisiae)

705. Sec31l1: SEC31 homolog A (S. cerevisiae)

706. Sectm1: secreted and transmembrane 1

707. Sema6c: sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C

708. Sephs1: selenophosphate synthetase 1

709. Serinc3: serine incorporator 3

710. Serpinb3: serpin peptidase inhibitor, clade B (ovalbumin), member 3

711. Serpine2: serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2

712. Sez6: seizure related 6 homolog (mouse)

713. Sf3b1: splicing factor 3b, subunit 1, 155 kDa

714. Sfpq: splicing factor proline/glutamine-rich (polypyrimidine tract binding protein associated)

715. Sfrp4: secreted frizzled-related protein 4

716. Sfrs10: transformer 2 beta homolog (Drosophila)

717. Sfrs8: splicing factor, arginine/serine-rich 8 (suppressor-of-white-apricot homolog, Drosophila)

718. Sfrs9: splicing factor, arginine/serine-rich 9

719. Sftpb: surfactant protein B

720. Sfxn3: sideroflexin 3

721. Sfxn5: sideroflexin 5

722. Sgca: sarcoglycan, alpha (50 kDa dystrophin-associated glycoprotein)

723. Sgtb: small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta

724. Sh2d4a: SH2 domain containing 4A

725. Sh3bp4: SH3-domain binding protein 4

726. Sh3bp5: SH3-domain binding protein 5 (BTK-associated)

727. Sh3gl3: SH3-domain GRB2-like 3

728. Sh3glb2: SH3-domain GRB2-like endophilin B2

729. Shank1: SH3 and multiple ankyrin repeat domains 1

730. Shank2: SH3 and multiple ankyrin repeat domains 2

731. Shc1: SHC (Src homology 2 domain containing) transforming protein 1

732. Shh: sonic hedgehog homolog (Drosophila)

733. Shoc2: soc-2 suppressor of clear homolog (C. elegans)

734. Siat7A: ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1

735. Sipa1: signal-induced proliferation-associated 1

736. Sipa1l2: signal-induced proliferation-associated 1 like 2

737. Sipa1l3: signal-induced proliferation-associated 1 like 3

738. Sirpa: signal-regulatory protein alpha

739. Sirt2: sirtuin (silent mating type information regulation 2 homolog) 2 (S. cerevisiae)

740. Sirt5: sirtuin (silent mating type information regulation 2 homolog) 5 (S. cerevisiae)

741. Slc11a2: solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2

742. Slc12a1: solute carrier family 12 (sodium/potassium/chloride transporters), member 1

743. Slc12a5: solute carrier family 12 (potassium-chloride transporter), member 5

744. Slco3a1: solute carrier organic anion transporter family, member 3A1

745. Slit1: slit homolog 1 (Drosophila)

746. Slit2: slit homolog 2 (Drosophila)

747. Slit3: slit homolog 3 (Drosophila)

748. Slk: STE20-like kinase (yeast)

749. Slu7: SLU7 splicing factor homolog (S. cerevisiae)

750. Smad1: SMAD family member 1

751. Smarca2: SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2

752. Smc1l1: structural maintenance of chromosomes 1A

753. Smo: smoothened homolog (Drosophila)

754. Smoc1: SPARC related modular calcium binding 1

755. Smu1: smu-1 suppressor of mec-8 and unc-52 homolog (C. elegans)

756. Sn: sialic acid binding Ig-like lectin 1, sialoadhesin

757. Snai1: snail homolog 1 (Drosophila)

758. Snai2: snail homolog 2 (Drosophila)

759. Snap23: synaptosomal-associated protein, 23 kDa

760. Snap25: synaptosomal-associated protein, 25 kDa

761. Snap91: synaptosomal-associated protein, 91 kDa homolog (mouse)

762. Snca: synuclein, alpha (non A4 component of amyloid precursor)

763. Sncb: synuclein, beta

764. Snd1: staphylococcal nuclease and tudor domain containing 1

765. Snph: syntaphilin

766. Snrk: SNF related kinase

767. Snx17: sorting nexin 17

768. Snx25: sorting nexin 25

769. Snx3: sorting nexin 3

770. Soat1: sterol O-acyltransferase 1

771. Socs1: suppressor of cytokine signaling 1

772. SOD1: superoxide dismutase 1, soluble

773. Sod2: superoxide dismutase 2, mitochondrial

774. Sord: sorbitol dehydrogenase

775. Sox10: SRY (sex determining region Y)-box 10

776. Sp2: Sp2 transcription factor

777. Sparc: secreted protein, acidic, cysteine-rich (osteonectin)

778. Spata20: spermatogenesis associated 20

779. Spint1: serine peptidase inhibitor, Kunitz type 1

780. Spp1: secreted phosphoprotein 1

781. Spsb4: splA/ryanodine receptor domain and SOCS box containing 4

782. Sqle: squalene epoxidase

783. Src: v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)

784. Srd5a2: steroid-5-alpha-reductase, alpha polypeptide 2

785. Srebf1: sterol regulatory element binding transcription factor 1

786. Srprb: signal recognition particle receptor, B subunit

787. Ssb: Sjogren syndrome antigen B (autoantigen La)

788. Ssr4: signal sequence receptor, delta (translocon-associated protein delta)

789. Ssrp1: structure specific recognition protein 1

790. Sstr2: somatostatin receptor 2

791. Ssx2ip: synovial sarcoma, X breakpoint 2 interacting protein

792. St14: suppression of tumorigenicity 14 (colon carcinoma)

793. St18: suppression of tumorigenicity 18 (breast carcinoma) (zinc finger protein)

794. St3gal1: ST3 beta-galactoside alpha-2,3-sialyltransferase 1

795. St6gal2: ST6 beta-galactosamide alpha-2,6-sialyltransferase 2

796. St7: suppression of tumorigenicity 7

797. St7l: suppression of tumorigenicity 7 like

798. Star: steroidogenic acute regulatory protein

799. Stard3nl: STARD3 N-terminal like

800. Stat1: signal transducer and activator of transcription 1, 91 kDa

801. Stat3: signal transducer and activator of transcription 3 (acute-phase response factor)

802. Stau1: staufen, RNA binding protein, homolog 1 (Drosophila)

803. Stch: heat shock protein 70 kDa family, member 13

804. Ste: sulfotransferase family 1E, estrogen-preferring, member 1

805. Stim2: stromal interaction molecule 2

806. Stip1: stress-induced-phosphoprotein 1

807. Stk10: serine/threonine kinase 10

808. Stk11: serine/threonine kinase 11

809. Stmn1: stathmin 1

810. Stmn2: stathmin-like 2

811. Stmn3: stathmin-like 3

812. Stmn4: stathmin-like 4

813. Stnl: eukaryotic translation elongation factor 1 alpha 2

814. Stom: stomatin

815. Strbp: spermatid perinuclear RNA binding protein

816. Strn: striatin, calmodulin binding protein

817. Stx12: syntaxin 12

818. Stx1a: syntaxin 1A (brain)

819. Stx4a: syntaxin 4

820. Stx5a: syntaxin 5

821. Stx6: syntaxin 6

822. Stx8: syntaxin 8

823. Stxbp3: syntaxin binding protein 3

824. Stxbp5: syntaxin binding protein 5 (tomosyn)

825. Suclg1: succinate-CoA ligase, alpha subunit

826. Sult1a1: sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1

827. Sult1c1: sulfotransferase family, cytosolic, 1C, member 2

828. Sult1c2: sulfotransferase family, cytosolic, 1C, member 2

829. Sult1e1: sulfotransferase family 1E, estrogen-preferring, member 1

830. Sult4a1: sulfotransferase family 4A, member 1

831. Supv3l1: suppressor of var1, 3-like 1 (S. cerevisiae)

832. Surf6: surfeit 6

833. Suv420h2: suppressor of variegation 4-20 homolog 2 (Drosophila)

834. Sv2a: synaptic vesicle glycoprotein 2A

835. Sv2b: synaptic vesicle glycoprotein 2B

836. Sycp1: synaptonemal complex protein 1

837. Sycp2: synaptonemal complex protein 2

838. Syn1: synapsin I

839. Syn2: synapsin II

840. Syn3: synapsin III

841. Syngap1: synaptic Ras GTPase activating protein 1 homolog (rat)

842. Synj1: synaptojanin 1

843. Synj2: synaptojanin 2

844. Synj2bp: synaptojanin 2 binding protein

845. Synpo: synaptopodin

846. Sypl: synaptophysin-like 1

847. Syt11: synaptotagmin XI

848. Syt12: synaptotagmin XII

849. Syt5: synaptotagmin V

850. Syt6: synaptotagmin VI

851. Syt8: synaptotagmin VIII

852. Tacc1: transforming, acidic coiled-coil containing protein 1

853. Tacc2: transforming, acidic coiled-coil containing protein 2

854. Tacr1: tachykinin receptor 1

855. Taf1c: TATA box binding protein (TBP)-associated factor, RNA polymerase I, C, 110 kDa

856. Taf9l: TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor, 31 kDa

857. Tagln: transgelin

858. Tagln3: transgelin 3

859. Taldo1: transaldolase 1

860. Taok1: TAO kinase 1

861. Tapbp: TAP binding protein (tapasin)

862. Tars: threonyl-tRNA synthetase

863. Tas2r41: taste receptor, type 2, member 41

864. Tat: tyrosine aminotransferase

865. Tax1bp1: Tax1 (human T-cell leukemia virus type I) binding protein 1

866. Tbc1d10b: TBC1 domain family, member 10B

867. Tbca: tubulin folding cofactor A

868. Tbx2: T-box 2

869. Tcirg1: T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3

870. Tcn2: transcobalamin II; macrocytic anemia

871. Tcp1: t-complex 1

872. Tcra: T cell receptor alpha locus

873. Tdg: thymine-DNA glycosylase

874. Tdrd7: tudor domain containing 7

875. Tead1: TEA domain family member 1 (SV40 transcriptional enhancer factor)

876. Tegt: transmembrane BAX inhibitor motif containing 6

877. Tg: thyroglobulin

878. Tgfb1: transforming growth factor, beta 1

879. Tgfbr3: transforming growth factor, beta receptor III

880. Tgm1: transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase)

881. Tgm2: transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase)

882. Thbd: thrombomodulin

883. Thbs4: thrombospondin 4

884. Thpo: thrombopoietin

885. Thra: thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian)

886. Thrap3: thyroid hormone receptor associated protein 3

887. Thrb: thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian)

888. Thy1: Thy-1 cell surface antigen

889. Tigd3: tigger transposable element derived 3

890. Timm44: translocase of inner mitochondrial membrane 44 homolog (yeast)

891. Timm8a: translocase of inner mitochondrial membrane 8 homolog A (yeast)

892. Tinag: tubulointerstitial nephritis antigen

893. Tjp1: tight junction protein 1 (zona occludens 1)

894. Tjp2: tight junction protein 2 (zona occludens 2)

895. Tkt: transketolase

896. Tle3: transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila)

897. Tlr3: toll-like receptor 3

898. Tlr4: toll-like receptor 4

899. Tlr5: toll-like receptor 5

900. Tlr6: toll-like receptor 6

901. Tlr9: toll-like receptor 9

902. Tm4sf8: tetraspanin 3

903. Tm9sf2: transmembrane 9 superfamily member 2

904. Tm9sf3: transmembrane 9 superfamily member 3

905. Tmco1: transmembrane and coiled-coil domains 1

906. Tmeff1: transmembrane protein with EGF-like and two follistatin-like domains 1

907. Tmem27: transmembrane protein 27

908. Tmf1: TATA element modulatory factor 1

909. Tmpo: thymopoietin

910. Tmsb10: thymosin beta 10

911. Tnfaip1: tumor necrosis factor, alpha-induced protein 1 (endothelial)

912. Tnni1: troponin I type 1 (skeletal, slow)

913. Tnni2: troponin I type 2 (skeletal, fast)

914. Tnnt3: troponin T type 3 (skeletal, fast)

915. Tob1: transducer of ERBB2, 1

916. Tob2: transducer of ERBB2, 2

917. Tom1: target of myb1 (chicken)

918. Tor3a: torsin family 3, member A

919. Tpbg: trophoblast glycoprotein

920. Tpd52l2: tumor protein D52-like 2

921. Tph2: tryptophan hydroxylase 2

922. Tpm3: tropomyosin 3

923. Tpo: thyroid peroxidase

924. Tpst2: tyrosylprotein sulfotransferase 2

925. Tpt1: tumor protein, translationally-controlled 1

926. Tr4: nuclear receptor subfamily 2, group C, member 2

927. Traf3ip1: TNF receptor-associated factor 3 interacting protein 1

928. Trak2: trafficking protein, kinesin binding 2

929. Trap1: TNF receptor-associated protein 1

930. Trib3: tribbles homolog 3 (Drosophila)

931. Trim13: tripartite motif-containing 13

932. Trim54: tripartite motif-containing 54

933. Trip10: thyroid hormone receptor interactor 10

934. Trpc2: transient receptor potential cation channel, subfamily C, member 2 (pseudogene)

935. Trpc4: transient receptor potential cation channel, subfamily C, member 4

936. Trpc5: transient receptor potential cation channel, subfamily C, member 5

937. Trpc7: transient receptor potential cation channel, subfamily C, member 7

938. Trpv1: transient receptor potential cation channel, subfamily V, member 1

939. Trpv4: transient receptor potential cation channel, subfamily V, member 4

940. Tsc1: tuberous sclerosis 1

941. Tsc2: tuberous sclerosis 2

942. Tsg101: tumor susceptibility gene 101

943. Tsga10: testis specific, 10

944. Tsga10ip: testis specific, 10 interacting protein

945. Tshr: thyroid stimulating hormone receptor

946. Tsn: translin

947. Tsnax: translin-associated factor X

948. Tst: thiosulfate sulfurtransferase (rhodanese)

949. Ttc1: tetratricopeptide repeat domain 1

950. Ttn: titin

951. Tub: tubby homolog (mouse)

952. Tuba1a: tubulin, alpha 1a

953. Tubb2b: tubulin, beta 2B

954. Tubb2c: tubulin, beta 2C

955. Tubb3: tubulin, beta 3

956. Tusc3: tumor suppressor candidate 3

957. Txn: thioredoxin

958. Txn2: thioredoxin 2

959. Txndc4: endoplasmic reticulum protein 44

960. Txnip: thioredoxin interacting protein

961. Txnl2: glutaredoxin 3

962. Txnrd1: thioredoxin reductase 1

963. Txnrd2: thioredoxin reductase 2

964. Ubc: ubiquitin C

965. Ube2e2: ubiquitin-conjugating enzyme E2E 2 (UBC4/5 homolog, yeast)

966. Ubl3: ubiquitin-like 3

967. Ubqln1: ubiquilin 1

968. Ubxd3: UBX domain protein 10

969. Uchl1: ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)

970. Ucp1: uncoupling protein 1 (mitochondrial, proton carrier)

971. Ucp2: uncoupling protein 2 (mitochondrial, proton carrier)

972. Ugt1a1: UDP glucuronosyltransferase 1 family, polypeptide A1

973. Umod: uromodulin

974. Unc13a: unc-13 homolog A (C. elegans)

975. Unc13b: unc-13 homolog B (C. elegans)

976. Unc13c: unc-13 homolog C (C. elegans)

977. Unc5b: unc-5 homolog B (C. elegans)

978. Uqcrc2: ubiquinol-cytochrome c reductase core protein II

979. Uqcrfs1: ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1

980. Uso1: USO1 homolog, vesicle docking protein (yeast)

981. Usp11: ubiquitin specific peptidase 11

982. Vamp1: vesicle-associated membrane protein 1 (synaptobrevin 1)

983. Vamp2: vesicle-associated membrane protein 2 (synaptobrevin 2)

984. Vamp3: vesicle-associated membrane protein 3 (cellubrevin)

985. Vapa: VAMP (vesicle-associated membrane protein)-associated protein A, 33 kDa

986. Vapb: VAMP (vesicle-associated membrane protein)-associated protein B and C

987. VCAN: versican

988. Vcan: versican

989. Vcp: valosin-containing protein

990. Vcpip1: valosin containing protein (p97)/p47 complex interacting protein 1

991. Vdac1: voltage-dependent anion channel 1

992. Vdac2: voltage-dependent anion channel 2

993. Vegfa: vascular endothelial growth factor A

994. Vgcnl1: sodium leak channel, non-selective

995. Vgf: VGF nerve growth factor inducible

996. Vipr2: vasoactive intestinal peptide receptor 2

997. Vpreb1: pre-B lymphocyte 1

998. Vps33a: vacuolar protein sorting 33 homolog A (S. cerevisiae)

999. Vps33b: vacuolar protein sorting 33 homolog B (yeast)

1000. Vps4a: vacuolar protein sorting 4 homolog A (S. cerevisiae)

1001. Vsnl1: visinin-like 1

1002. Vtn: vitronectin

1003. Wars: tryptophanyl-tRNA synthetase

1004. Wbp2: WW domain binding protein 2

1005. Wdr10: intraflagellar transport 122 homolog (Chlamydomonas)

1006. Wdr44: WD repeat domain 44

1007. Wdr7: WD repeat domain 7

1008. Wfs1: Wolfram syndrome 1 (wolframin)

1009. Wif1: WNT inhibitory factor 1

1010. Wipf1: WAS/WASL interacting protein family, member 1

1011. Wnk4: WNK lysine deficient protein kinase 4

1012. Wnt5a: wingless-type MMTV integration site family, member 5A

1013. Wnt7a: wingless-type MMTV integration site family, member 7A

1014. Xkr6: XK, Kell blood group complex subunit-related family, member 6

1015. Xpnpep2: X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound

1016. Xpo1: exportin 1 (CRM1 homolog, yeast)

1017. Xpo6: exportin 6

1018. Xrcc1: X-ray repair complementing defective repair in Chinese hamster cells 1

1019. Xrcc5: X-ray repair complementing defective repair in Chinese hamster cells 5

1020. Xylt1: xylosyltransferase I

1021. Yars2: tyrosyl-tRNA synthetase 2, mitochondrial

1022. Yes1: v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1

1023. Ykt6: YKT6 v-SNARE homolog (S. cerevisiae)

1024. Ywhab: tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide

1025. Yy1: YY1 transcription factor

1026. Znf382: zinc finger protein 382

1027. Zranb1: zinc finger, RAN-binding domain containing 1

1028. Zwint: ZW10 interactor.

B. {#sec8}
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Lipid raft-derived extracted proteins from Alzheimer\'s disease (3xTgAD) mouse 16-month-old cortical tissue. Specific proteins isolated from 3xTgAD mouse cortex were identified with multidimensional protein identification technology (MudPIT) LC MS/MS. Each protein was identified in at least two out of three experimental replicate animals and from at least two isolated peptides per protein. The following are the protein symbol and its corresponding definition.

1.  Abca1: ATP-binding cassette, sub-family A (ABC1), member 1

2.  ABCA7: ATP-binding cassette, sub-family A (ABC1), member 7

3.  Abcb4: ATP-binding cassette, sub-family B (MDR/TAP), member 4

4.  Abcc1: ATP-binding cassette, sub-family C (CFTR/MRP), member 1

5.  Abcc2: ATP-binding cassette, sub-family C (CFTR/MRP), member 2

6.  Abcc4: ATP-binding cassette, sub-family C (CFTR/MRP), member 4

7.  Abi1: abl-interactor 1

8.  Acadl: acyl-Coenzyme A dehydrogenase, long chain

9.  Acat1: acetyl-Coenzyme A acetyltransferase 1

10. Acin1: apoptotic chromatin condensation inducer 1

11. Acmsd: aminocarboxymuconate semialdehyde decarboxylase

12. Acp2: acid phosphatase 2, lysosomal

13. Acta1: actin, alpha 1, skeletal muscle

14. Actb: actin, beta

15. Actn4: actinin, alpha 4

16. Acvr1: activin A receptor, type I

17. Adam2: ADAM metallopeptidase domain 2

18. Adam6: ADAM metallopeptidase domain 6 (pseudogene)

19. Adcy1: adenylate cyclase 1 (brain)

20. Adcy5: adenylate cyclase 5

21. Adcy8: adenylate cyclase 8 (brain)

22. Adcyap1: adenylate cyclase activating polypeptide 1 (pituitary)

23. Adcyap1r1: adenylate cyclase activating polypeptide 1 (pituitary) receptor type I

24. Add1: adducin 1 (alpha)

25. Add2: adducin 2 (beta)

26. Adrbk1: adrenergic, beta, receptor kinase 1

27. Aes: amino-terminal enhancer of split

28. Agpat1: 1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)

29. Agpat4: 1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)

30. Agrn: agrin

31. Ahi1: Abelson helper integration site 1

32. Ahr: aryl hydrocarbon receptor

33. Ahrr: aryl-hydrocarbon receptor repressor

34. Ak3: adenylate kinase 3

35. Akap12: A kinase (PRKA) anchor protein 12

36. Akap3: A kinase (PRKA) anchor protein 3

37. Akap4: A kinase (PRKA) anchor protein 4

38. Akap9: A kinase (PRKA) anchor protein (yotiao) 9

39. Alad: aminolevulinate, delta-, dehydratase

40. Aldh1a3: aldehyde dehydrogenase 1 family, member A3

41. Alox5: arachidonate 5-lipoxygenase

42. Ampd1: adenosine monophosphate deaminase 1 (isoform M)

43. Anxa3: annexin A3

44. Anxa6: annexin A6

45. Apex2: APEX nuclease (apurinic/apyrimidinic endonuclease) 2

46. Apob: apolipoprotein B (including Ag(x) antigen)

47. Apod: apolipoprotein D

48. App: amyloid beta (A4) precursor protein

49. Aps: kallikrein-related peptidase 3

50. Aqp3: aquaporin 3 (Gill blood group)

51. Aqp4: aquaporin 4

52. Aqp8: aquaporin 8

53. Arf1: ADP-ribosylation factor 1

54. Arf4: ADP-ribosylation factor 4

55. Arf6: ADP-ribosylation factor 6

56. Arfip1: ADP-ribosylation factor interacting protein 1

57. Arhgap20: Rho GTPase activating protein 20

58. Arhgap8: Rho GTPase activating protein 8

59. Arhgdia: Rho GDP dissociation inhibitor (GDI) alpha

60. Arhgef11: Rho guanine nucleotide exchange factor (GEF) 11

61. Arhgef12: Rho guanine nucleotide exchange factor (GEF) 12

62. Arhgef6: Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6

63. Arnt: aryl hydrocarbon receptor nuclear translocator

64. Arntl: aryl hydrocarbon receptor nuclear translocator-like

65. Arpp19: cAMP-regulated phosphoprotein, 19 kDa

66. Ascc1: activating signal cointegrator 1 complex subunit 1

67. Asz1: ankyrin repeat, SAM and basic leucine zipper domain containing 1

68. Atcay: ataxia, cerebellar, Cayman type

69. Atf3: activating transcription factor 3

70. Atm: ataxia telangiectasia mutated

71. Atp1a1: ATPase, Na+/K+ transporting, alpha 1 polypeptide

72. Atp1a4: ATPase, Na+/K+ transporting, alpha 4 polypeptide

73. Atp1b1: ATPase, Na+/K+ transporting, beta 1 polypeptide

74. ATP2B1: ATPase, Ca++ transporting, plasma membrane 1

75. Atp2b1: ATPase, Ca++ transporting, plasma membrane 1

76. Atp2b2: ATPase, Ca++ transporting, plasma membrane 2

77. Atp5a1: ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle

78. Atp5b: ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide

79. Atp5f1: ATP synthase, H+ transporting, mitochondrial F0 complex, subunit B1

80. Atp5h: ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d

81. Atp5i: ATP synthase, H+ transporting, mitochondrial F0 complex, subunit E

82. Atp5j: ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F6

83. Atp6b2: ATPase, H+ transporting, lysosomal 56/58 kDa, V1 subunit B2

84. Atp6l: ATPase, H+ transporting, lysosomal 16 kDa, V0 subunit c

85. Atp6v0a1: ATPase, H+ transporting, lysosomal V0 subunit a1

86. ATPBD1C: GPN-loop GTPase 3

87. Atxn3: ataxin 3

88. Avil: advillin

89. B3gat1: beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)

90. Bace1: beta-site APP-cleaving enzyme 1

91. Basp1: brain abundant, membrane attached signal protein 1

92. Bat2: HLA-B associated transcript 2

93. Bat5: HLA-B associated transcript 5

94. Bax: BCL2-associated X protein

95. Bcl10: B-cell CLL/lymphoma 10

96. Begain: brain-enriched guanylate kinase-associated homolog (rat)

97. Bmp6: bone morphogenetic protein 6

98. Bnip1: BCL2/adenovirus E1B 19 kDa interacting protein 1

99. Bnip3: BCL2/adenovirus E1B 19 kDa interacting protein 3

100. Bpnt1: 3^\'^(2^\'^), 5^\'^-bisphosphate nucleotidase 1

101. Brd2: bromodomain containing 2

102. Brd8: bromodomain containing 8

103. Bst1: bone marrow stromal cell antigen 1

104. Btg2: BTG family, member 2

105. Bzrap1: benzodiazepine receptor (peripheral) associated protein 1

106. c3orf6: coiled-coil domain containing 50

107. C4a: complement component 4A (Rodgers blood group)

108. c8b: complement component 8, beta polypeptide

109. Cabc1: chaperone, ABC1 activity of bc1 complex homolog (S. pombe)

110. Cabin1: calcineurin binding protein 1

111. Cacna1g: calcium channel, voltage-dependent, T type, alpha 1G subunit

112. Cacna2d1: calcium channel, voltage-dependent, alpha 2/delta subunit 1

113. Cacna2d2: calcium channel, voltage-dependent, alpha 2/delta subunit 2

114. Cacna2d3: calcium channel, voltage-dependent, alpha 2/delta subunit 3

115. Cacnb2: calcium channel, voltage-dependent, beta 2 subunit

116. Calb1: calbindin 1, 28 kDa

117. Calb2: calbindin 2

118. Cald1: caldesmon 1

119. calm2: calmodulin 2 (phosphorylase kinase, delta)

120. Calr: calreticulin

121. Camk2g: calcium/calmodulin-dependent protein kinase II gamma

122. Camkk1: calcium/calmodulin-dependent protein kinase kinase 1, alpha

123. Camkv: CaM kinase-like vesicle-associated

124. Canx: calnexin

125. Cap1: CAP, adenylate cyclase-associated protein 1 (yeast)

126. Capn1: calpain 1, (mu/l) large subunit

127. Capn5: calpain 5

128. Capn6: calpain 6

129. Capzb: capping protein (actin filament) muscle Z-line, beta

130. Card9: caspase recruitment domain family, member 9

131. Carhsp1: calcium regulated heat stable protein 1, 24 kDa

132. Caskin1: CASK interacting protein 1

133. Casp7: caspase 7, apoptosis-related cysteine peptidase

134. Cast: calpastatin

135. Cbp: opsin 1 (cone pigments), long-wave-sensitive

136. Cbx3: chromobox homolog 3 (HP1 gamma homolog, Drosophila)

137. Ccnd2: cyclin D2

138. Ccs: copper chaperone for superoxide dismutase

139. Cct2: chaperonin containing TCP1, subunit 2 (beta)

140. Cd2ap: CD2-associated protein

141. Cd36: CD36 molecule (thrombospondin receptor)

142. Cd86: CD86 molecule

143. Cdc25b: cell division cycle 25 homolog B (S. pombe)

144. Cdc42: cell division cycle 42 (GTP binding protein, 25 kDa)

145. Cdc5l: CDC5 cell division cycle 5-like (S. pombe)

146. Cdh1: cadherin 1, type 1, E-cadherin (epithelial)

147. Cdh10: cadherin 10, type 2 (T2-cadherin)

148. Cdh13: cadherin 13, H-cadherin (heart)

149. Cdh2: cadherin 2, type 1, N-cadherin (neuronal)

150. Cdk5rap2: CDK5 regulatory subunit associated protein 2

151. Cdkn1b: cyclin-dependent kinase inhibitor 1B (p27, Kip1)

152. Cds1: CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1

153. Cdv1: intraflagellar transport 81 homolog (Chlamydomonas)

154. Cebp: CCAAT/enhancer binding protein (C/EBP), alpha

155. Cend1: cell cycle exit and neuronal differentiation 1

156. Cenpc1: centromere protein C 1

157. Cenpi: centromere protein I

158. Centa1: ArfGAP with dual PH domains 1

159. Ces1: carboxylesterase 1 (monocyte/macrophage serine esterase 1)

160. Cetn2: centrin, EF-hand protein, 2

161. Cfd: complement factor D (adipsin)

162. Cfl1: cofilin 1 (nonmuscle)

163. Cftr: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)

164. Chgb: chromogranin B (secretogranin 1)

165. Chka: choline kinase alpha

166. Chm: choroideremia (Rab escort protein 1)

167. Chst10: carbohydrate sulfotransferase 10

168. Chx10: visual system homeobox 2

169. Cktsf1b1: gremlin 1, cysteine knot superfamily, homolog (Xenopus laevis)

170. Clcf1: cardiotrophin-like cytokine factor 1

171. Cldn18: claudin 18

172. Clic4: chloride intracellular channel 4

173. Clip3: CAP-GLY domain containing linker protein 3

174. Clta: clathrin, light chain (Lca)

175. Cltb: clathrin, light chain (Lcb)

176. Cltc: clathrin, heavy chain (Hc)

177. Clu: clusterin

178. Cnga1: cyclic nucleotide gated channel alpha 1

179. Cngb1: cyclic nucleotide gated channel beta 1

180. Cnot4: CCR4-NOT transcription complex, subunit 4

181. Cnr1: cannabinoid receptor 1 (brain)

182. Col5a3: collagen, type V, alpha 3

183. Copb1: coatomer protein complex, subunit beta 1

184. Cops4: COP9 constitutive photomorphogenic homolog subunit 4 (Arabidopsis)

185. Coro1a: coronin, actin binding protein, 1A

186. Cp: ceruloplasmin (ferroxidase)

187. Cpa2: carboxypeptidase A2 (pancreatic)

188. Cpt2: carnitine palmitoyltransferase 2

189. Creb1: cAMP responsive element binding protein 1

190. Crhbp: corticotropin releasing hormone binding protein

191. Crip2: cysteine-rich protein 2

192. Cript: cysteine-rich PDZ-binding protein

193. Crmp1: collapsin response mediator protein 1

194. Cry2: cryptochrome 2 (photolyase-like)

195. Csf1: colony stimulating factor 1 (macrophage)

196. Csh1: chorionic somatomammotropin hormone 1 (placental lactogen)

197. Csnk1e: casein kinase 1, epsilon

198. Csnk1g1: casein kinase 1, gamma 1

199. Csnk1g3: casein kinase 1, gamma 3

200. Cspg6: structural maintenance of chromosomes 3

201. Cst6: cystatin E/M

202. Cstb: cystatin B (stefin B)

203. Ctnnb1: catenin (cadherin-associated protein), beta 1, 88 kDa

204. Cttn: cortactin

205. Cugbp2: CUG triplet repeat, RNA binding protein 2

206. Cul5: cullin 5

207. Cutl1: cut-like homeobox 1

208. Cxadr: coxsackie virus and adenovirus receptor

209. Cxcl10: chemokine (C-X-C motif) ligand 10

210. Cyb5r4: cytochrome b5 reductase 4

211. Cyln2: CAP-GLY domain containing linker protein 2

212. Cyp19a1: cytochrome P450, family 19, subfamily A, polypeptide 1

213. Cyp1a1: cytochrome P450, family 1, subfamily A, polypeptide 1

214. Cyp4x1: cytochrome P450, family 4, subfamily X, polypeptide 1

215. Dab2ip: DAB2 interacting protein

216. Dbn1: drebrin 1

217. Dctn1: dynactin 1 (p150, glued homolog, Drosophila)

218. Dctn2: dynactin 2 (p50)

219. Dctn4: dynactin 4 (p62)

220. Dcxr: dicarbonyl/L-xylulose reductase

221. Ddah2: dimethylarginine dimethylaminohydrolase 2

222. Ddb1: damage-specific DNA binding protein 1, 127 kDa

223. Ddt: D-dopachrome tautomerase

224. Ddx1: DEAD (Asp-Glu-Ala-Asp) box polypeptide 1

225. Ddx19: DEAD (Asp-Glu-Ala-As) box polypeptide 19B

226. Ddx27: DEAD (Asp-Glu-Ala-Asp) box polypeptide 27

227. Ddx5: DEAD (Asp-Glu-Ala-Asp) box polypeptide 5

228. Dedd: death effector domain containing

229. Degs1: degenerative spermatocyte homolog 1, lipid desaturase (Drosophila)

230. Des: desmin

231. Dgkg: diacylglycerol kinase, gamma 90 kDa

232. Dhcr7: 7-dehydrocholesterol reductase

233. Dhodh: dihydroorotate dehydrogenase

234. Dhx40: DEAH (Asp-Glu-Ala-His) box polypeptide 40

235. Dia1: cytochrome b5 reductase 3

236. Disc1: disrupted in schizophrenia 1

237. Dkc1: dyskeratosis congenita 1, dyskerin

238. Dlat: dihydrolipoamide S-acetyltransferase

239. Dlc1: deleted in liver cancer 1

240. Dlgap2: discs, large (Drosophila) homolog-associated protein 2

241. Dlgap4: discs, large (Drosophila) homolog-associated protein 4

242. Dll1: delta-like 1 (Drosophila)

243. Dnah7: dynein, axonemal, heavy chain 7

244. Dnah9: dynein, axonemal, heavy chain 9

245. Dnajc5: DnaJ (Hsp40) homolog, subfamily C, member 5

246. Dnch1: dynein, cytoplasmic 1, heavy chain 1

247. Dnch2: dynein, cytoplasmic 2, heavy chain 1

248. Dnm1: dynamin 1

249. Dnmt1: DNA (cytosine-5-)-methyltransferase 1

250. Dnmt3a: DNA (cytosine-5-)-methyltransferase 3 alpha

251. Dntt: deoxynucleotidyltransferase, terminal

252. Dpp3: dipeptidyl-peptidase 3

253. Dpp6: dipeptidyl-peptidase 6

254. Dpyd: dihydropyrimidine dehydrogenase

255. Drd1ip: calcyon neuron-specific vesicular protein

256. Drg1: developmentally regulated GTP binding protein 1

257. Dtnb: dystrobrevin, beta

258. Dtnbp1: dystrobrevin binding protein 1

259. Duox1: dual oxidase 1

260. Dvl1: dishevelled, dsh homolog 1 (Drosophila)

261. Dyx1c1: dyslexia susceptibility 1 candidate 1

262. Eaf2: ELL associated factor 2

263. Echs1: enoyl Coenzyme A hydratase, short chain, 1, mitochondrial

264. Eef1g: eukaryotic translation elongation factor 1 gamma

265. Eef2: eukaryotic translation elongation factor 2

266. Eef2k: eukaryotic elongation factor-2 kinase

267. Efemp2: EGF-containing fibulin-like extracellular matrix protein 2

268. Egfr: epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)

269. Eif2ak3: eukaryotic translation initiation factor 2-alpha kinase 3

270. Eif2b1: eukaryotic translation initiation factor 2B, subunit 1 alpha, 26 kDa

271. Eif2c2: eukaryotic translation initiation factor 2C, 2

272. Eif2s2: eukaryotic translation initiation factor 2, subunit 2 beta, 38 kDa

273. eif4a1: eukaryotic translation initiation factor 4A, isoform 1

274. Elavl3: ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C)

275. ELK1: ELK1, member of ETS oncogene family

276. Emd: emerin

277. Eno2: enolase 2 (gamma, neuronal)

278. Enpp2: ectonucleotide pyrophosphatase/phosphodiesterase 2

279. Entpd8: ectonucleoside triphosphate diphosphohydrolase 8

280. Ephx2: epoxide hydrolase 2, cytoplasmic

281. Epn1: epsin 1

282. Erp29: endoplasmic reticulum protein 29

283. Esd: esterase D/formylglutathione hydrolase

284. Espn: espin

285. Esrrb: estrogen-related receptor beta

286. Etfa: electron-transfer-flavoprotein, alpha polypeptide

287. Etfb: electron-transfer-flavoprotein, beta polypeptide

288. Exoc7: exocyst complex component 7

289. Ezr: ezrin

290. F5: coagulation factor V (proaccelerin, labile factor)

291. Fabp1: fatty acid binding protein 1, liver

292. Fancd2: Fanconi anemia, complementation group D2

293. Fat: FAT tumor suppressor homolog 1 (Drosophila)

294. Fat2: FAT tumor suppressor homolog 2 (Drosophila)

295. Fat3: FAT tumor suppressor homolog 3 (Drosophila)

296. Fbn1: fibrillin 1

297. Fdps: farnesyl diphosphate synthase

298. Fgfr1op2: FGFR1 oncogene partner 2

299. Filip1: filamin A interacting protein 1

300. Fkbp1b: FK506 binding protein 1B, 12.6 kDa

301. Flg: filaggrin

302. Flot1: flotillin 1

303. Flot2: flotillin 2

304. Fosl1: FOS-like antigen 1

305. Fosl2: FOS-like antigen 2

306. Fpgt: fucose-1-phosphate guanylyltransferase

307. Frap1: mechanistic target of rapamycin (serine/threonine kinase)

308. Freq: frequenin homolog (Drosophila)

309. Fyn: FYN oncogene related to SRC, FGR, YES

310. Gaa: glucosidase, alpha; acid

311. Gabbr1: gamma-aminobutyric acid (GABA) B receptor, 1

312. Gabra3: gamma-aminobutyric acid (GABA) A receptor, alpha 3

313. Gabre: gamma-aminobutyric acid (GABA) A receptor, epsilon

314. Gadd45a: growth arrest and DNA-damage-inducible, alpha

315. Galc: galactosylceramidase

316. Galk1: galactokinase 1

317. Galnt10: UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 10

318. Gars: glycyl-tRNA synthetase

319. Gas7: growth arrest-specific 7

320. Gc: group-specific component (vitamin D binding protein)

321. Gdi1: GDP dissociation inhibitor 1

322. Gdi2: GDP dissociation inhibitor 2

323. Gfap: glial fibrillary acidic protein

324. Gif: gastric intrinsic factor (vitamin B synthesis)

325. Gjb2: gap junction protein, beta 2, 26 kDa

326. Gla: galactosidase, alpha

327. Gldc: glycine dehydrogenase (decarboxylating)

328. Glra2: glycine receptor, alpha 2

329. Glut3: solute carrier family 2 (facilitated glucose transporter), member 3

330. Gmcl1: germ cell-less homolog 1 (Drosophila)

331. Gmfb: glia maturation factor, beta

332. Gna11: guanine nucleotide binding protein (G protein), alpha 11 (Gq class)

333. Gnai1: guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1

334. Gnai2: guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2

335. Gnao1: guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O

336. Gnaq: guanine nucleotide binding protein (G protein), q polypeptide

337. Gnaz: guanine nucleotide binding protein (G protein), alpha z polypeptide

338. Gnb2l1: guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1

339. Gnl3: guanine nucleotide binding protein-like 3 (nucleolar)

340. Gnpat: glyceronephosphate O-acyltransferase

341. Gpi: glucose phosphate isomerase

342. Gpm6a: glycoprotein M6A

343. Gpr1: G protein-coupled receptor 1

344. Gpr141: G protein-coupled receptor 141

345. Gpr56: G protein-coupled receptor 56

346. Gpsm1: G-protein signaling modulator 1 (AGS3-like, C. elegans)

347. Gpt2: glutamic pyruvate transaminase (alanine aminotransferase) 2

348. Grin1: glutamate receptor, ionotropic, N-methyl D-aspartate 1

349. Grpel1: GrpE-like 1, mitochondrial (E. coli)

350. Gstm2: glutathione S-transferase mu 2 (muscle)

351. Gstm3: glutathione S-transferase mu 3 (brain)

352. Gucy2d: guanylate cyclase 2D, membrane (retina-specific)

353. Gucy2f: guanylate cyclase 2F, retinal

354. H1f0: H1 histone family, member 0

355. H1f4: histone cluster 1, H1e

356. H2afy: H2A histone family, member Y

357. Haao: 3-hydroxyanthranilate 3,4-dioxygenase

358. Hap1: huntingtin-associated protein 1

359. Hapln3: hyaluronan and proteoglycan link protein 3

360. Hbld2: iron-sulfur cluster assembly 1 homolog (S. cerevisiae)

361. Hck: hemopoietic cell kinase

362. Hcn1: hyperpolarization activated cyclic nucleotide-gated potassium channel 1

363. Hdac6: histone deacetylase 6

364. Hdgf: hepatoma-derived growth factor (high-mobility group protein 1-like)

365. Hdlbp: high density lipoprotein binding protein

366. Hey1: hairy/enhancer-of-split related with YRPW motif 1

367. Hgf: hepatocyte growth factor (hepapoietin A; scatter factor)

368. Hip1r: huntingtin interacting protein 1 related

369. Hivep1: human immunodeficiency virus type I enhancer binding protein 1

370. Hk1: hexokinase 1

371. Hmga2: high mobility group AT-hook 2

372. Hmgcr: 3-hydroxy-3-methylglutaryl-Coenzyme A reductase

373. Hmgcs1: 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble)

374. Hmgn3: high mobility group nucleosomal binding domain 3

375. Hn1: hematological and neurological expressed 1

376. Hnf4a: hepatocyte nuclear factor 4, alpha

377. Hnmt: histamine N-methyltransferase

378. Hnrnph1: heterogeneous nuclear ribonucleoprotein H1 (H)

379. Hnrpa1: heterogeneous nuclear ribonucleoprotein A1

380. Hnrpk: heterogeneous nuclear ribonucleoprotein K

381. Hnrpu: heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A)

382. hook3: hook homolog 3 (Drosophila)

383. Hps5: Hermansky-Pudlak syndrome 5

384. Hpse: heparanase

385. Hras1: v-Ha-ras Harvey rat sarcoma viral oncogene homolog

386. Hsd11b2: hydroxysteroid (11-beta) dehydrogenase 2

387. Hsd17B1: hydroxysteroid (17-beta) dehydrogenase 1

388. Hsf1: heat shock transcription factor 1

389. Hsp90ab1: heat shock protein 90 kDa alpha (cytosolic), class B member 1

390. Hspa14: heat shock 70 kDa protein 14

391. Hspe1: heat shock 10 kDa protein 1 (chaperonin 10)

392. Htr2c: 5-hydroxytryptamine (serotonin) receptor 2C

393. Htr3a: 5-hydroxytryptamine (serotonin) receptor 3A

394. Htr4: 5-hydroxytryptamine (serotonin) receptor 4

395. Hyou1: hypoxia up-regulated 1

396. Id2: inhibitor of DNA binding 2, dominant negative helix-loop-helix protein

397. Idh1: isocitrate dehydrogenase 1 (NADP+), soluble

398. Igf1r: insulin-like growth factor 1 receptor

399. Igf2r: insulin-like growth factor 2 receptor

400. Ikbkap: inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein

401. IL1b: interleukin 1, beta

402. Il1r2: interleukin 1 receptor, type II

403. Il1rapl1: interleukin 1 receptor accessory protein-like 1

404. Il6: interleukin 6 (interferon, beta 2)

405. Ilf3: interleukin enhancer binding factor 3, 90 kDa

406. Inhbc: inhibin, beta C

407. Inpp4a: inositol polyphosphate-4-phosphatase, type I, 107 kDa

408. Inpp4b: inositol polyphosphate-4-phosphatase, type II, 105 kDa

409. Inpp5d: inositol polyphosphate-5-phosphatase, 145 kDa

410. Irs1: insulin receptor substrate 1

411. Irs2: insulin receptor substrate 2

412. Isg20: interferon stimulated exonuclease gene 20 kDa

413. Itga6: integrin, alpha 6

414. Itm2c: integral membrane protein 2C

415. Itpr2: inositol 1,4,5-triphosphate receptor, type 2

416. Itpr3: inositol 1,4,5-triphosphate receptor, type 3

417. Ivl: involucrin

418. Jag1: jagged 1 (Alagille syndrome)

419. Jak1: Janus kinase 1

420. Jak2: Janus kinase 2

421. Junb: jun B proto-oncogene

422. Kalrn: kalirin, RhoGEF kinase

423. Katna1: katanin p60 (ATPase-containing) subunit A 1

424. Kcnh1: potassium voltage-gated channel, subfamily H (eag-related), member 1

425. Kcnh2: potassium voltage-gated channel, subfamily H (eag-related), member 2

426. Kcnk2: potassium channel, subfamily K, member 2

427. Kcns1: potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1

428. Kcns3: potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3

429. Kcnt1: potassium channel, subfamily T, member 1

430. Kif5a: kinesin family member 5A

431. Klc1: kinesin light chain 1

432. Klhl12: kelch-like 12 (Drosophila)

433. Kpnb1: karyopherin (importin) beta 1

434. Kras: v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog

435. Lama5: laminin, alpha 5

436. Lancl1: LanC lantibiotic synthetase component C-like 1 (bacterial)

437. Lars: leucyl-tRNA synthetase

438. Lbp: lipopolysaccharide binding protein

439. Lcmt1: leucine carboxyl methyltransferase 1

440. Letm1: leucine zipper-EF-hand containing transmembrane protein 1

441. Lgi1: leucine-rich, glioma inactivated 1

442. Lgr7: relaxin/insulin-like family peptide receptor 1

443. Lhfpl4: lipoma HMGIC fusion partner-like 4

444. Lhx3: LIM homeobox 3

445. Lifr: leukemia inhibitory factor receptor alpha

446. Lin10: chromosome 16 open reading frame 70

447. LMO7: LIM domain 7

448. Lphn1: latrophilin 1

449. Lphn2: latrophilin 2

450. Lpin1: lipin 1

451. Lrpap1: low density lipoprotein receptor-related protein associated protein 1

452. Lsamp: limbic system-associated membrane protein

453. Ltbp1: latent transforming growth factor beta binding protein 1

454. Luzp1: leucine zipper protein 1

455. Ly6g5b: lymphocyte antigen 6 complex, locus G5B

456. Lyar: Ly1 antibody reactive homolog (mouse)

457. LYL1: lymphoblastic leukemia derived sequence 1

458. Lyst: lysosomal trafficking regulator

459. Lzic: leucine zipper and CTNNBIP1 domain containing

460. M6pr: mannose-6-phosphate receptor (cation dependent)

461. Magi3: membrane associated guanylate kinase, WW and PDZ domain containing 3

462. Maoa: monoamine oxidase A

463. Map1lc3a: microtubule-associated protein 1 light chain 3 alpha

464. Map2: microtubule-associated protein 2

465. Map3k7ip2: mitogen-activated protein kinase kinase kinase 7 interacting protein 2

466. Map4: microtubule-associated protein 4

467. Mapk1: mitogen-activated protein kinase 1

468. Mapkapk2: mitogen-activated protein kinase-activated protein kinase 2

469. Mark1: MAP/microtubule affinity-regulating kinase 1

470. Mark3: MAP/microtubule affinity-regulating kinase 3

471. Matr3: matrin 3

472. Mcm7: minichromosome maintenance complex component 7

473. Mdga2: MAM domain containing glycosylphosphatidylinositol anchor 2

474. Mdh1: malate dehydrogenase 1, NAD (soluble)

475. Mecp2: methyl CpG binding protein 2 (Rett syndrome)

476. Mfap3: microfibrillar-associated protein 3

477. Mgat1: mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase

478. Mgat5: mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase

479. Mid1: midline 1 (Opitz/BBB syndrome)

480. Mkln1: muskelin 1, intracellular mediator containing kelch motifs

481. Mkrn2: makorin ring finger protein 2

482. Mlp: MARCKS-like 1

483. Mmp10: matrix metallopeptidase 10 (stromelysin 2)

484. Mnat1: ménage à trois homolog 1, cyclin H assembly factor (Xenopus laevis)

485. Mpdz: multiple PDZ domain protein

486. Mpi: mannose phosphate isomerase

487. Mpo: myeloperoxidase

488. mpp7: membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7)

489. mre11: MRE11 meiotic recombination 11 homolog A (S. cerevisiae)

490. Mrpl38: mitochondrial ribosomal protein L38

491. Mrpl9: mitochondrial ribosomal protein L9

492. Mrps9: mitochondrial ribosomal protein S9

493. Msn: moesin

494. Mtap: methylthioadenosine phosphorylase

495. Mtdh: metadherin

496. Mtmr3: myotubularin-related protein 3

497. Mtr: 5-methyltetrahydrofolate-homocysteine methyltransferase

498. Mtus1: microtubule-associated tumor suppressor 1

499. Mx1: myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse)

500. Mybpc1: myosin binding protein C, slow type

501. myc: v-myc myelocytomatosis viral oncogene homolog (avian)

502. Mycbpap: MYCBP associated protein

503. Myh10: myosin, heavy chain 10, nonmuscle

504. Myh6: myosin, heavy chain 6, cardiac muscle, alpha

505. Myh9: myosin, heavy chain 9, nonmuscle

506. Myo1a: myosin IA

507. Myo1e: myosin IE

508. Myo5a: myosin VA (heavy chain 12, myoxin)

509. Myo5b: myosin VB

510. Myo7a: myosin VIIA

511. Myo9a: myosin IXA

512. Myom1: myomesin 1, 185 kDa

513. Nab1: NGFI-A binding protein 1 (EGR1 binding protein 1)

514. Nab2: NGFI-A binding protein 2 (EGR1 binding protein 2)

515. Naca: nascent polypeptide-associated complex alpha subunit

516. Naglu: N-acetylglucosaminidase, alpha-

517. Nap1l3: nucleosome assembly protein 1-like 3

518. Napepld: N-acyl phosphatidylethanolamine phospholipase D

519. Nasp: nuclear autoantigenic sperm protein (histone-binding)

520. Ncam1: neural cell adhesion molecule 1

521. Ncam2: neural cell adhesion molecule 2

522. Ncdn: neurochondrin

523. Ncl: nucleolin

524. Ncstn: nicastrin

525. Ndel1: nudE nuclear distribution gene E homolog (A. nidulans)-like 1

526. Ndufa9: NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39 kDa

527. Ndufc2: NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5 kDa

528. Ndufs1: NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75 kDa (NADH-coenzyme Q reductase)

529. Ndufs6: NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13 kDa (NADH-coenzyme Q reductase)

530. Ndufs7: NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20 kDa (NADH-coenzyme Q reductase)

531. Nedd4: neural precursor cell expressed, developmentally down-regulated 4

532. Nef3: neurofilament, medium polypeptide

533. Nefh: neurofilament, heavy polypeptide

534. Negr1: neuronal growth regulator 1

535. Nell1: NEL-like 1 (chicken)

536. Neo1: neogenin homolog 1 (chicken)

537. Nes: nestin

538. Nexn: nexilin (F actin binding protein)

539. Nf2: neurofibromin 2 (merlin)

540. Nfix: nuclear factor I/X (CCAAT-binding transcription factor)

541. Nfkb1: nuclear factor of kappa light polypeptide gene enhancer in B-cells 1

542. Ninj1: ninjurin 1

543. Nlgn2: neuroligin 2

544. Nlgn3: neuroligin 3

545. Nme2: non-metastatic cells 2, protein (NM23B) expressed in

546. Nolc1: nucleolar and coiled-body phosphoprotein 1

547. Nos1: nitric oxide synthase 1 (neuronal)

548. Nos3: nitric oxide synthase 3 (endothelial cell)

549. Notch1: Notch homolog 1, translocation-associated (Drosophila)

550. Notch2: Notch homolog 2 (Drosophila)

551. Notch4: Notch homolog 4 (Drosophila)

552. Npc2: Niemann-Pick disease, type C2

553. Npdc1: neural proliferation, differentiation and control, 1

554. Npepps: aminopeptidase puromycin sensitive

555. Npm1: nucleophosmin (nucleolar phosphoprotein B23, numatrin)

556. Npr2: natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B)

557. Npvf: neuropeptide VF precursor

558. Npy5r: neuropeptide Y receptor Y5

559. Nr1i2: nuclear receptor subfamily 1, group I, member 2

560. Nr5a2: nuclear receptor subfamily 5, group A, member 2

561. Nr6a1: nuclear receptor subfamily 6, group A, member 1

562. Nras: neuroblastoma RAS viral (v-ras) oncogene homolog

563. Nrbf2: nuclear receptor binding factor 2

564. Nrp2: neuropilin 2

565. Nsf: N-ethylmaleimide-sensitive factor

566. Ntrk2: neurotrophic tyrosine kinase, receptor, type 2

567. Nucb1: nucleobindin 1

568. Nucb2: nucleobindin 2

569. Nudc: nuclear distribution gene C homolog (A. nidulans)

570. Nup88: nucleoporin 88 kDa

571. Oas3: 2^\'^-5^\'^-oligoadenylate synthetase 3, 100 kDa

572. Obscn: obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF

573. Ociad1: OCIA domain containing 1

574. Odc1: ornithine decarboxylase 1

575. Odf2: outer dense fiber of sperm tails 2

576. Ogfr: opioid growth factor receptor

577. Olfm2: olfactomedin 2

578. Olfm3: olfactomedin 3

579. Omg: oligodendrocyte myelin glycoprotein

580. Optn: optineurin

581. Osbp: oxysterol binding protein

582. Oxr1: oxidation resistance 1

583. P4hb: prolyl 4-hydroxylase, beta polypeptide

584. Pabpc1: poly(A) binding protein, cytoplasmic 1

585. Pabpc4: poly(A) binding protein, cytoplasmic 4 (inducible form)

586. Padi2: peptidyl arginine deiminase, type II

587. Pak3: p21 protein (Cdc42/Rac)-activated kinase 3

588. Palm: paralemmin

589. Panx1: pannexin 1

590. Pard3: par-3 partitioning defective 3 homolog (C. elegans)

591. Parg: poly (ADP-ribose) glycohydrolase

592. Park7: Parkinson disease (autosomal recessive, early onset) 7

593. Pbp: phosphatidylethanolamine binding protein 1

594. Pcca: propionyl Coenzyme A carboxylase, alpha polypeptide

595. Pcdh21: protocadherin 21

596. Pcdha3: protocadherin alpha 3

597. Pcdhb1: protocadherin beta 1

598. Pcdhb10: protocadherin beta 10

599. Pcdhga12: protocadherin gamma subfamily A, 12

600. Pclo: piccolo (presynaptic cytomatrix protein)

601. Pcolce: procollagen C-endopeptidase enhancer

602. Pcsk1n: proprotein convertase subtilisin/kexin type 1 inhibitor

603. Pcsk5: proprotein convertase subtilisin/kexin type 5

604. Pcyox1: prenylcysteine oxidase 1

605. Pdap1: PDGFA associated protein 1

606. Pdcd4: programmed cell death 4 (neoplastic transformation inhibitor)

607. Pdcl: phosducin-like

608. Pde10a: phosphodiesterase 10A

609. Pde4b: phosphodiesterase 4B, cAMP-specific (phosphodiesterase E4 dunce homolog, Drosophila)

610. Pdlim7: PDZ and LIM domain 7 (enigma)

611. Pea15: phosphoprotein enriched in astrocytes 15

612. Pecr: peroxisomal trans-2-enoyl-CoA reductase

613. Per1: period homolog 1 (Drosophila)

614. Per3: period homolog 3 (Drosophila)

615. Pfkl: phosphofructokinase, liver

616. PGAP1: post-GPI attachment to proteins 1

617. Phactr3: phosphatase and actin regulator 3

618. Phb: prohibitin

619. Phka1: phosphorylase kinase, alpha 1 (muscle)

620. Phkg2: phosphorylase kinase, gamma 2 (testis)

621. Pi4ka: phosphatidylinositol 4-kinase, catalytic, alpha

622. Picalm: phosphatidylinositol binding clathrin assembly protein

623. Pik3c3: phosphoinositide-3-kinase, class 3

624. Pik3cb: phosphoinositide-3-kinase, catalytic, beta polypeptide

625. Pik3r2: phosphoinositide-3-kinase, regulatory subunit 2 (beta)

626. Pim1: pim-1 oncogene

627. Pip5k2a: phosphatidylinositol-5-phosphate 4-kinase, type II, alpha

628. Pitpnm1: phosphatidylinositol transfer protein, membrane-associated 1

629. Pkia: protein kinase (cAMP-dependent, catalytic) inhibitor alpha

630. Pkm2: pyruvate kinase, muscle

631. Pla2g2a: phospholipase A2, group IIA (platelets, synovial fluid)

632. Plb1: phospholipase B1

633. Plcb4: phospholipase C, beta 4

634. Plcd4: phospholipase C, delta 4

635. Plec1: plectin 1, intermediate filament binding protein 500kDa

636. Plk1: polo-like kinase 1 (Drosophila)

637. Pnkp: polynucleotide kinase 3\'-phosphatase

638. Pnma1: paraneoplastic antigen MA1

639. Ppara: peroxisome proliferator-activated receptor alpha

640. Ppargc1b: peroxisome proliferator-activated receptor gamma, coactivator 1 beta

641. ppfibp2: PTPRF interacting protein, binding protein 2 (liprin beta 2)

642. Ppia: peptidylprolyl isomerase A (cyclophilin A)

643. Ppm2c: pyruvate dehydrogenase phosphatase catalytic subunit 1

644. Ppp1r14b: protein phosphatase 1, regulatory (inhibitor) subunit 14B

645. Ppp1r1a: protein phosphatase 1, regulatory (inhibitor) subunit 1A

646. Ppp1r9a: protein phosphatase 1, regulatory (inhibitor) subunit 9A

647. Ppp2r1a: protein phosphatase 2 (formerly 2A), regulatory subunit A, alpha isoform

648. Ppp3cc: protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform

649. Pqlc1: PQ loop repeat containing 1

650. Prdx1: peroxiredoxin 1

651. Prdx6: peroxiredoxin 6

652. Prg3: proteoglycan 3

653. Prkaa2: protein kinase, AMP-activated, alpha 2 catalytic subunit

654. Prkaca: protein kinase, cAMP-dependent, catalytic, alpha

655. Prkar1a: protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)

656. Prkar2a: protein kinase, cAMP-dependent, regulatory, type II, alpha

657. Prkcd: protein kinase C, delta

658. PRKCQ: protein kinase C, theta

659. Prkwnk1: WNK lysine deficient protein kinase 1

660. Prlh: prolactin releasing hormone

661. Prmt3: protein arginine methyltransferase 3

662. Prpsap2: phosphoribosyl pyrophosphate synthetase-associated protein 2

663. Prrx2: paired related homeobox 2

664. Prss12: protease, serine, 12 (neurotrypsin, motopsin)

665. Prss15: lon peptidase 1, mitochondrial

666. Prx: periaxin

667. Psap: prosaposin

668. Pscd2: cytohesin 2

669. Pscd3: cytohesin 3

670. Psg4: pregnancy specific beta-1-glycoprotein 4

671. Psma1: proteasome (prosome, macropain) subunit, alpha type, 1

672. Psma2: proteasome (prosome, macropain) subunit, alpha type, 2

673. Psmc4: proteasome (prosome, macropain) 26S subunit, ATPase, 4

674. Psme2: proteasome (prosome, macropain) activator subunit 2 (PA28 beta)

675. Ptbp1: polypyrimidine tract binding protein 1

676. Ptch1: patched homolog 1 (Drosophila)

677. Pth: parathyroid hormone

678. Pthr2: parathyroid hormone 2 receptor

679. Ptk2b: PTK2B protein tyrosine kinase 2 beta

680. Ptp4a1: protein tyrosine phosphatase type IVA, member 1

681. Ptpn11: protein tyrosine phosphatase, non-receptor type 11

682. Ptpn23: protein tyrosine phosphatase, non-receptor type 23

683. Ptprj: protein tyrosine phosphatase, receptor type, J

684. Ptprr: protein tyrosine phosphatase, receptor type, R

685. Ptprv: protein tyrosine phosphatase, receptor type, V (pseudogene)

686. Pxn: paxillin

687. Pygl: phosphorylase, glycogen, liver

688. Qscn6: quiescin Q6 sulfhydryl oxidase 1

689. Rab10: RAB10, member RAS oncogene family

690. Rab14: RAB14, member RAS oncogene family

691. Rab2: RAB2A, member RAS oncogene family

692. Rab21: RAB21, member RAS oncogene family

693. Rab35: RAB35, member RAS oncogene family

694. Rab3il1: RAB3A interacting protein (rabin3)-like 1

695. Rab4a: RAB4A, member RAS oncogene family

696. Rab5a: RAB5A, member RAS oncogene family

697. Rab7: RAB7A, member RAS oncogene family

698. Rab9: RAB9A, member RAS oncogene family

699. Rabac1: Rab acceptor 1 (prenylated)

700. Rabggta: Rab geranylgeranyltransferase, alpha subunit

701. Rac1: ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)

702. Rala: v-ral simian leukemia viral oncogene homolog A (ras related)

703. RalB: v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein)

704. Ralb: v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein)

705. Raly: RNA binding protein, autoantigenic (hnRNP associated with lethal yellow homolog (mouse))

706. RanGap1: Ran GTPase activating protein 1

707. Rap2b: RAP2B, member of RAS oncogene family

708. Rbbp6: retinoblastoma binding protein 6

709. Rbl2: retinoblastoma-like 2 (p130)

710. Rbm3: RNA binding motif (RNP1, RRM) protein 3

711. Rcn1: reticulocalbin 1, EF-hand calcium binding domain

712. Rcvrn: recoverin

713. Rdh10: retinol dehydrogenase 10 (all-trans)

714. Rdx: radixin

715. Rest: RE1-silencing transcription factor

716. Rgs4: regulator of G-protein signaling 4

717. Rgs5: regulator of G-protein signaling 5

718. Rgs7: regulator of G-protein signaling 7

719. Rhoa: ras homolog gene family, member A

720. RhoB: ras homolog gene family, member B

721. Rhoj: ras homolog gene family, member J

722. Rims1: regulating synaptic membrane exocytosis 1

723. Rnasel: ribonuclease L (2^\'^,5^\'^-oligoisoadenylate synthetase-dependent)

724. Rnf36: tripartite motif-containing 69

725. Rnf40: ring finger protein 40

726. Robo1: roundabout, axon guidance receptor, homolog 1 (Drosophila)

727. Robo4: roundabout homolog 4, magic roundabout (Drosophila)

728. Rock1: Rho-associated, coiled-coil containing protein kinase 1

729. Rock2: Rho-associated, coiled-coil containing protein kinase 2

730. rora: RAR-related orphan receptor A

731. Rpe65: retinal pigment epithelium-specific protein 65 kDa

732. Rpl13: ribosomal protein L13

733. Rpl6: ribosomal protein L6

734. Rplp1: ribosomal protein, large, P1

735. Rpn2: ribophorin II

736. Rps15: ribosomal protein S15

737. Rps16: ribosomal protein S16

738. Rps6ka2: ribosomal protein S6 kinase, 90 kDa, polypeptide 2

739. Rtcd1: RNA terminal phosphate cyclase domain 1

740. Rtkn: rhotekin

741. Rtn1: reticulon 1

742. Rtn3: reticulon 3

743. Rtn4: reticulon 4

744. Rtn4r: reticulon 4 receptor

745. Samsn1: SAM domain, SH3 domain and nuclear localization signals 1

746. Sardh: sarcosine dehydrogenase

747. Sart1: squamous cell carcinoma antigen recognized by T cells

748. Sbds: Shwachman-Bodian-Diamond syndrome

749. Sc4mol: sterol-C4-methyl oxidase-like

750. Sca10: ataxin 10

751. Scg2: secretogranin II (chromogranin C)

752. Scg3: secretogranin III

753. Scn1a: sodium channel, voltage-gated, type I, alpha subunit

754. Scn2a1: sodium channel, voltage-gated, type II, alpha subunit

755. Scn5a: sodium channel, voltage-gated, type V, alpha subunit

756. Scn8a: sodium channel, voltage gated, type VIII, alpha subunit

757. Scoc: short coiled-coil protein

758. Scp2: sterol carrier protein 2

759. SCYB11: chemokine (C-X-C motif) ligand 11

760. Scye1: aminoacyl tRNA synthetase complex-interacting multifunctional protein 1

761. Sdfr1: neuroplastin

762. Sdpr: serum deprivation response

763. SH3gl1: SH3-domain GRB2-like 1

764. SH3glb1: SH3-domain GRB2-like endophilin B1

765. Shank1: SH3 and multiple ankyrin repeat domains 1

766. Sirpa: signal-regulatory protein alpha

767. Skiv2l2: superkiller viralicidic activity 2-like 2 (S. cerevisiae)

768. Slc12a2: solute carrier family 12 (sodium/potassium/chloride transporters), member 2

769. Slc12a9: solute carrier family 12 (potassium/chloride transporters), member 9

770. Slc13a3: solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3

771. Slc17a6: solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6

772. Slc1a1: solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1

773. Slc26a4: solute carrier family 26, member 4

774. Slc27a5: solute carrier family 27 (fatty acid transporter), member 5

775. Slc30a1: solute carrier family 30 (zinc transporter), member 1

776. Slc44a4: solute carrier family 44, member 4

777. Slc5a1: solute carrier family 5 (sodium/glucose cotransporter), member 1

778. Slc6a8: solute carrier family 6 (neurotransmitter transporter, creatine), member 8

779. Slc8a1: solute carrier family 8 (sodium/calcium exchanger), member 1

780. Smad4: SMAD family member 4

781. Smc1l1: structural maintenance of chromosomes 1A

782. Smoc1: SPARC related modular calcium binding 1

783. Snai2: snail homolog 2 (Drosophila)

784. Snap25: synaptosomal-associated protein, 25 kDa

785. Snap91: synaptosomal-associated protein, 91 kDa homolog (mouse)

786. Snca: synuclein, alpha (non A4 component of amyloid precursor)

787. Sncb: synuclein, beta

788. Snx3: sorting nexin 3

789. Snx7: sorting nexin 7

790. sod1: superoxide dismutase 1, soluble

791. Sod2: superoxide dismutase 2, mitochondrial

792. Son: SON DNA binding protein

793. Sord: sorbitol dehydrogenase

794. Sox5: SRY (sex determining region Y)-box 5

795. Sp4: Sp4 transcription factor

796. Sp7: Sp7 transcription factor

797. Sqle: squalene epoxidase

798. Srfbp1: serum response factor binding protein 1

799. Sst: somatostatin

800. St6gal2: ST6 beta-galactosamide alpha-2,6-sialyltransferase 2

801. St7l: suppression of tumorigenicity 7 like

802. Stard3nl: STARD3 N-terminal like

803. Stat3: signal transducer and activator of transcription 3 (acute-phase response factor)

804. Stat5a: signal transducer and activator of transcription 5A

805. Stip1: stress-induced-phosphoprotein 1

806. Stk2: NIMA (never in mitosis gene a)-related kinase 4

807. Stk22a: testis-specific serine kinase 1A pseudogene

808. Stmn1: stathmin 1

809. Stmn2: stathmin-like 2

810. Stmn4: stathmin-like 4

811. Strbp: spermatid perinuclear RNA binding protein

812. Stx1a: syntaxin 1A (brain)

813. Stx1b2: syntaxin 1B

814. Stx5: syntaxin 5

815. stxbp1: syntaxin binding protein 1

816. Stxbp3: syntaxin binding protein 3

817. Sulf1: sulfatase 1

818. Svop: SV2 related protein homolog (rat)

819. SYAP1: synapse associated protein 1, SAP47 homolog (Drosophila)

820. Sycp1: synaptonemal complex protein 1

821. Sycp2: synaptonemal complex protein 2

822. Synj2: synaptojanin 2

823. Syt3: synaptotagmin III

824. Syt4: synaptotagmin IV

825. Tacc2: transforming, acidic coiled-coil containing protein 2

826. Tacc3: transforming, acidic coiled-coil containing protein 3

827. Tbx2: T-box 2

828. Tceb3: transcription elongation factor B (SIII), polypeptide 3 (110 kDa, elongin A)

829. Tcp1: t-complex 1

830. Tcp11: t-complex 11 homolog (mouse)

831. Tdg: thymine-DNA glycosylase

832. Tdrd7: tudor domain containing 7

833. Tesk2: testis-specific kinase 2

834. Tfrc: transferrin receptor (p90, CD71)

835. Tgfb1: transforming growth factor, beta 1

836. Thrap3: thyroid hormone receptor associated protein 3

837. Thrb: thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian)

838. Thy1: Thy-1 cell surface antigen

839. Tinag: tubulointerstitial nephritis antigen

840. Tkt: transketolase

841. Tle3: transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila)

842. Tlr5: toll-like receptor 5

843. Tm4sf8: tetraspanin 3

844. Tm9sf2: transmembrane 9 superfamily member 2

845. Tmeff1: transmembrane protein with EGF-like and two follistatin-like domains 1

846. Tmem17: transmembrane protein 17

847. Tmlhe: trimethyllysine hydroxylase, epsilon

848. Tmod2: tropomodulin 2 (neuronal)

849. Tmpo: thymopoietin

850. Tnfrsf14: tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)

851. Top1: topoisomerase (DNA) I

852. Tpd52l2: tumor protein D52-like 2

853. Tpm4: tropomyosin 4

854. Tra1: heat shock protein 90kDa beta (Grp94), member 1

855. Traf4: TNF receptor-associated factor 4

856. Trib3: tribbles homolog 3 (Drosophila)

857. Trim10: tripartite motif-containing 10

858. Trim25: tripartite motif-containing 25

859. Trim50: tripartite motif-containing 50

860. Trpa1: transient receptor potential cation channel, subfamily A, member 1

861. TrpV6: transient receptor potential cation channel, subfamily V, member 6

862. Tsc1: tuberous sclerosis 1

863. Tsga10: testis specific, 10

864. Tshr: thyroid stimulating hormone receptor

865. Ttc1: tetratricopeptide repeat domain 1

866. Ttn: titin

867. Tub: tubby homolog (mouse)

868. Tubb: tubulin, beta

869. Tubb2: tubulin, beta 2A

870. Txn: thioredoxin

871. U2af2: U2 small nuclear RNA auxiliary factor 2

872. Ubc: ubiquitin C

873. Ube2l3: ubiquitin-conjugating enzyme E2L 3

874. Ubqln1: ubiquilin 1

875. Uchl1: ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)

876. Ugcgl1: UDP-glucose glycoprotein glucosyltransferase 1

877. Uhrf1: ubiquitin-like with PHD and ring finger domains 1

878. Unc13: unc-13 homolog B (C. elegans)

879. Unc13a: unc-13 homolog A (C. elegans)

880. Unc13d: unc-13 homolog D (C. elegans)

881. Uqcrfs1: ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1

882. Usp14: ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase)

883. Usp15: ubiquitin specific peptidase 15

884. Vamp2: vesicle-associated membrane protein 2 (synaptobrevin 2)

885. Vangl2: vang-like 2 (van gogh, Drosophila)

886. Vapa: VAMP (vesicle-associated membrane protein)-associated protein A, 33 kDa

887. Vapb: VAMP (vesicle-associated membrane protein)-associated protein B and C

888. Vav1: vav 1 guanine nucleotide exchange factor

889. Vcp: valosin-containing protein

890. Vdac2: voltage-dependent anion channel 2

891. Vegfa: vascular endothelial growth factor A

892. Vgf: VGF nerve growth factor inducible

893. Viaat: solute carrier family 32 (GABA vesicular transporter), member 1

894. Vim: vimentin

895. Vldlr: very low density lipoprotein receptor

896. Vps4a: vacuolar protein sorting 4 homolog A (S. cerevisiae)

897. Vps52: vacuolar protein sorting 52 homolog (S. cerevisiae)

898. Vps54: vacuolar protein sorting 54 homolog (S. cerevisiae)

899. Vsnl1: visinin-like 1

900. Vti1a: vesicle transport through interaction with t-SNAREs homolog 1A (yeast)

901. Vtn: vitronectin

902. Wbp11: WW domain binding protein 11

903. Wbscr1: eukaryotic translation initiation factor 4H

904. Whsc2: Wolf-Hirschhorn syndrome candidate 2

905. Wif1: WNT inhibitory factor 1

906. Wnk4: WNK lysine deficient protein kinase 4

907. Wrnip1: Werner helicase interacting protein 1

908. Xpo7: exportin 7

909. Xrcc5: X-ray repair complementing defective repair in Chinese hamster cells 5

910. Ybx1: Y box binding protein 1

911. yes1: v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1

912. Ywhah: tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide

913. Ywhaq: tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide

914. Zbtb7a: zinc finger and BTB domain containing 7A

915. Zeb1: zinc finger E-box binding homeobox 1

916. Zfhx2: zinc finger homeobox 2

917. Zfp57: zinc finger protein 57 homolog (mouse)

918. Zmynd19: zinc finger, MYND-type containing 19

919. Znf219: zinc finger protein 219

920. Znf291: S-phase cyclin A-associated protein in the ER

921. Znf292: zinc finger protein 292

922. Znf382: zinc finger protein 382.

C. {#sec9}
==

Cellular signaling pathway clusters of extracted proteins from primary cortical tissue. Specific cellular signaling pathway clusters generated in an un-biased manner using Ingenuity Pathway Analysis (v. 8.5). The relative score generated for the degree of pathway population by proteins from the respective input sets (control or 3xTgAD) is shown in bold. The following are different types of signaling pathways.

C.1. ERK/MAPK Signaling (Enrichment Ratio\*−log  10(*p*)) {#sec9.1}
---------------------------------------------------------

Control Protein (**1.32502**)PPP2R2A, CRK, PPP1R14B, DUSP2, PTK2, SHC1, PAK1, PPP1R10, PPP1R7, PIK3CG, STAT1, PRKCA, ETS1, SRC, PAK2, YWHAB, CRKL, PRKAR2A, STAT3, PLA2G4C, FOS, PPP2CB, PPP2R1A, PRKAR2B, PRKCI, PAK3, PPP2R2B, PRKACA, PPP2R5E, ELK1, PPP2R1B, PRKAR1A, PRKCB.

3xTgAD Protein (**0.1537**)PXN, YWHAH, PTK2B, RAC1, PRKAR2A, PLA2G2A, STAT3, MYC, YWHAQ (includes EG:10971), PPP2R1A, PAK3, PIK3C3, PRKCD, PRKACA, PIK3CB, PIK3R2, ELK1, FYN, PRKAR1A.

C.2. Inositol Phosphate Metabolism (Enrichment Ratio\*−log  10(*p*)) {#sec9.2}
--------------------------------------------------------------------

Control Protein (**0.86424**)PDIA3, OCRL, PAK1, PIK3CG, PRKAA2, PLCB1, PLCL1, PI4KA, PMPCA, ATM, GRK4, PRKCQ, PAK2, CDK7, CDK6, PLK1, GRK5, ITPKA, SYNJ2, PIP5K1A, PAK3, SYNJ1, PIP5K1C, GRK6, PIP4K2A, PIP4K2C, CDK2.

3xTgAD Protein (**0.15355**)PLK1, INPP5D, SYNJ2, INPP4A, INPP4B, INPP4B, PAK3, PIM1, PRKCD, PIK3C3, PRKAA2, PIK3CB, PIK3R2, PIP4K2A, PLCD4, PI4KA, ATM.

C.3. Wnt/*β*-Catenin Signaling (Enrichment Ratio\*−log  10(*p*)) {#sec9.3}
----------------------------------------------------------------

Control Protein (**0.5609**)PPP2R2A, SOX10, CSNK1E, WIF1, WNT7A, TGFB1, SMO, CSNK2A1, CSNK2B, CTNNB1, SRC, SFRP4, GJA1, CSNK1G2, DVL1, FZD9, PPP2CB, CDH2, CDH1, PPP2R1A, PPP2R2B, TLE3, PPP2R5E, UBC, PPP2R1B, WNT5A.

3xTgAD Protein (**0.12772**)CSNK1G1, CSNK1G3, DVL1, ACVR1, APC, MYC, CSNK1E, PPP2R1A, CDH2, CDH1, WIF1, TGFB1, GNAO1, TLE3, UBC, CTNNB1, SOX5 (includes EG:6660).

C.4. Calcium Signaling (Enrichment Ratio\*−log  10(*p*)) {#sec9.4}
--------------------------------------------------------

Control Protein (**0.33825**)TRPC2, GRIN2A, TNNI2, GRIA1, RCAN2, CALM2, CHRNB4, TRPC5, TNNT3, RYR3, GRIK1, GRIN2B, PRKAR2A, TRPC4, PPP3CC, TRPC7, CHRNG, PRKAR2B, TPM3, CAMKK1, PRKACA, TNNI1, CHRNB3, CAMKK2, PRKAR1A.

3xTgAD Protein (**0.110875**)RAP2B, MYH10, CALR, MYH6, ATP2B1, PRKAR2A, TPM4, PPP3CC, ATP2B2, HDAC6, TRPV6, HTR3A, CAMKK1, PRKACA, MYH9, SLC8A1, ACTA1, PRKAR1A.

C.5. Tight Junction Signaling (Enrichment Ratio\*−log  10(*p*)) {#sec9.5}
---------------------------------------------------------------

Control Protein (**0.4147**)TJP2, CDC42, TJP1, PPP2R2A, CLDN19, VAPA, PRKAR2A, PRKCZ, FOS, PPP2CB, PPP2R1A, PRKCI, PRKAR2B, CLDN4, CLDN1, TGFB1, PPP2R2B, PRKACA, PPP2R5E, STX4, CTNNB1, PPP2R1B, PRKAR1A.

3xTgAD Protein (**0.24514**)MYH10, MYH6, CDC42, ACTB, HSF1, CLDN18, VAPA, RAC1, PRKAR2A, MPDZ, PPP2R1A, TGFB1, RHOA, CEBPA, PRKACA, MYH9, CTNNB1, ACTA1, PRKAR1A.

C.6. NF-*κ*B Signaling (Enrichment Ratio\*−log  10(*p*)) {#sec9.6}
--------------------------------------------------------

Control Protein (**0.12096**)PRKCQ, EGF, PRKCZ, TLR9, TLR4, TLR5, PIK3CG, TLR6, PRKACA, CSNK2A1, PDGFRA, TLR3, CSNK2B, PRKCB, EGFR.

3xTgAD Protein (**0.0190128**)*IL1R2, TLR5, BCL10, PIK3C3, PRKACA, IL1B, PIK3CB, PIK3R2, NFKB1, EGFR*.

C.7. PTEN Signaling (Enrichment Ratio\*−log  10(*p*)) {#sec9.7}
-----------------------------------------------------

Control Protein (**0.1368**)PTK2, SHC1, CDC42, PIK3CG, CSNK2A1, PDGFRA, CSNK2B, CDKN1B, PRKCZ, FASLG, EGFR.

3xTgAD Protein (**0.1199**)CDC42, YWHAH, RAC1, PIK3CB, PIK3R2, CDKN1B, NFKB1, INPP5D, EGFR, MAGI3.

C.8. SAPK/JNK Signaling (Enrichment Ratio\*−log  10(*p*)) {#sec9.8}
---------------------------------------------------------

Control Protein (**0.0544984**)SHC1, CDC42, GADD45A, CRKL, PIK3CG, CRK, ELK1, GNG7.

3xTgAD Protein (**0.0717288**)CDC42, GADD45A, IRS1, PIK3C3, RAC1, PIK3CB, PIK3R2, ELK1, HNRNPK.

C.9. PI3K/AKT Signaling (Enrichment Ratio\*−log  10(*p*)) {#sec9.9}
---------------------------------------------------------

Control Protein (**0.15481**)TSC1, PPP2R2A, YWHAB, PRKCZ, PPP2CB, SHC1, PPP2R1A, PIK3CG, TSC2, PPP2R2B, PPP2R5E, CDKN1B, CTNNB1, PPP2R1B.

3xTgAD Protein (**0.19323**)TSC1, JAK1, YWHAH, JAK2, NOS3, INPP5D, YWHAQ (includes EG:10971), MTOR, PPP2R1A, HSP90AB1, PIK3CB, PIK3R2, CDKN1B, CTNNB1.

C.10. p38 MAPK Signaling (Enrichment Ratio\*−log  10(*p*)) {#sec9.10}
----------------------------------------------------------

Control Protein (**0**) 

3xTgAD Protein (**0.0630702**)IL1R2, MYC, TGFB1, MAP3K7IP2, IL1B, PLA2G2A, EEF2K, MAPKAPK2, ELK1.

C.11. p53 Signaling (Enrichment Ratio\*−log  10(*p*)) {#sec9.11}
-----------------------------------------------------

Control Protein (**0.037996**)GADD45A, FASN, PIK3CG, SNAI2, CTNNB1, CDK2, ATM, SERPINE2.

3xTgAD Protein (**0.12075**)CCND2, GADD45A, PIK3C3, SNAI2, CABC1, PIK3CB, PIK3R2, BAX, CTNNB1, ATM.

C.12. JAK/Stat Signaling (Enrichment Ratio\*−log  10(*p*)) {#sec9.12}
----------------------------------------------------------

Control Protein (**0.051714**)SHC1, SOCS1, PTPN11, PIK3CG, STAT3, STAT1.

3xTgAD Protein (**0.25857**)STAT5A, MTOR, JAK1, PTPN11, PIK3C3, PIK3CB, STAT3, PIK3R2, JAK2.

D. {#sec10}
==

Neuronal function pathway clusters of extracted proteins from primary cortical tissue. Specific neuronal function pathway clusters generated in an un-biased manner using Ingenuity Pathway Analysis (v. 8.5). The relative score generated for the degree of pathway population by proteins from the respective input sets (control or 3xTgAD) is shown in bold. The following are different types of signaling pathways.

D.1. Synaptic Long-Term Potentiation (Enrichment Ratio\*−log  10(*p*)) {#sec10.1}
----------------------------------------------------------------------

Control Protein (**1.27872**)GRIN2B, GRIN2A, PRKCQ, PPP1R1A, GRIA1, PRKAR2A, CALM2, CACNA1C, PPP3CC, GRM4, PPP1R14B, PRKCZ, GRM5, PRKCI, PRKAR2B, PPP1R10, PPP1R7, PPP1R14D, PRKACA, PLCB1, PRKD1, PRKCA, PRKAR1A, PRKCB

3xTgAD Protein (**0**) 

D.2. Axonal Guidance Signaling (Enrichment Ratio\*−log  10(*p*)) {#sec10.2}
----------------------------------------------------------------

Control Protein (**0.69525**)NOS1, GUCY1B2, PRKCQ, GUCY1A3, GUCY2D, PPP2R2A, GRID2, GRIA1, GRM4, PRKCZ, GRM5, PPP2CB, PPP2R1A, PRKCI, PPP2R2B, RYR3, GUCY1A2, PLCB1, PPP2R5E, PPP2R1B, PRKD1, PRKCA, PRKCB.

3xTgAD Protein (**0.1918**)NOS1, GUCY2D, GNAI1, PLA2G2A, GNAZ, NOS3, PRDX6, GNAI2, PPP2R1A, PRKCD, GNAO1, IGF1R, GUCY2F, ADCY8, NPR2.

D.3. Synaptic Long-Term Depression (Enrichment Ratio\*−log  10(*p*)) {#sec10.3}
--------------------------------------------------------------------

Control Protein (**0.47428**)NOS1, GUCY1B2, PRKCQ, GUCY1A3, GUCY2D, PPP2R2A, GRID2, GRIA1, GRM4, PRKCZ, GRM5, PPP2CB, PPP2R1A, PRKCI, PPP2R2B, RYR3, GUCY1A2, PLCB1, PPP2R5E, PPP2R1B, PRKD1, PRKCA, PRKCB.

3xTgAD Protein (**0.11112**)NOS1, GUCY2D, GNAI1, PLA2G2A, GNAZ, NOS3, PRDX6, GNAI2, PPP2R1A, PRKCD, GNAO1, IGF1R, GUCY2F, ADCY8, NPR2.

D.4. Parkinson\'s Signaling (Enrichment Ratio\*−log  10(*p*)) {#sec10.4}
-------------------------------------------------------------

Control Protein (**0.168256**)UCHL1, PARK7, SNCA.

3xTgAD Protein (**0.18656**)UCHL1, PARK7, SNCA.

D.5. Huntington\'s Disease Signaling (Enrichment Ratio\*−log  10(*p*)) {#sec10.5}
----------------------------------------------------------------------

Control Protein (**0.20048**)EGF, GNG7, PRKCZ, TGM2, CTSD, SHC1, PIK3CG, VAMP3, PLCB1, PRKD1, PRKCA, EGFR, SDHA, GRIN2B, PRKCQ, YKT6, SH3GL3, STX1A, SNAP25, TAF9B, GRM5, PRKCI, UBC, GOSR2, SNCA, PRKCB.

3xTgAD Protein (**0.36179**)VTI1A, HSPA14, REST, GNB2L1, HDAC6, NSF, MTOR, PIK3C3, IGF1R, PIK3R2, EGFR, CAPN5, CAPN6, CLTC, BAX, STX1A, SNAP25, DNM1, DNAJC5, ATP5B, CAPN1, PRKCD, HAP1, DCTN1, PIK3CB, UBC, SNCA, CASP7.

D.6. Regulation of Actin-Based Motility by Rho (Enrichment Ratio\*−log  10(*p*)) {#sec10.6}
--------------------------------------------------------------------------------

Control Protein (**0.1476**)PIP5K1A, WIPF1, PAK1, PAK2, CDC42, CFL1, PAK3, PIP5K1C, PIP4K2A, PIP4K2C, PI4KA.

3xTgAD Protein (**0.3243**)CDC42, CFL1, ACTB, RAC1, RHOJ, ROCK1, PAK3, RHOB, RHOA, ARHGDIA, PIP4K2A, ACTA1, PI4KA.

D.7. Amyotrophic Lateral Sclerosis Signaling (Enrichment Ratio\*−log  10(*p*)) {#sec10.7}
------------------------------------------------------------------------------

Control Protein (**0.23184**)NOS1, GRIN2B, GRIN2A, SOD1, GRIA1, PGF, VEGFA, PAK1, GRIK4, PIK3CG, CAT, GLUL, SSR4.

3xTgAD Protein (**0.55955**)NOS1, CAPN5, CAPN6, SOD1, RAB5A, RAC1, NEFH, BAX, CCS, VEGFA, CAPN1, PIK3C3, NEFM, PIK3CB, PIK3R2, CASP7.

D.8. Actin Cytoskeleton Signaling (Enrichment Ratio\*−log  10(*p*)) {#sec10.8}
-------------------------------------------------------------------

Control Protein (**0.0763861**)PAK2, CFL1, CDC42, CRKL, EGF, CRK, TTN, PTK2, SHC1, PAK1, PIP5K1A, PAK3, PIP5K1C, FGF18, PIK3CG, EZR, FGF23, PIP4K2A, PIP4K2C, GIT1.

3xTgAD Protein (**0.44928**)MYH10, MYH6, CDC42, ROCK2, PIK3C3, EZR, PIK3R2, LBP, ACTA1, PXN, ARHGEF12, CFL1, ACTB, RAC1, RDX, APC, TTN, ROCK1, PAK3, RHOA, ARHGEF6, MYH9, VAV1, PIK3CB, ACTN4, PIP4K2A, MSN.

D.9. Amyloid Processing (Enrichment Ratio\*−log  10(*p*)) {#sec10.9}
---------------------------------------------------------

Control Protein (**0.20636**)CSNK1E, PRKAR2B, CSNK2A, PRKAR2A, PRKACA, NCSTN, CSNK2B, PRKAR1A.

3xTgAD Protein (**0.66144**)CSNK1E, CAPN5, CAPN6, CAPN1, MARK1, PRKAR2A, PRKACA, NCSTN, BACE1, APP, PRKAR1A.

E. {#sec11}
==

Energy regulation/Metabolism pathway clusters of extracted proteins from primary cortical tissue. Specific energy regulation/metabolism pathway clusters generated in an un-biased manner using Ingenuity Pathway Analysis (v. 8.5). The relative score generated for the degree of pathway population by proteins from the respective input sets (control or 3xTgAD) is shown in bold. The following are different types of signaling pathways.

E.1. Amino Sugars Metabolism (Enrichment Ratio\*−log  10(*p*)) {#sec11.1}
--------------------------------------------------------------

Control Protein (**0.61425**)FMO3, PDE7A, PDE10A, GM2A, CYB5R1, PDE4A, PDE4B, PDE1A, PDE4D, GFPT2, PDE1C, PDE7B, GALK1, CYB5R3.

3xTgAD Protein (**0.0471409**)HK1, CYB5R4, PDE10A, GALK1, CYB5R3, PDE4B.

E.2. Pentose Phosphate Pathway (Enrichment Ratio\*−log  10(*p*)) {#sec11.2}
----------------------------------------------------------------

Control Protein (**0.48608**)GPI, PGD, TKT, TALDO1, PRPSAP1, PGM1, PRPSAP2, PFKP, PFKL, PDHB, PFKM.

3xTgAD Protein (**0.0245154**)GPI, TKT, PRPSAP2, PFKL.

E.3. Glutamate Metabolism (Enrichment Ratio\*−log  10(*p*)) {#sec11.3}
-----------------------------------------------------------

Control Protein (**0.31165**)FMO3, GPT, GLUL, GCLC, GLUD1, GOT1, GOT2, GFPT2, EPRS.

3xTgAD Protein (**0**) 

E.4. Pantothenate and CoA Biosynthesis (Enrichment Ratio\*−log  10(*p*)) {#sec11.4}
------------------------------------------------------------------------

Control Protein (**0.34188**)ENPP3, CRMP1, BCAT1, DPYD, DPYSL3, ENPP5, ENPP2.

3xTgAD Protein (**0.0348908**)CRMP1, DPYD, ENPP2.

E.5. Glycolysis/Gluconeogenesis (Enrichment Ratio\*−log  10(*p*)) {#sec11.5}
-----------------------------------------------------------------

Control Protein (**0.28363**)PKM2, PGK1, ENO3, ENO2, GAPDH (includes EG:2597), PGM1, ALDH1L1, PFKP, PFKL, PDHB, PFKM, GPI, GALK1, DLAT, PGAM1, DLD.

3xTgAD Protein (**0.0610449**)PKM2, HK1, ADH1A, GPI, ALDH1A3, DLAT, GALK1, ENO2, PFKL, ACSL1.

E.6. Citrate Cycle (Enrichment Ratio\*−log  10(*p*)) {#sec11.6}
----------------------------------------------------

Control Protein (**0.1581**)SDHA, PC, CS, SUCLG1, DLD, PCK1.

3xTgAD Protein (**0**) 

E.7. Galactose Metabolism {#sec11.7}
-------------------------

Control Protein (**0.104958**)GLA, GALT, GALK1, GAA, PGM1, PFKP, PFKL, PFKM.

3xTgAD Protein (**0.0486688**)HK1, GLA, GALK1, GAA, PFKL, AKR1B1.

E.8. Glycosphingolipid Biosynthesis---Globoseries (Enrichment Ratio\*−log  10(*p*)) {#sec11.8}
-----------------------------------------------------------------------------------

Control Protein (**0.0411384**)GLA, ST3GAL1, GM2A.

3xTgAD Protein (**0**) 

E.9. Glycosphingolipid Biosynthesis---Ganglioseries (Enrichment Ratio\*−log  10(*p*)) {#sec11.9}
-------------------------------------------------------------------------------------

Control Protein (**0.008832**)ST3GAL1, GM2A.

3xTgAD Protein (**0**) 

E.10. N-Glycan Biosynthesis (Enrichment Ratio\*−log  10(*p*)) {#sec11.10}
-------------------------------------------------------------

Control Protein (**0**) 

3xTgAD Protein (**0.015272**)RPN2, ST6GAL2, MGAT5, MGAT1.

E.11. Pentose and Glucuronate Interconversions (Enrichment Ratio\*−log  10(*p*)) {#sec11.11}
--------------------------------------------------------------------------------

Control Protein (**0**) 

3xTgAD Protein (**0.0184464**)UCHL1, B3GAT1, HPSE, DCXR, AKR1B1.

E.12. Fatty Acid Elongation in Mitochondria (Enrichment Ratio\*−log  10(*p*)) {#sec11.12}
-----------------------------------------------------------------------------

Control Protein (**0**) 

3xTgAD Protein (**0.0206016**)ECHS1, PECR.

E.13. Glycerophospholipid Metabolism (Enrichment Ratio\*−log  10(*p*)) {#sec11.13}
----------------------------------------------------------------------

Control Protein (**0.0232106**)GPAM, PCYT1B, PLD3, CDS1, PDIA3, GNPAT, DGKB, DGKG, PLCB1, PLCL1.

3xTgAD Protein (**0.048204**)AGPAT4, CDS1, GNPAT, CHKA, AGPAT1, DGKG, PLA2G2A, CLCF1, PHKA1, PLCD4, PRDX6.

E.14. Fatty Acid Biosynthesis (Enrichment Ratio\*−log  10(*p*)) {#sec11.14}
---------------------------------------------------------------

Control Protein (**0**) 

3xTgAD Protein (**0.0329256**)ACACB, ACACA.

E.15. Purine Metabolism (Enrichment Ratio\*−log  10(*p*)) {#sec11.15}
---------------------------------------------------------

Control Protein (**0.08616**)ENTPD8, PDE7A, PDE4A, DNTT, PDE1A, PDE4D, PSMC5, PDE7B, VCP, DHX16, ENPP2, PRPSAP2, PKM2, TJP2, GUCY1B2, GUCY1A3, GUCY2D, PDE10A, ENPP5, PDE4B, PDE1C, ENPP3, PSMC1, ENTPD2, PRPSAP1, GUCY1A2, PDE5A, DDX1, GMPR2, PSMC3.

3xTgAD Protein (**0.124932**)MYH6, ENTPD8, NME2, DNTT, WRNIP1, ABCC1, VCP, KATNA1, ATP5H (includes EG:10476), ENPP2, PRPSAP2, ADCY8, ATP5F1, ATP5I, ATP5J, PKM2, ATP1B1, GUCY2D, PDE10A, AMPD1, ATP5A1, AK3, PSMC4, PDE4B, DDX19B, ATP5B, GUCY2F, MYH9, DDX1, NPR2.

E.16. Pyruvate Metabolism (Enrichment Ratio\*−log  10(*p*)) {#sec11.16}
-----------------------------------------------------------

Control Protein (**0.0214935**)PKM2, PC, DLAT, DLD, PCK1, PDHB, GLO1.

3xTgAD Protein (**0.070173**)PKM2, ACACB, ALDH1A3, DLAT, ACAT1, ACACA, MDH1, AKR1B1, ACSL1.

E.17. Butanoate Metabolism (Enrichment Ratio\*−log  10(*p*)) {#sec11.17}
------------------------------------------------------------

Control Protein (**0**) 

3xTgAD Protein (**0.0523452**)ECHS1, ALDH1A3, AACS, ACAT1, MYO5B, DCXR, HMGCS1.

E.18. Synthesis and Degradation of Ketone Bodies (Enrichment Ratio\*−log  10(*p*)) {#sec11.18}
----------------------------------------------------------------------------------

Control Protein (**0**) 

3xTgAD Protein (**0.071505**)ACAT1, HMGCS1.

F. {#sec12}
==

Cellular stress/damage pathway clusters of extracted proteins from primary cortical tissue. Specific energy cellular stress/damage pathway clusters generated in an un-biased manner using Ingenuity Pathway Analysis (v. 8.5). The relative score generated for the degree of pathway population by proteins from the respective input sets (control or 3xTgAD) is shown in bold. The following are different types of signaling pathways.

F.1. NRF2-mediated Oxidative Stress Response (Enrichment Ratio\*−log  10(*p*)) {#sec12.1}
------------------------------------------------------------------------------

Control Protein (**0.44064**)PRDX1, PPIB, GCLC, PRKCZ, GSTM2, SOD2, PIK3CG, VCP, DNAJA2, TXN, FKBP5, PRKD1, CBR1, PRKCA, GSTK1, SOD1, PRKCQ, TXNRD1, GSTO1, FOS, PRKCI, ERP29, STIP1, CAT, PRKCB, EPHX1.

3xTgAD Protein (**0.23751**)USP14, SOD1, PRDX1, ACTB, GSTM3 (includes EG:2947), JUNB, DNAJC5, GSTM2, SOD2, ERP29, STIP1, PIK3C3, PRKCD, ABCC1, VCP, PIK3CB, FOSL1, PIK3R2, TXN, EIF2AK3, ACTA1.

F.2. Ceramide Signaling (Enrichment Ratio\*−log  10(*p*)) {#sec12.2}
---------------------------------------------------------

Control Protein (**0.15748**)CTSD, PPP2CB, FOS, PPP2R1A, PPP2R2A, PIK3CG, PPP2R2B, PPP2R5E, PPP2R1B.

3xTgAD Protein (**0**) 

F.3. Glutathione Metabolism (Enrichment Ratio\*−log  10(*p*)) {#sec12.3}
-------------------------------------------------------------

Control Protein (**0.094285**)OPLAH, PGD, GSTM2, GGT5, GCLC, GGT1, GSTO1, GSTK1, GGT7.

3xTgAD Protein (**0**) 

F.4. LPS/IL-1 Mediated Inhibition of RXR Function (Enrichment Ratio\*−log  10(*p*)) {#sec12.4}
-----------------------------------------------------------------------------------

Control Protein (**0.19071**)SULT1C2, FMO3, CPT1A, CHST7, ALDH1L1, NR1H3, GSTO1, SULT4A1, GSTM2, NR1I2, SREBF1, SULT1A1, CAT, CPT2, FABP4, XPO1, FABP1, FABP7, SULT1E1, FABP3, GSTK1, TLR4, FABP2.

3xTgAD Protein (**0.13872**)PPARA, GSTM3 (includes EG:2947), ABCA1, IL1R2, ABCC2, SLC27A5, GSTM2, ALDH1A3, NR1I2, CPT2, ACSL4, FABP1, IL1B, NR5A2, CHST10, LBP, ABCC4, HMGCS1, ACSL1, MAOA.

F.5. Fatty Acid Elongation in Mitochondria (Enrichment Ratio\*−log  10(*p*)) {#sec12.5}
----------------------------------------------------------------------------

Control Protein (**0**) 

3xTgAD Protein (**0.0206016**)ECHS1, PECR

F.6. Endoplasmic Reticulum Stress Pathway (Enrichment Ratio\*−log  10(*p*)) {#sec12.6}
---------------------------------------------------------------------------

Control Protein (**0**) 

3xTgAD Protein (**0.047841**)EIF2AK3, CASP7.

F.7. Apoptosis Signaling (Enrichment Ratio\*−log  10(*p*)) {#sec12.7}
----------------------------------------------------------

Control Protein (**0**) 

3xTgAD Protein (**0.059156**)ACIN1, ROCK1, CAPN5, CAPN6, CAPN1, BAX, CASP7, PARP1.

F.8. Hypoxia Signaling (Enrichment Ratio\*−log  10(*p*)) {#sec12.8}
--------------------------------------------------------

Control protein (**0**) 

3xTgAD Protein (**0.111983**)VEGFA, P4HB, HSP90AB1, UBE2L3, NOS3, UBC, ARNT, ATM.

F.9. PPAR*α*/RXR*α* Activation (Enrichment Ratio\*−log  10(*p*)) {#sec12.9}
----------------------------------------------------------------

Control Protein (**0.0315615**)PDIA3, PRKAR2A, NR2C2, SHC1, PRKAR2B, TGFB1, FASN, PRKACA, PLCB1, GOT2, PLCL1, PRKCB, PRKCA, PRKAR1A.

3xTgAD Protein (**0.14586**)PPARA, ACVR1, PRKAR2A, CD36, IL6, JAK2, ABCA1, IL1R2, ACADL, HSP90AB1, TGFB1, IRS1, PRKACA, SMAD4, IL1B, ADCY8, PLCD4, PRKAR1A.

G. {#sec13}
==

Receptor signaling pathway clusters of extracted proteins from primary cortical tissue. Specific receptor signaling pathway clusters generated in an un-biased manner using Ingenuity Pathway Analysis (v. 8.5). The relative score generated for the degree of pathway population by proteins from the respective input sets (control or 3xTgAD) is shown in bold. The following are different types of signaling pathways.

G.1. Dopamine Receptor Signaling {#sec13.1}
--------------------------------

Control Protein (**0.65824**)PPP2R2A, PRKAR2A, PPP1R14B, PPP2CB, PPP2R1A, PRKAR2B, PPP1R10, PPP1R14D, PPP1R7, PPP2R2B, PRKACA, FREQ, PPP2R5E, PPP2R1B, PRKAR1A, CALY.

3xTgAD Protein (**0.071199**)PPP2R1A, FREQ, PRKAR2A, PRKACA, ADCY8, CALY, MAOA, PRKAR1A.

G.2. PDGF Signaling {#sec13.2}
-------------------

Control Protein (**0.73892**)SRC, CRKL, CRK, STAT3, FOS, SHC1, PIK3CG, CSNK2A1, PDGFRA, CAV1, CSNK2B, ELK1, STAT1, PRKCB, PRKCA.

3xTgAD Protein (**0.15738**)MYC, JAK1, PIK3C3, STAT3, PIK3R2, JAK2, ELK1, INPP5D.

G.3. EGF Signaling {#sec13.3}
------------------

Control Protein (**0.7956**)SHC1, FOS, PIK3CG, CSNK2A1, EGF, CSNK2B, STAT3, STAT1, ELK1, PRKCA, EGFR.

3xTgAD Protein (**0.22499**)JAK1, PIK3C3, PIK3CB, STAT3, PIK3R2, ELK1, EGFR.

G.4. Neuregulin Signaling {#sec13.4}
-------------------------

Control Protein (**0.68068**)SRC, PRKCQ, CRKL, EGF, CRK, ERBB3, PRKCZ, SHC1, PRKCI, PTPN11, ERBB4, CDKN1B, ELK1, PRKD1, PRKCB, EGFR, PRKCA.

3xTgAD Protein (**0.1276**)MYC, STAT5A, MTOR, PTPN11, HSP90AB1, PRKCD, PIK3R2, CDKN1B, ELK1, EGFR.

G.5. Glutamate Receptor Signaling {#sec13.5}
---------------------------------

Control Protein (**0.53342**)GRM5, GRIN2B, GRIN2A, GRIK4, GRIA1, GRID2, CALM2, GLUL, GRIP1, GRM4, GNG7, GRIK1.

3xTgAD Protein (**0**) 

G.6. Sonic Hedgehog Signaling {#sec13.6}
-----------------------------

Control Protein (**0.73272**)SHH, CCNB1, PRKAR2B, PRKAR2A, PRKACA, SMO, GLI1, PRKAR1A.

3xTgAD Protein (**0.20769**)ADRBK1, PTCH1, PRKAR2A, PRKACA, PRKAR1A.

G.7. TR/RXR Activation {#sec13.7}
----------------------

Control Protein (**0.5481**)UCP2, RCAN2, UCP1, THRA, GRIP1, PFKP, PCK1, KLF9, SREBF1, DIO1, FASN, PIK3CG, STRBP, THRB, FGA, SYT12.

3xTgAD Protein (**0.0321142**)MTOR, PIK3C3, STRBP, ACACA, PIK3CB, PIK3R2, THRB.

G.8. Ephrin Receptor Signaling {#sec13.8}
------------------------------

Control Protein (**0.62472**)GRIN2A, CDC42, EGF, CRK, GNG7, PGF, VEGFA, PTK2, SHC1, PAK1, SDC2, PIK3CG, EFNB1, EPHA7, GRIN2B, SRC, PAK2, CFL1, CRKL, EPHA3, STAT3, WIPF1, SDCBP, PTPN11, PAK3, EPHA5, EPHB3.

3xTgAD Protein (**0.21037**)FYN, PXN, CFL1, CDC42, KALRN, GNB2L1, GNAI1, RAC1, JAK2, STAT3, GNAZ, ROCK1, VEGFA, GNAI2, ROCK2, ABI1, PTPN11, PAK3, RHOA, GNAO1.

G.9. G-Protein Coupled Receptor Signaling {#sec13.9}
-----------------------------------------

Control Protein (**0.3808**)PDE7A, PDE4A, PDE1A, PDE4D, SHC1, SYNGAP1, PDE7B, PIK3CG, PLCB1, PRKCA, SRC, GRK4, EDNRB, PDE10A, PRKAR2A, PDE4B, STAT3, GRM4, PDE1C, CHRM5, GRM5, OPRD1, PRKAR2B, PRKACA, PRKCB, PRKAR1A.

3xTgAD Protein (**0.13938**)FYN, PTK2B, HTR4, ADRBK1, PDE10A, RGS7, PRKAR2A, GNAI1, RGS4, STAT3, PDE4B, GNAI2, HTR2C, PIK3C3, GNAO1, PRKACA, PIK3CB, PIK3R2, ADCY8, PRKAR1A.

G.10. Chemokine Signaling {#sec13.10}
-------------------------

Control Protein (**0.23961**)PTK2, NOX1, SRC, FOS, CCL4, CFL1, PIK3CG, CALM2, PLCB1, PRKCA, PRKCB.

3xTgAD Protein (**0.03232**)ROCK2, GNAI2, CFL1, PTK2B, RHOA, GNAI1.

G.11. Ceramide Signaling {#sec13.11}
------------------------

Control Protein (**0.15748**)CTSD, PPP2CB, FOS, PPP2R1A, PPP2R2A, PIK3CG, PPP2R2B, PPP2R5E, PPP2R1B, PRKCZ.

3xTgAD protein (**0**) 

G.12. FGF (Fibroblast Growth Factor) Signaling {#sec13.12}
----------------------------------------------

Control Protein (**0.17423**)FGFR3, PTPN11, FGF18, CRKL, PIK3CG, FGFR1, FGF23, FGFR2, CRK, STAT3, PRKCA.

3xTgAD Protein (**0.0667352**)PTPN11, PIK3C3, HGF, RAC1, PIK3CB, STAT3, PIK3R2, MAPKAPK2.

G.13. Toll-like Receptor Signaling {#sec13.13}
----------------------------------

Control Protein (**0.1644**)TLR4, FOS, TLR5, TLR6, TLR3, ELK1, TLR9.

3xTgAD Protein (**0.065562**)PPARA, TLR5, MAP3K7IP2, LBP, ELK1.

G.14. Nitric Oxide Signaling {#sec13.14}
----------------------------

Control Protein (**0.41157**)GUCY1B2, GUCY1A3, GUCY2D, CALM2, PRKAR2A, PGF, VEGFA, PRKAR2B, PIK3CG, GUCY1A2, CAV1, PRKACA, PRKAR1A.

3xTgAD Protein (**0.36801**)VEGFA, HSP90AB1, GUCY2D, PRKCD, PIK3C3, GUCY2F, PRKAR2A, PRKACA, PIK3CB, PIK3R2, NOS3, PRKAR1A.

G.15. cAMP-Mediated Signaling {#sec13.15}
-----------------------------

Control Protein (**0.39295**)GRK4, SRC, CNGA4, PDE7A, PDE10A, PRKAR2A, CALM2, PDE4A, PPP3CC, STAT3, PDE4B, GRM4, PDE1A, PDE4D, CNGA1, PDE1C, CHRM5, OPRD1, PRKAR2B, PDE7B, PRKACA, PKIA, PRKAR1A.

3xTgAD Protein (**0.40848**)AKAP12, HTR4, ADRBK1, PDE10A, RGS7, PRKAR2A, GNAI1, RGS4, AKAP3, PPP3CC, STAT3, PDE4B, CNGA1, GNAI2, AKAP4, GNAO1, PRKACA, CNGB1, PKIA, ADCY8, AKAP9, PRKAR1A.

G.16. TGF-*β* Signaling {#sec13.16}
-----------------------

Control protein (**0**) 

3xTgAD Protein (**0.0236421**)TGFB1, ACVR1, SMAD4, HNF4A, UBC, INHBC.

G.17. Neurotrophin/TRK Signaling {#sec13.17}
--------------------------------

Control Protein (**0.016851**)SHC1, FOS, CDC42, PTPN11, PIK3CG.

3xTgAD Protein (**0.0440592**)NTRK2, CDC42, PTPN11, PIK3C3, PIK3CB, PIK3R2.

G.18. IGF-1 Signaling {#sec13.18}
---------------------

Control Protein (**0.49715**)PRKAR2A, PTK2, SHC1, FOS, PRKAR2B, PTPN11, PIK3CG, PRKACA, CSNK2A1, CSNK2B, ELK1, PRKAR1A.

3xTgAD Protein (**0.52722**)PXN, YWHAH, PRKAR2A, NEDD4, YWHAQ, PTPN11, IRS1, PIK3C3, PRKACA, IGF1R, IRS2, PIK3CB, PIK3R2, ELK1, PRKAR1A.

G.19. Serotonin Receptor Signaling {#sec13.19}
----------------------------------

Control protein (**0**) 

3xTgAD Protein (**0.059769**)HTR2C, HTR4, HTR3A, MAOA.

G.20. Glucocorticoid Receptor Signaling {#sec13.20}
---------------------------------------

Control protein (**0**) 

3xTgAD Protein (**0.066**)STAT5A, JAK1, YWHAH, HSPA14, RAC1, IL6, PPP3CC, STAT3, JAK2, NFKB1, MNAT1, IL1R2, HSP90AB1, TGFB1, PIK3C3, CEBPA, PRKACA, SMAD4, IL1B, PIK3CB, PIK3R2, ELK1.

G.21. Aryl Hydrocarbon Receptor Signaling {#sec13.21}
-----------------------------------------

Control Protein (**0.1218**)SRC, CDK6, ALDH1L1, GSTO1, TGM2, CTSD, FOS, GSTM2, TGFB1, FASN, CDKN1B, ESR2, CDK2, FASLG, ATM, GSTK1.

3xTgAD Protein (**0.31125**)CYP1A1, NFIX, GSTM3, IL6, BAX, NFKB1, ARNT, MYC, AHRR, GSTM2, CCND2, HSP90AB1, TGFB1, ALDH1A3, IL1B, CDKN1B, AHR, MCM7, ATM.

G.22. Insulin Receptor Signaling {#sec13.22}
--------------------------------

Control Protein (**0.28288**)TSC1, TRIP10, CRKL, PRKAR2A, CRK, VAMP2, PPP1R14B, PRKCZ, SHC1, PRKCI, PPP1R10, PTPN11, PIK3CG, TSC2, PRKACA.

3xTgAD Protein (**0.5056**)TSC1, FYN, JAK1, PRKAR2A, JAK2, VAMP2, INPP5D, MTOR, PTPN11, IRS1, PIK3C3, PRKACA, EIF2B1, PIK3CB, IRS2, PIK3R2, PRKAR1A.

G.23. Notch Signaling {#sec13.23}
---------------------

Control Protein (**0.0437248**)DLL1, CNTN1, NCSTN, DLL3.

3xTgAD Protein (**0.30609**)NOTCH4, DLL1, NOTCH2, NCSTN, JAG1, NOTCH1, HEY1.

G.24. GABA Receptor Signaling {#sec13.24}
-----------------------------

Control Protein (**0.099214**)GABRG2, UBQLN1, GABBR1, GABARAP, UBC, GABRA3.

3xTgAD Protein (**0.4216**)DNM1, NSF, SLC32A1, UBQLN1, GABBR1, MYO5B, GABRE, UBC, GABRA3.

G.25. VEGF Signaling {#sec13.25}
--------------------

Control Protein (**0.0252652**)VEGFA, PTK2, SHC1, PIK3CG, PGF, PRKCA, PRKCB.

3xTgAD Protein (**0.53464**)EIF2S2, PXN, PTK2B, ACTB, NOS3, ARNT, ROCK2, VEGFA, ROCK1, PIK3C3, EIF2B1, PIK3CB, PIK3R2, ACTN4, ACTA1.

G.26. Integrin Signaling {#sec13.26}
------------------------

Control protein (**0**) 

3xTgAD Protein (**0.54604**)RAP2B, FYN, RALA, CDC42, TSPAN3, ARF6, RHOB, PIK3C3, ARF4, PIK3R2, ACTA1, CAPN5, CAPN6, PXN, ACTB, RALB, RAC1, ITGA6, RHOJ.

H. {#sec14}
==

Heatmap Protein Position KeyThe individual position numbers are correlated to the specific multidimensional proteins represented by colored blocks in [Figure 6](#fig6){ref-type="fig"}. The following are the symbols of the proteins (the numbers between brackets refer to the position).adcyap1: adenylate cyclase activating polypeptide 1 (pituitary)adcyap1r1: adenylate cyclase activating polypeptide 1 (pituitary) receptor type Ihap1: huntingtin-associated protein 1htr4: 5-hydroxytryptamine (serotonin) receptor 4ntrk2: neurotrophic tyrosine kinase, receptor, type 2Kalrn: kalirin, RhoGEF kinaseklc1: kinesin light chain 1adrbk1: adrenergic, beta, receptor kinase 1agrn: agrinapod: apolipoprotein Dapp: amyloid beta (A4) precursor proteinarhgef11: Rho guanine nucleotide exchange factor (GEF) 11arpp19: cAMP-regulated phosphoprotein, 19 kDabace1: beta-site APP-cleaving enzyme 1ccs: copper chaperone for superoxide dismutasechgb: chromogranin B (secretogranin 1)flot1: flotillin 1flot2: flotillin 2gnb2l1: guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1hyou1: hypoxia up-regulated 1lphn1: latrophilin 1lphn2: latrophilin 2magi3: membrane associated guanylate kinase, WW and PDZ domain containing 3nefh: neurofilament, heavy polypeptideprdx6: peroxiredoxin 6pscd2: cytohesin 2rtn3: reticulon 3rtn4r: reticulon 4 receptorslc44a4: solute carrier family 44, member 4stxbp1: syntaxin binding protein 1abca1: ATP-binding cassette, sub-family A (ABC1), member 1abi1: abl-interactor 1adcy1: adenylate cyclase 1 (brain)adcy5: adenylate cyclase 5akap9: A kinase (PRKA) anchor protein 9aldh1a3: aldehyde dehydrogenase 1 family, member A3alox5: arachidonate 5-lipoxygenasearf6: ADP-ribosylation factor 6arhgef12: Rho guanine nucleotide exchange factor (GEF) 12atcay: ataxia, cerebellar, Cayman typeatp2b1: ATPase, Ca++ transporting, plasma membrane 1atxn3: ataxin 3begain: brain-enriched guanylate kinase-associated homolog (rat)cabc1: chaperone, ABC1 activity of bc1 complex homolog (S. pombe)capn1: calpain 1, (mu/l) large subunitcaskin1: CASK interacting protein 1casp7: caspase 7, apoptosis-related cysteine peptidasecd36: CD36 molecule (thrombospondin receptor)cfd: complement factor D (adipsin)clu: clusterincpa2: carboxypeptidase A2 (pancreatic)cript: cysteine-rich PDZ-binding proteindpp6: dipeptidyl-peptidase 6espn: espinfdps: farnesyl diphosphate synthasefilip1: filamin A interacting protein 1gna11: guanine nucleotide binding protein (G protein), alpha 11 (Gq class)gnai2: guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2gnao1: guanine nucleotide binding protein (G protein), alpha activating activity polypeptide Ognaq: guanine nucleotide binding protein (G protein), q polypeptidegnaz: guanine nucleotide binding protein (G protein), alpha z polypeptidegpr56: G protein-coupled receptor 56hip1r: huntingtin interacting protein 1 relatedhmgcr: 3-hydroxy-3-methylglutaryl-Coenzyme A reductasehsf1: heat shock transcription factor 1htr2c: 5-hydroxytryptamine (serotonin) receptor 2Citm2c: integral membrane protein 2Citpr3: inositol 1,4,5-triphosphate receptor, type 3lsamp: limbic system-associated membrane proteinmaoa: monoamine oxidase Amap1lc3a: microtubule-associated protein 1 light chain 3 alphamapkapk2: mitogen-activated protein kinase-activated protein kinase 2mark1: MAP/microtubule affinity-regulating kinase  1mdga2: MAM domain containing glycosylphosphatidylinositol anchor 2mpdz: multiple PDZ domain proteinmpo: myeloperoxidasempp7: membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7)ncam1: neural cell adhesion molecule 1ncam2: neural cell adhesion molecule 2ncdn: neurochondrinndufs1: NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75 kDa (NADH-coenzyme Q reductase)ndufs7: NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20 kDa (NADH-coenzyme Q reductase)nes: nestinnlgn2: neuroligin 2nlgn3: neuroligin 3npc2: Niemann-Pick disease, type C2npdc1: neural proliferation, differentiation and control, 1npy5r: neuropeptide Y receptor Y5nsf: N-ethylmaleimide-sensitive factorpadi2: peptidyl arginine deiminase, type IIplcb4: phospholipase C, beta 4pxn: paxillinrab5a: RAB5A, member RAS oncogene familyrgs4: regulator of G-protein signaling 4rgs7: regulator of G-protein signaling 7rims1: regulating synaptic membrane exocytosis 1rora: RAR-related orphan receptor Ash3gl1: SH3-domain GRB2-like 1sod2: superoxide dismutase 2, mitochondrialsst: somatostatinvldlr: very low density lipoprotein receptorcamkk1: calcium/calmodulin-dependent protein kinase kinase 1, alphacacna2d2: calcium channel, voltage-dependent, alpha 2/delta subunit 2vcp: valosin-containing proteinstx1a: syntaxin 1A (brain)vgf: VGF nerve growth factor induciblecalb2: calbindin 2prdx1: peroxiredoxin 1stmn2: stathmin-like 2vsnl1: visinin-like 1cdh2: cadherin 2, type 1, N-cadherin (neuronal)dbn1: drebrin 1oxr1: oxidation resistance 1gpsm1: G-protein signaling modulator 1 (AGS3-like, C. elegans)gmfb: glia maturation factor, betacd2ap: CD2-associated proteincenta1: ArfGAP with dual PH domains 1ncstn: nicastrinpak3: p21 protein (Cdc42/Rac)-activated kinase 3sncb: synuclein, betacalb1: calbindin 1cnr1: cannabinoid receptor 1 (brain)disc1: disrupted in schizophrenia 1dlgap2: discs, large (Drosophila) homolog-associated protein 2dlgap4: discs, large (Drosophila) homolog-associated protein 4dtnb: dystrobrevin, betadvl1: dishevelled, dsh homolog 1 (Drosophila)exoc7: exocyst complex component 7gabbr1: gamma-aminobutyric acid (GABA) B receptor, 1panx1: pannexin 1pclo: piccolo (presynaptic cytomatrix protein)phactr3: phosphatase and actin regulator 3picalm: phosphatidylinositol binding clathrin assembly proteinshank1: SH3 and multiple ankyrin repeat domains 1snap91: synaptosomal-associated protein, 91 kDa homolog (mouse)stmn4: stathmin-like 4sod1: superoxide dismutase 1, solublesynj2: synaptojanin 2tub: tubby homolog (mouse)snca: synuclein, alpha (non A4 component of amyloid precursor)park7: Parkinson disease (autosomal recessive, early onset) 7pcsk1n: proprotein convertase subtilisin/kexin type 1 inhibitorpalm: Paralemminvapb: VAMP (vesicle-associated membrane protein)-associated protein B and Ccttn: cortactincacna1a: calcium channel, voltage-dependent, P/Q type, alpha 1A subunitcelsr3: cadherin, EGF LAG seven-pass G-type receptor 3 (flamingo homolog, Drosophila)chl1: cell adhesion molecule with homology to L1CAM (close homolog of L1)chrm5: cholinergic receptor, muscarinic 5cnksr2: connector enhancer of kinase suppressor of Ras 2cnp: 2^\'^,3^\'^-cyclic nucleotide 3^\'^ phosphodiesterasecntfr: ciliary neurotrophic factor receptorcntn1: contactin 1cplx1: complexin 1dag1: dystroglycan 1 (dystrophin-associated glycoprotein 1)dbndd2: dysbindin (dystrobrevin binding protein 1) domain containing 2dbnl: drebrin-likedclk2: doublecortin-like kinase 2dlgap1: discs, large (Drosophila) homolog-associated protein 1dscam: Down syndrome cell adhesion moleculeecel1: endothelin converting enzyme-like 1efnb1: ephrin-B1eml5: echinoderm microtubule associated protein like 5epha3: EPH receptor A3epha5: EPH receptor A5epha7: EPH receptor A7ephb3: EPH receptor B3erbb4: v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)evl: Enah/Vasp-likeexoc5: exocyst complex component 5fzd9: frizzled homolog 9 (Drosophila)GABARAP: GABA(A) receptor-associated proteingabarapl2: GABA(A) receptor-associated protein-like  2gabrr3: gamma-aminobutyric acid (GABA) A receptor, alpha 3gcgr: glucagon receptorgng7: guanine nucleotide binding protein (G protein), gamma 7got1: glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)got2: glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2)gprc6a: G protein-coupled receptor, family C, group 6, member Agria1: glutamate receptor, ionotropic, AMPA 1grid2: glutamate receptor, ionotropic, delta 2grik4: glutamate receptor, ionotropic, kainate 4grin2a: glutamate receptor, ionotropic, N-methyl D-aspartate 2Agrip1: glutamate receptor interacting protein 1gripap1: GRIP1 associated protein 1grk6: G protein-coupled receptor kinase 6opa1: optic atrophy 1 (autosomal dominant)pak1: p21 protein (Cdc42/Rac)-activated kinase 1pak2: p21 protein (Cdc42/Rac)-activated kinase 2pawr: PRKC, apoptosis, WT1, regulatorphactr1: phosphatase and actin regulator 1pip5k1c: phosphatidylinositol-4-phosphate 5-kinase, type I, gammaplcb1: phospholipase C, beta 1 (phosphoinositide-specific)pld3: phospholipase D family, member 3ppfia3: protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3ppid: peptidylprolyl isomerase Dppp2cb: protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoformppp2r2a: protein phosphatase 2 (formerly 2A), regulatory subunit B, alpha isoformprkar2b: protein kinase, cAMP-dependent, regulatory, type II, betaprnp: prion proteinptk2: PTK2 protein tyrosine kinase 2ptn: pleiotrophinryr3: ryanodine receptor 3sdcbp: syndecan binding protein (syntenin)sh3gl3: SH3-domain GRB2-like 3shank2: SH3 and multiple ankyrin repeat domains 2sirt2: sirtuin (silent mating type information regulation 2 homolog) 2 (S. cerevisiae)smu1: smu-1 suppressor of mec-8 and unc-52 homolog (C. elegans)soat1: sterol O-acyltransferase 1sstr2: somatostatin receptor 2ssx2ip: synovial sarcoma, X breakpoint 2 interacting proteinstau1: staufen, RNA binding protein, homolog 1 (Drosophila)stmn3: stathmin-like 3strn: striatin, calmodulin binding proteinsyn1: synapsin Isyngap1: synaptic Ras GTPase activating protein 1 homolog (rat)synj2bp: synaptojanin 2 binding proteinsynpo: synaptopodinsyt11: synaptotagmin XItrap1: TNF receptor-associated protein 1trpc2: transient receptor potential cation channel, subfamily C, member 2 (pseudogene)trpc4: transient receptor potential cation channel, subfamily C, member 4trpc5: transient receptor potential cation channel, subfamily C, member 5wnt7a: wingless-type MMTV integration site family, member 7Atuba1a: tubulin, alpha 1avipr2: vasoactive intestinal peptide receptor 2trak2: trafficking protein, kinesin binding 2snx17: sorting nexin 17psd: pleckstrin and Sec7 domain containingppp2r2b: protein phosphatase 2 (formerly 2A), regulatory subunit B, beta isoformppp1r9b: protein phosphatase 1, regulatory (inhibitor) subunit 9Bgrm5: glutamate receptor, metabotropic 5grk5: G protein-coupled receptor kinase 5grin2b: glutamate receptor, ionotropic, N-methyl D-aspartate 2Bgrik1: glutamate receptor, ionotropic, kainate 1grasp: GRP1 (general receptor for phosphoinositides 1)-associated scaffold proteingipc1: GIPC PDZ domain containing family, member  1dpysl4: dihydropyrimidinase-like 4dpysl3: dihydropyrimidinase-like 3dgkb: diacylglycerol kinase, beta 90 kDaddn: dendrincit: citron (rho-interacting, serine/threonine kinase 21)grm4: glutamate receptor, metabotropic 4ctnnd2: catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein).

I. {#sec15}
==

Receptor-specific protein interaction networks in lipid raft extracts from control animals. IPA-generated receptor-specific protein lists from control lipid raft samples were clustered into coherent functional interaction networks. Focus molecules (**BOLD** in "molecules in network") denote the proteins that are present in the predicted reaction network as well as the experimental input protein set. The following are different types of interaction networks.

\(1\) Control: *cell signaling, nucleic acid metabolism, small molecule biochemistry;*score: 32; focus molecule: 15; molecules in network: ADCY, Akt, Beta-Arrestin, **CD4**, **CHRM5**, **CNTFR**, Creb, **EDNRB**, ERK1/2, **FSHR**, **GABBR1**, **GCGR**, Gpcr, GPR3, GPR12, GPR20, GPR34, GPR65, GPR161, **GRM5**, hCG, Mapk, **OPRD1**, OVGP1, P2RY6, P2RY11, PDGF BB, PI3K, Pkc(s), **PTGER2**, **SFRP4**, **SSTR2**, **THBD**, **UNC5B**, **VIPR2**.

\(2\) Control: *infectious disease, antigen presentation, antimicrobial response;*score: 31; focus molecule: 15; molecules in network: Ap1, **CHRNB3**, **CHRNB4**, **CHRNG**, **CLDN4**, **CNR1**, **CXADR**, G alphai, Ifn, IFN Beta, IFN TYPE 1, IgG, IKK (complex), IL-1R/TLR, IL12 (complex), Il12 (family), Interferon alpha, IRAK, IRF, NFkB (complex), NRG, **OSMR**, P38 MAPK, **SMO**, **TACR1**, Tlr, **TLR3**, **TLR4**, **TLR5**, **TLR6**, **TLR9**, **TSHR**, Ubiquitin.

\(3\) Control: *cellular development tumor morphology, cell death;*score: 18; focus molecule: 10; molecules in network: APOL5, ARR3, ARTN, ASB16, Cadherin (E,N,P,VE), **CELSR2**, **CELSR3**, CTNNB1, CTNN*β*-CDHE/N, **DAG1**, EVX1, **FZD9**, GDNF, **GFRA1**, **GFRA3**, GLTSCR1, **GPRC6A**, GRB2, **GRM4**, HRH4, KCNN1, **OPN1LW**, OPN1SW, PALM2-AKAP2, PHACTR2, PRICKLE3, **PTH2R**, SAG, SEPN1, SHROOM2, SRC.

\(4\) Control: *carbohydrate metabolism;*score: 2; focus molecule: 1; molecules in network: **CLEC4A**, IL13.

\(5\) Control: *cell-to-cell signaling and interaction, nervous system development and function;*score: 2; focus molecule: 1; molecules in network: **PRPH2**, ROM1.

\(6\) Control: *protein synthesis, molecular transport, protein trafficking;*score: 2; focus molecule: 1; molecules in network: **GABRR3**, PRKCZ, SQSTM1.

J. {#sec16}
==

Receptor-specific protein interaction networks in lipid raft extracts from 3xTgAD animals. IPA-generated receptor-specific protein lists from 3xTgAD lipid raft samples were clustered into coherent functional interaction networks. Focus molecules (BOLD in "molecules in network") denote the proteins that are present in the predicted reaction network as well as the experimental input protein set. The following are different types of interaction networks.

\(1\) 3xTgAD: *metabolic disease, endocrine system disorders, cell signaling;*score: 45; focus molecule: 18; molecules in network: **ADCYAP1R1**, Ap1, **CD36**, **CD86**, **CNR1**, Creb, CREB-NFkB, **CXADR**, ERK, ERK1/2, **GABBR1**, **GPR56**, hCG, **HTR4**, **HTR2C**, **IGF1R**, **IGF2R**, IgG, IL12 (complex), **IL1R2**, Insulin, Jnk, LDL, **LIFR**, **LRPAP1**, Mapk, MIP1, NFkB (complex), **NPR2**, OVGP1, P38 MAPK, Pkc(s), **TLR5**, **TNFRSF14**, **TSHR**.

\(2\) 3xTgAD: *cell signaling, nucleic acid metabolism, small molecule biochemistry;*score: 13; focus molecule: 7; molecules in network: AATK, ABR, AKR1A1, BPI, CACNG5, CRYM, cyclic AMP, CYP26B1, DHRS3, DLG4, GH1, Histone h3, HSD17B11, KCTD11, KIF3C, LAP3, **LPHN1**, **LPHN2**, **OPN1LW**, OPN1SW, P2RY11, **PTCH1**, **PTH2R**, RLN3, RN5S, **ROBO1**, ROS1, **RXFP1**, RXFP2, SERPINB8, TMEM49, TNF, USP3.

\(3\) 3xTgAD: *cell signaling, cellular function and maintenance, molecular transport;*score: 2; focus molecule: 1; molecules in network: CFTR, FREQ, **IL1RAPL1**, MYD88.

\(4\) 3xTgAD: *cell-to-cell signaling and interaction, cellular function and maintenance, cellular movement;*score: 2; focus molecule: 1; molecules in network: **GPR1**, PAX3, PRDM5.

\(5\) 3xTgAD: *behavior, digestive system development and function, cell morphology;*score: 2; focus molecule: 1; molecules in network: NPY, **NPY5R**, PPY, PYY, SSB.

\(6\) 3xTgAD: *cancer, reproductive system disease, gene expression;*score: 2; focus molecule: 1; molecules in network: FOS, MIR103-1, MIR103-2, MIR107, MIRLET7G, MYC, **OMG**, RHOA, RTN4R.

![Morris Water Maze testing of control and 3xTgAD mice. (a) Distance travelled (cm) in the nonvisible probe target results for control (*n* = 10, blue bars) and 3xTgAD mice (*n* = 10, red bars) for 8 days of training. (b) Water maze escape latency (s) for days 1 to 8 of training in the nonvisible probe target. (c) Swim speed (cm/s) assessment of control and 3xTgAD animals during days 1--8 of training. \**P* \< .05; \*\**P* \< .01.](IJAD2010-604792.001){#fig1}

![Quantification of detergent-resistant lipid rafts. (a) The pictorial panel depicts an image of iodixanol-separated detergent resistant membrane fractions (centered on red arrow), captured using a Nikon 3200 digital camera. The line diagram indicates the direction of collection of centrifugal fractions 1--10, and the associated Western blot for flotillin-1 demonstrates its enrichment in the raft fractions. (b) Captured Joint Photographic Expert Group (JPG) images were converted to a Tagged Image File Format (TIFF) version and imported to Image Gauge (v4.2) software and the specific area of interest (red box), that is, the detergent-resistant, flotillin-1-rich lipid raft band was quantified into absorbance units minus background absorbance per square pixel area ((AU-B)/px^2^) values. (c) Representative set of male 8-month-old control (1) and 3xTgAD (2) mice detergent-resistant membranes isolated from plasma membrane fractions separated using an Iodixanol gradient. The associated histogram depicts mean [±]{.ul} s.e. (standard error) mean detergent-resistant membrane intensity ((AU-B)/px^2^) from at least three separate control and 3xTgAD mice (*P* = .033, nonpaired, two-tailed *t*-test). (d) Representative set of male 16-month-old control (1) and 3xTgAD (2) mice detergent resistant membranes isolated from plasma membrane fractions separated using an Iodixanol gradient. The associated histogram depicts mean [±]{.ul} s.e. (standard error) mean detergent resistant membrane intensity ((AU-B)/px^2^) from at least three separate C57-BL6 and 3xTgAD mice (*P* = .0224, non-paired, two-tailed *t*-test). (e) Representative flotillin-1 Western blot for the lipid raft fraction series for 3xTgAD (red outline) or control (C57-BL6: blue outline) mice. The associated histogram depicts mean [±]{.ul} s.e. (standard error) mean fraction 2 flotillin expression intensity ((AU-B)/px^2^) from at least three separate C57-BL6 and 3xTgAD mice (*P* = .015, non-paired, two-tailed *t*-test).](IJAD2010-604792.002){#fig2}

![Differential protein expression in control versus 3xTgAD lipid raft extracts. (a) Proportionately drawn Venn diagram analysis of reliably identified proteins from control lipid rafts (blue line) and 3xTgAD rafts (red line). (b) Total protein loading control for centrifugal fraction 2. A total of 50 mg of fraction 2 protein was loaded and stained with SYPRO Ruby and scanned using a phosphorimager. (c)--(n). Representative western blots from multiple expression analysis experiments for differential presentation of proteins in fraction 2 extracts from control (blue) or 3xTgAD mice (red). Associated with each panel (c)--(n) the associated histograms represent the mean ± s.e. mean of protein expression intensity (measured in ((AU-B)/px~2~)) from at least three separate experiments. \**P* \< .05; \*\**P* \< .01; \*\*\**P* \< .001. Protein abbreviations are as follows. FAK: focal adhesion kinase; Pyk2: proline-rich tyrosine kinase 2; GIT-1: GRK interactor-1; Jak2: Janus kinase 2; Crk: v-Crk avian sarcoma virus CT10 oncogene homolog; Fyn: Fyn tyrosine kinase; IRS-1: insulin receptor substrate-1; casp 7: caspase 7; mTOR: mammalian target of rapamycin; Grin2: G protein-regulated inducer of neurite outgrowth 2; IGF-1R: insulin-like growth factor-1 receptor.](IJAD2010-604792.003){#fig3}

![Functional pathway informatic clustering of control and 3xTgAD lipid raft proteins. (a) Subtractive representation of hybrid score generation after clustering of lipid raft proteins from control and 3xTgAD animal rafts into cellular signaling pathways. The hybrid scores were generated by multiplication of the protein enrichment ratio of the specific pathway with the negative log~10~ (−log~10~) of the probability of that enrichment (see [Section 2](#sec2){ref-type="sec"}). The data is presented as a numerical value of the control pathway hybrid score subtracted from the 3xTgAD pathway hybrid score. Pathways in which the score in 3xTgAD was greater than the control are denoted in red; pathways in which the control hybrid score is greater than the 3xTgAD hybrid score are denoted in blue. A similar depiction format is employed for differential analysis of control versus 3xTgAD Neuronal Function pathways (b), Energy Regulation/Metabolism pathways (c), and Stress Response pathways (d).](IJAD2010-604792.004){#fig4}

![Functional receptor signaling pathway informatic clustering of control and 3xTgAD lipid raft proteins. Subtractive representation of hybrid score generation after clustering of raft proteins from control and 3xTgAD animal rafts into receptor signaling pathways. The data is presented as a numerical value of the control pathway hybrid score subtracted from the 3xTgAD pathway hybrid score. Pathways in which the score in 3xTgAD was greater than the control are denoted in red; pathways in which the control hybrid score was greater than the 3xTgAD hybrid score are denoted in blue.](IJAD2010-604792.005){#fig5}

![Multidimensional protein latent semantic indexing (LSI) analysis of proteins extracted from control and 3xTgAD lipid rafts. Proteins from the control or 3xTgAD extracted datasets that possessed an explicit latent semantic indexing (LSI, GeneIndexer, Computable Genomix) score in at least two of the multiple GeneIndexer interrogation terms (Alzheimer\'s, oxidation, neurodegeneration, synaptic transmission, neurogenesis, scaffolding, and GPCR) are represented in a heatmap format. Proteins are identified on the left side of the heatmap as an individual number (see [Appendix H](#sec14){ref-type="sec"} for key). The presence of a colored panel (3xTgAD, red: control, blue: 3xTgAD and control: yellow) on the same lateral as the numbered protein denotes explicit textual correlation of that protein with the specific vertical interrogation term.](IJAD2010-604792.006){#fig6}

![Receptor-restricted control and 3xTgAD network interaction analysis. (a) Proportionally drawn Venn diagram depicting the relative distribution between control or 3xTgAD raft samples of receptor-specific proteins filtered using IPA version 8.5 (control filtered protein list, [Table 1](#tab1){ref-type="table"}; 3xTgAD filtered protein list, [Table 2](#tab2){ref-type="table"}). (b) The highest scoring protein interaction network generated from IPA Network analysis (network scores and focus molecules are listed in [Appendix I](#sec15){ref-type="sec"}) of the receptor-specific control dataset. (c) The highest scoring protein interaction network generated from IPA Network analysis (network scores and focus molecules are listed in [Appendix I](#sec15){ref-type="sec"}) of the receptor-specific 3xTgAD dataset ([Appendix J](#sec16){ref-type="sec"}). A full description of the nature of interactions based on the connecting lines can be found at the following webpage linked to the IPA analysis module ([https://analysis.ingenuity.com/pa/info/help/help.htm\#ipa_help.htm](https://analysis.ingenuity.com/pa/info/help/help.htm)). Dashed lines represent indirect gene interactions while solid lines represent empirically measured direct interactions. The two highest significantly scoring networks (B---control, C---3xTgAD) are based on the highest percentage of the network occupation by specific proteins (focus molecules) from the input receptor-specific datasets.](IJAD2010-604792.007){#fig7}

![Alzheimer\'s disease correlation of control or 3xTgAD receptor-specific lipid raft proteins. (a) The histogram represents the number of receptor-specific raft proteins ([Table 1](#tab1){ref-type="table"}: control, [Table 2](#tab2){ref-type="table"}: 3xTgAD) that demonstrate an explicit LSI correlation to the term "Alzheimer\'s" for control (blue) or 3xTgAD (red) extracts. (b) The histogram depicts the cumulated LSI correlation scores for the Alzheimer\'s-related receptor-specific proteins identified in (a). panels (c) and (d) represent the phylogenetic dendrograms for the receptor-specific raft proteins linked to the interrogation term "Alzheimer\'s" from control (c) or 3xTgAD (d) datasets. The proteins highlighted in red or blue and indicated by an arrow were specifically clustered into the highest scoring protein interaction networks for control ([Figure 7(b)](#fig7){ref-type="fig"}) or 3xTgAD ([Figure 7(c)](#fig7){ref-type="fig"}) samples.](IJAD2010-604792.008){#fig8}

###### 

*Receptor-specific protein list from lipid raft extracts from control animals*. Primary protein lists of extracted lipid raft proteins were filtered for a specific receptor profile using IPA v. 8.5.

  Symbol    Protein definition                                        Location          Protein type
  --------- --------------------------------------------------------- ----------------- ----------------------------
  Cd4       CD4 molecule                                              Plasma membrane   Transmembrane receptor
  Celsr2    Cadherin, EGF LAG seven-pass G-type receptor 2            Plasma membrane   G-protein coupled receptor
  Celsr3    Cadherin, EGF LAG seven-pass G-type receptor 3            Plasma membrane   G-protein coupled receptor
  Chrm5     Cholinergic receptor, muscarinic 5                        Plasma membrane   G-protein coupled receptor
  Chrnb3    Cholinergic receptor, nicotinic, beta 3                   Plasma membrane   Transmembrane receptor
  Chrnb4    Cholinergic receptor, nicotinic, beta 4                   Plasma membrane   Transmembrane receptor
  Chrng     Cholinergic receptor, nicotinic, gamma                    Plasma membrane   Transmembrane receptor
  Cldn4     Claudin 4                                                 Plasma membrane   Transmembrane receptor
  Clecsf6   C-type lectin domain family 4, member A                   Plasma membrane   Transmembrane receptor
  Cnr1      Cannabinoid receptor 1 (brain)                            Plasma membrane   G-protein coupled receptor
  Cntfr     Ciliary neurotrophic factor receptor                      Plasma membrane   Transmembrane receptor
  Cxadr     Coxsackie virus and adenovirus receptor                   Plasma membrane   Transmembrane receptor
  Dag1      Dystroglycan 1 (dystrophin-associated glycoprotein 1)     Plasma membrane   Transmembrane receptor
  Ednrb     Endothelin receptor type B                                Plasma membrane   G-protein coupled receptor
  Fshr      Follicle stimulating hormone receptor                     Plasma membrane   G-protein coupled receptor
  Fzd9      Frizzled homolog 9 (Drosophila)                           Plasma membrane   G-protein coupled receptor
  Gabbr1    Gamma-aminobutyric acid (GABA) B receptor, 1              Plasma membrane   G-protein coupled receptor
  Gabrr3    Gamma-aminobutyric acid (GABA) receptor, rho 3            Plasma membrane   Transmembrane receptor
  Gcgr      Glucagon receptor                                         Plasma membrane   G-protein coupled receptor
  Gfra1     GDNF family receptor alpha 1                              Plasma membrane   Transmembrane receptor
  Gfra3     GDNF family receptor alpha 3                              Plasma membrane   Transmembrane receptor
  Gpr116    G protein-coupled receptor 116                            Plasma membrane   G-protein coupled receptor
  Gpr141    G protein-coupled receptor 141                            Plasma membrane   G-protein coupled receptor
  Gprc6a    G protein-coupled receptor, family C, group 6, member A   Plasma membrane   G-protein coupled receptor
  Grm4      Glutamate receptor, metabotropic 4                        Plasma membrane   G-protein coupled receptor
  Grm5      Glutamate receptor, metabotropic 5                        Plasma membrane   G-protein coupled receptor
  Cbp       Opsin 1 (cone pigments), long-wave-sensitive              Plasma membrane   G-protein coupled receptor
  Oprd1     Opioid receptor, delta 1                                  Plasma membrane   G-protein coupled receptor
  Osmr      Oncostatin M receptor                                     Plasma membrane   Transmembrane receptor
  Prom2     Prominin 2                                                Plasma membrane   Transmembrane receptor
  Prph2     Peripherin 2 (retinal degeneration, slow)                 Plasma membrane   Transmembrane receptor
  Ptger2    Prostaglandin E receptor 2 (subtype EP2), 53kda           Plasma membrane   G-protein coupled receptor
  Pthr2     Parathyroid hormone 2 receptor                            Plasma membrane   G-protein coupled receptor
  Sfrp4     Secreted frizzled-related protein 4                       Plasma membrane   Transmembrane receptor
  Smo       Smoothened homolog (Drosophila)                           Plasma membrane   G-protein coupled receptor
  Sstr2     Somatostatin receptor 2                                   Plasma membrane   G-protein coupled receptor
  Tacr1     Tachykinin receptor 1                                     Plasma membrane   G-protein coupled receptor
  Tas2r41   Taste receptor, type 2, member 41                         Plasma membrane   G-protein coupled receptor
  Thbd      Thrombomodulin                                            Plasma membrane   Transmembrane receptor
  Tlr3      Toll-like receptor 3                                      Plasma membrane   Transmembrane receptor
  Tlr4      Toll-like receptor 4                                      Plasma membrane   Transmembrane receptor
  Tlr5      Toll-like receptor 5                                      Plasma membrane   Transmembrane receptor
  Tlr6      Toll-like receptor 6                                      Plasma membrane   Transmembrane receptor
  Tlr9      Toll-like receptor 9                                      Plasma membrane   Transmembrane receptor
  Tshr      Thyroid stimulating hormone receptor                      Plasma membrane   G-protein coupled receptor
  Unc5b     Unc-5 homolog B (C. Elegans)                              Plasma membrane   Transmembrane receptor
  Vipr2     Vasoactive intestinal peptide receptor 2                  Plasma membrane   G-protein coupled receptor

###### 

*Receptor-specific protein list from lipid raft extracts from 3xTgAD animals*. Primary protein lists of extracted lipid raft proteins were filtered for a specific receptor profile using IPA v. 8.5.

  Symbol      Protein definition                                                       Location          Protein type
  ----------- ------------------------------------------------------------------------ ----------------- ----------------------------
  Adcyap1r1   Adenylate cyclase activating polypeptide 1 (pituitary) receptor type I   Plasma membrane   G-protein coupled receptor
  Cd36        CD36 molecule (thrombospondin receptor)                                  Plasma membrane   Transmembrane receptor
  Cd86        CD86 molecule                                                            Plasma membrane   Transmembrane receptor
  Cnr1        Cannabinoid receptor 1 (brain)                                           Plasma membrane   G-protein coupled receptor
  Cxadr       Coxsackie virus and adenovirus receptor                                  Plasma membrane   Transmembrane receptor
  Gabbr1      Gamma-aminobutyric acid (GABA) B receptor, 1                             Plasma membrane   G-protein coupled receptor
  Gpr1        G protein-coupled receptor 1                                             Plasma membrane   G-protein coupled receptor
  Gpr141      G protein-coupled receptor 141                                           Plasma membrane   G-protein coupled receptor
  Gpr56       G protein-coupled receptor 56                                            Plasma membrane   G-protein coupled receptor
  Htr2c       5-hydroxytryptamine (serotonin) receptor 2C                              Plasma membrane   G-protein coupled receptor
  Htr4        5-hydroxytryptamine (serotonin) receptor 4                               Plasma membrane   G-protein coupled receptor
  Igf1r       Insulin-like growth factor 1 receptor                                    Plasma membrane   Transmembrane receptor
  Igf2r       Insulin-like growth factor 2 receptor                                    Plasma membrane   Transmembrane receptor
  Il1r2       Interleukin 1 receptor, type II                                          Plasma membrane   Transmembrane receptor
  Il1rapl1    Interleukin 1 receptor accessory protein-like 1                          Plasma membrane   Transmembrane receptor
  Lifr        Leukemia inhibitory factor receptor alpha                                Plasma membrane   Transmembrane receptor
  Lphn1       Latrophilin 1                                                            Plasma membrane   G-protein coupled receptor
  Lphn2       Latrophilin 2                                                            Plasma membrane   G-protein coupled receptor
  Lrpap1      Low density lipoprotein receptor-related protein associated protein 1    Plasma membrane   Transmembrane receptor
  Npr2        Natriuretic peptide receptor B/guanylate cyclase B                       Plasma membrane   G-protein coupled receptor
  Npy5r       Neuropeptide Y receptor Y5                                               Plasma membrane   G-protein coupled receptor
  Omg         Oligodendrocyte myelin glycoprotein                                      Plasma membrane   G-protein coupled receptor
  Cbp         Opsin 1 (cone pigments), long-wave-sensitive                             Plasma membrane   G-protein coupled receptor
  Ptch1       Patched homolog 1 (Drosophila)                                           Plasma membrane   Transmembrane receptor
  Pthr2       Parathyroid hormone 2 receptor                                           Plasma membrane   G-protein coupled receptor
  Robo1       Roundabout, axon guidance receptor, homolog 1 (Drosophila)               Plasma membrane   Transmembrane receptor
  Lgr7        Relaxin/insulin-like family peptide receptor 1                           Plasma membrane   G-protein coupled receptor
  Tlr5        Toll-like receptor 5                                                     Plasma membrane   Transmembrane receptor
  Tnfrsf14    Tumor necrosis factor receptor superfamily, member 14                    Plasma membrane   Transmembrane receptor
  Tshr        Thyroid stimulating hormone receptor                                     Plasma membrane   G-protein coupled receptor

[^1]: Academic Editor: Gemma Casadesus
